СРЕДСТВО ХРОНОБИОЛОГИЧЕСКОЙ КОРРЕКЦИИ (ВАРИАНТЫ) И СПОСОБ ХРОНОБИОЛОГИЧЕСКОЙ КОРРЕКЦИИ

Изобретение относится к медицине и может быть использовано для коррекции десинхроноза функций различных органов и систем организма человека, вызванного профессиональными и техногенными факторами. Предложены варианты средства хронобиологической коррекции с учетом органотропности проявления десинхроноза. Все варианты заявляемого средства хронобиологической коррекции состоят из двух комплексов. Утренний комплекс включает растительные компоненты мягкого тонизирующего и биостимулирующего действия и комплекс растительных адаптогенов, вечерний комплекс включает растительные компоненты мягкого успокаивающего и седативного действия и стимулирующие восстановление клеточных ресурсов. Кроме того, утренний и вечерний комплексы включают витамины, минеральные вещества, антиоксиданты и специфические биологически активные вещества, направленные на коррекцию специфических органных или системных нарушений, развивающихся вследствие хронического десинхроноза. Предложен способ хронобиологической коррекции с ...

ФИТОКОМПЛЕКС ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ОНКОЛОГИЧЕСКИХ БОЛЬНЫХ И СПОСОБ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ОНКОЛОГИЧЕСКИХ БОЛЬНЫХ

Изобретение относится к медицине, а конкретно к созданию средств для лечения онкологических больных. Фитокомплекс для профилактики и лечения онкологических больных представляет собой настой лекарственных растений, полученный на отваре также лекарственных растений. Для отвара берут в заданных соотношениях зверобой продырявленный, листья земляники лесной, цветки клевера лугового, татарник колючий или зверобой продырявленный, хвощ полевой, девясил высокий, листья кипрея узколистного, цветки клевера лугового. Для настоя в соответствии со сбором лекарственных растений, взятых для отвара, берут в заданных соотношениях соцветия пижмы обыкновенной, донник лекарственный, полынь обыкновенную, пустырник пятилопастный, цветки ноготков лекарственных, мяту полевую, чистотел большой, душицу обыкновенную, багульник болотный, мать-и-мачеху, березу повислую, крапиву двудомную или цветки ноготков, пустырник пятилопастный, мелиссу лекарственную, боярышник кроваво-красный, тысячелистник обыкновенный, ромашку ...

СРЕДСТВО ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ОПОРНО-ДВИГАТЕЛЬНОГО АППАРАТА

Изобретение относится к фармацевтической промышленности, а именно к средству для профилактики и лечения заболеваний опорно-двигательного аппарата. Средство для профилактики и лечения заболеваний опорно-двигательного аппарата, содержащее змеиный яд, хитозан и воду при определенном соотношении компонентов. Вышеописанное средство обладает повышенной эффективностью, для снятия мышечного напряжения и ускорения восстановления после тяжелых физических нагрузок, травм и растяжений. 7 з.п. ф-лы, 1 табл., 1 пр.

НОВЫЕ ЛЕКАРСТВЕННЫЕ ФОРМЫ ЗАМЕЩЕННЫХ БЕНЗИМИДАЗОЛОВ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ

Описаны твердые фармацевтические композиции для лечения желудочно-кишечных нарушений. Композиция содержит в качестве ингибитора протонного насоса омепразол, по меньшей мере часть которого не покрыта энтеросолюбильной оболочкой, и бикарбонат натрия как буферизующий агент. Композиция выполнена в форме жевательной таблетки. Согласно второму варианту композиция содержит омепразол, по меньшей мере часть которого не покрыта энтеросолюбильной оболочкой, бикарбонат натрия как буферизующий агент, и по меньшей мере, один дезинтегрант и/или смазку. При оральном введении пациенту указанных фармацевтических композиций терапевтически эффективное количество омепразола напрямую всасывается через желудок пациента для немедленного и эффективного лечения нарушений, связанных с желудочной кислотой. Новые лекарственные формы омепразола удобны для приготовления и обеспечивают его быстрое всасывание, а также делают доступным препарат омепразол для определенной категории больных, неспособных проглатывать твердые ...

СПОСОБ ПРЕДУПРЕЖДЕНИЯ РЕЦИДИВОВ МНОЖЕСТВЕННЫХ ПАПИЛЛОМ КОЖИ

Изобретение относится к медицине, а именно к дерматологии, и может быть использовано для лечения папиллом кожи. Для этого вводят иммуномодулятор: полиоксидоний или иммунофан, при этом после удаления папиллом больным с сопутствующими заболеваниями желудочно-кишечного тракта и числом папиллом до 50 вводят полиоксидоний по схеме: по одной свече 5 дней подряд и одной свече через день числом 5, а пациентам с большей распространенностью процесса и с хроническим тонзиллитом - иммунофан по схеме: по1 мл числом 5 подкожно через день, далее 1 раз дважды в неделю числом 5, затем 1 раз в неделю числом 5; и после основного курса лечения иммуномодуляторами вводят настой иммуностимулирующего сбора трав следующего состава: кора крушины 60,0; листья мяты перечной 20,0; корень одуванчика 20,0; плоды фенхеля и петрушки по 20,0, при этом две столовые ложки смеси заливают двумя стаканами кипятка, кипятят 5 минут, настаивают 1 час и принимают по два стакана утром натощак в течение 20 дней, а также вводят «Аевит ...

СПОСОБ ЛЕЧЕНИЯ ПРОСТАТИТА

Изобретение относится к медицине, а именно к физиотерапии. Животным с моделью простатита вводят минеральную воду “Ессентуки №17” один раз в день в течение 23-24 дней и проводят курс ингаляций эфирных масел с помощью фитоаэроионизатора ежедневно в течение 5-6 минут, на курс 12-14 процедур. Используют эфирные масла шалфея, лаванды и мяты в соотношении 1:1:1. Способ позволяет нормализовать липидный и углеводный обмен веществ, снизить содержание в крови пролактина и эстрадиола. 2 табл.

Лекарственный сбор с тонизирующим и адаптогенным действием

Изобретение относится к фармацевтической промышленности, а именно к лекарственному сбору с тонизирующим и адаптогенным действием. Лекарственный сбор с тонизирующим и адаптогенным действием, включающий плоды грецкого ореха, листья мяты перечной, плоды лимонника китайского и корневища с корнями левзеи сафлоровидной, в определенном соотношении компонентов. Вышеописанный сбор обладает выраженным тонизирующим и адаптогенным действием. 3 пр.

АРОМАТИЧЕСКАЯ СМЕСЬ ДЛЯ МАСКИРОВКИ НЕПРИЯТНОГО ВКУСА СОЕДИНЕНИЙ ЦИНКА

Изобретение относится к ароматизации косметических, пищевых и фармацевтических продуктов. Композиция для маскировки нежелательного вкуса ионизируемого соединения цинка содержит ароматическое масло, лауриловый спирт, соответствующий носитель, компоненты берут в определенном количественном содержании. Композиция обеспечивает эффективную маскировку неприятного вкуса или остаточного привкуса цинка в различных продуктах. 3 с. и 12 з.п.ф-лы, 2 табл.

ДОКТОРСКИЙ БАЛЬЗАМ "ЗДОРОВЬЯ ДЛЯ"

Изобретение относиться к лечебно-профилактическим бальзамам и может быть использовано для профилактики болезней нервной системы, органов кровообращения, дыхания, пищеварения, опорно-двигательного аппарата, обмена веществ, мочевыводящей и половой систем и кожи. Докторский бальзам "Здоровья для" содержит водные и водно-спиртовые экстракты из семян, плодов, листьев и корней применяющихся для пищевых целей лекарственных растений: листья перечной мяты, семена тмина, плоды шиповника коричного, плоды рябины обыкновенной, листья черной смородины, семена калины, корни пырея, и дополнительно следующих растений: корни лопуха, корни пастернака посевного, корни дягиля, корни цикория, гвоздику, корицу, семена укропа, семена кориандра, семена расторопши, семена арбуза, цветы боярышника красного, цветы граната, плоды черноплодной рябины, чернослив, абрикос сушеный (курага), плоды боярышника красного, плоды боярышника черного, плоды шиповника собачьего, плоды барбариса, плоды каштана сладкого, арбузные ...

СБОР ЛЕКАРСТВЕННЫХ РАСТЕНИЙ ГИПОТЕНЗИВНОГО ДЕЙСТВИЯ

Изобретение относится к химико-фармацевтической промышленности, а именно к сбору лекарственных растений гипотензивного действия, который включает плоды боярышника однопестичного, плоды рябины черноплодной, траву пустырника пятилопастного, траву хвоща полевого, траву чабреца, траву омелы белой, траву мяты перечной и траву мелиссы лекарственной, взятых в определенном соотношении. Заявленный сбор лекарственных растений гипотензивного действия обладает повышенной фармакологической активностью при лечении гипертонической болезни. 3 пр.

ТВЕРДАЯ ЛЕКАРСТВЕННАЯ ФОРМА ПРЕПАРАТА СЕДАТИВНОГО И СНОТВОРНОГО ДЕЙСТВИЯ

Изобретение относится к твердой лекарственной форме седативного и снотворного действия. Указанная лекарственная форма представляет собой таблетку или капсулу, которая содержит гидроксизин в количестве от 3,33 до 4,5 мас.%, этиловый эфир α-бромизовалериановой кислоты в количестве от 5,47 до 7 мас.%, масло мяты или его смесь с маслом хмеля в количестве от 0,39 до 0,48 мас.%, β-циклодекстрин в количестве от 37 до 50 мас.% и вспомогательные вещества, включая связанную воду. Изобретение характеризуется повышенной седативной и снотворной эффективностью по сравнению с известными аналогами, что обеспечивает большую продолжительность сна и более быстрое его наступление. 2 з.п. ф-лы, 3 табл., 3 пр.

ВДЫХАЕМЫЕ СОСТАВЫ НА ОСНОВЕ НИКОТИНА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ

Группа изобретений относится к сухому порошкообразному составу для вдыхания для имитирования эффектов курения. Сухой порошкообразный состав на основе никотина, содержащий частицы, где частицы содержат: соль никотина, по меньшей мере один сахар, и по меньшей мере одну аминокислоту, выбранную из группы, состоящей из глицина, лизина, лейцина и их комбинации, где частицы имеют размер от 1 до 7 микрон, где концентрация никотина составляет от 0,5% до 10% по весу, и концентрация по меньшей мере одного сахара составляет от 50% до 99% по весу, и где состав является подходящим для вдыхания для имитирования эффектов курения. Сухой порошкообразный состав на основе никотина, состоящий из частиц, содержащих никотин, по меньшей мере один сахар, ментол и по меньшей мере одну аминокислоту, выбранную из группы, состоящей из глицина, лизина и лейцина, где частицы имеют размер от 1 до 7 микрон, где концентрация никотина составляет от 0,5% до 10% по весу, и концентрация по меньшей мере одного сахара составляет ...

БИОЛОГИЧЕСКИ АКТИВНАЯ ДОБАВКА К ПИЩЕ "КОРРИДА" ДЛЯ ОТВЫКАНИЯ ОТ КУРЕНИЯ

Изобретение относится к медицине, и может быть использовано в виде добавки к пище для отвыкания от курения. Предложенная добавка представляет собой смесь растительных порошков и вспомогательных ингредиентов, необходимых для получения таблетируемой формы. В результате приема данной добавки происходит очищение организма от накапливаемых вредных веществ при табакокурении. 1 з.п.ф-лы.

СОСТАВ, ОБЛАДАЮЩИЙ СЕДАТИВНЫМ ДЕЙСТВИЕМ

Изобретение относится к медицине, в частности к созданию составов, обладающих седативным действием. Заявляемый состав содержит хмель (15-25%), пустырник (15-25%), овес (20-30%), боярышник (5-15%), мелиссу или мяту (10-20%), кориандр (3-7%), донник (3-7%). Технический результат, получаемый при осуществлении изобретения, выражается в повышении терапевтического эффекта с одновременным снижением отрицательных побочных явлений, что, в конечном счете, приводит к сокращению сроков лечения больных. 2 табл.

ЛЕДЕНЦЫ ДЛЯ ПРОФИЛАКТИКИ ПОСТОПЕРАЦИОННЫХ ОСЛОЖНЕНИЙ У ДЕТЕЙ ПОСЛЕ УРАНОПЛАСТИКИ

Настоящее изобретение относится к области медицины, а именно к средству для профилактики постоперационных осложнений у детей после уранопластики, выполненное в виде леденцов, содержащих в качестве биологически активных веществ растительный экстракт и эфирное масло мяты перечной, а в качестве карамельной массы сорбит и воду очищенную, где в качестве растительного экстракта содержится густой экстракт полиэкстракта, содержащего полученный перколяцией при соотношении сырье:экстрагент 1:1 экстракт цветков календулы лекарственной, полученный с использованием 70% спирта этилового, и полученный мацерацией при соотношении сырье:экстрагент 1:10 водный экстракт сбора, содержащего цветки ромашки аптечной, листья мяты перечной и корни солодки голой, взятые в равном соотношении, при следующем соотношении исходных компонентов, г: густой экстракт полиэкстракта 5, эфирное масло мяты перечной 0,02, сорбит 100, вода очищенная 15. Настоящее изобретение обеспечивает оптимальные условия для заживления раны и ...

Седативное лекарственное средство в форме таблеток

Изобретение относится к области фармацевтики, в частности к препаратам, применяемым в качестве успокаивающего и сосудорасширяющего средства при функциональных расстройствах сердечно-сосудистой системы, неврозоподобных состояниях, сопровождающихся повышенной раздражительностью, при нарушении засыпания, тахикардии, состоянии возбуждения с выраженными вегетативными проявлениями, а также в качестве спазмолитического средства - при спазмах кишечника. Средство содержит мелиссы лекарственной листьев экстракт, мяты перечной масло, пустырника травы экстракт и вспомогательные вещества. Компоненты используются в заявленных количествах. Использование изобретения обеспечивает уменьшение побочных явлений и противопоказаний за счет исключения бромсодержащего соединения и уменьшения дозировки активных ингредиентов при сохранении терапевтической эффективности. 2 з.п. ф-лы, 2 табл., 10 пр.

АНТИПОХМЕЛЬНЫЕ ТАБЛЕТКИ "ПОХМЕТОН-НОРМА+"

Изобретение относится к области создания биологически активной добавки и может быть использовано в качестве общеукрепляющего антигипоксического средства, способствующего снижению токсического воздействия алкоголя. Биологически активная добавка содержит янтарную кислоту, пиколинат хрома, аскорбиновую кислоту, витамин В6, ментол и глюкозу, а в качестве вспомогательных веществ содержит крахмал, стеарат кальция или магния, взятые в определенном соотношении компонентов. Полученные экспериментальные результаты свидетельствуют о высокой детоксицирующей функции печени и отсутствии побочных явлений. 4 табл.

Фитокомпозиция для гигиены полости рта

Изобретение относится к медицине, а именно к стоматологии, и может быть использовано для ухода за зубами и полостью рта, для гигиены полости рта, в частности, у онкологических больных. Фитокомпозиция для гигиены полости рта у онкологических больных, страдающих сопутствующими заболеваниями зубов и десен и прошедших химио- и лучевую терапию, характеризуется тем, что представляет собой порошок измельченных лекарственных растений: травы мяты перечной, травы череды, травы чистотела, цветов, листьев и стебля эхинацеи, травы тысячелистника, цветов календулы, цветов пижмы, цветов лабазника, корня аира, листа подорожника, взятые в равных соотношениях 1:1, при этом порошок получен методом дробного измельчения до частиц, проходящих сквозь сито 0,5 мм. Фитокомпозиция может быть выполнена в виде разовой дозы порошка массой 3 г. Порошок может применяться в виде водного настоя, который получают при заливании 3 г порошка 200 мл кипятка. Водный настой может применяться в виде порционных кубиков льда. Порошок ...

СПОСОБ ВЫДЕЛЕНИЯ БИОЛОГИЧЕСКИ АКТИВНЫХ ВЕЩЕСТВ ИЗРАСТИТЕЛЬНОГО СЫРЬЯ

Изобретение относится к химико-фармацевтической промышленности и может быть использовано при изготовлении лекарственных препаратов и косметических средств. Проводят замачивание сырья в водном растворе этилового спирта. Осуществляют последующую экстракцию жирорастворимых биологически активных веществ (БАВ) путем обработки сырья маслом в присутствии спирта. Экстракцию жирорастворимых БАВ проводят одновременно с механической дезинтеграцией растительного сырья. Изобретение позволяет повысить выход продукта. 4 з.п. ф-лы.

СПОСОБ ПОЛУЧЕНИЯ МЕДА С ПОВЫШЕННОЙ БИОЛОГИЧЕСКОЙ АКТИВНОСТЬЮ

Предназначенный для людей с заболеваниями печени и желчевыводящих путей, мед получают путем смешивания натурального меда с соком смесей растений. Полученную смесь скармливают пчелам в условиях отсутствия естественного взятка. Выработанный таким образом мед, обогащенный целебными компонентами растений, обладает в сравнении с майским разнотравным методом большей биологической активностью. 4 з.п.ф-лы.

БИОЛОГИЧЕСКИ АКТИВНАЯ ДОБАВКА ДЛЯ БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ И ЛИЦ, ПРЕДРАСПОЛОЖЕННЫХ К ДАННОМУ ЗАБОЛЕВАНИЮ

Изобретение относится к медицине, а именно к созданию средства в виде биологически активной добавки для больных сахарным диабетом и лиц, предрасположенных к данному заболеванию. Добавка содержит природные компоненты растительного происхождения. Добавка м.б. в виде сиропа, желе, мармелада. Предложенное средство исключает какое-либо побочное воздействие на организм в связи с максимально выдержанным составом природного происхождения. 6 з.п. ф-лы, 1 табл.

ДОБАВКА БИОЛОГИЧЕСКИ АКТИВНАЯ ПИЩЕВАЯ "АЛИНА"

Изобретение относится к медицине, в частности к лекарствам для профилактики и лечения заболеваний. Сущность изобретения состоит в том, что добавка состоит из 32%-ный спиртовой настойки лекарственных средств. Прием данной добавки повышает антиоксидантную защиту организма и иммунный статус. 1 табл.

МУЛЬТИАКТИВНЫЙ ЭКСТРАКТ ДЛЯ ВАНН

Изобретение относится к фармацевтической и косметической промышленности, в частности к мультиактивному экстракту для ванн. Мультиактивный экстракт для ванн, содержащий живичный скипидар, масло, водно-спирто-масляно-скипидарный экстракт лекарственных растений, полученный из почек сосны и березы, цветков календулы, ромашки и тысячелистника, травы душицы, зверобоя, чабреца, череды, полыни горькой, чистотела и пустырника, корней одуванчика, валерианы и аира, плодов фенхеля, листьев крапивы, шалфея, подорожника, мяты перечной и эвкалипта, цветков бессмертника и липы, травы золототысячника и сушеницы топяной, плодов боярышника и шиповника, корня родиолы розовой и дягиля, а также чаги, взятых в равном соотношении. Вышеописанный экстракт для ванн позволяет расширить спектр лечебных воздействий на организм, увеличить работоспособность и устойчивость к неблагоприятным воздействиям внешней среды, а также улучшить трофические и обменные процессы в коже. 5 з.п. ф-лы.

СБОР ДЛЯ ЛЕЧЕНИЯ БРОНХИТОВ

Использование: изобретение относится к медицине и касается сбора для лечения бронхитов. Целью изобретения является повышение эффективности лечения. Сущность изобретения заключается в приготовлении сбора из следующих лекарственных растений: сабельник болотный (трава), ноготки лекарственные (цветки), тысячелистник обыкновенный (трава), пижма обыкновенная (цветки), девясил высокий (корни), шалфей лекарственный (листья), буквица лекарственная (трава), донник лекарственный (трава), лапчатка гусиная (трава), тимьян ползучий (трава), фиалка полевая (трава), фиалка трехцветная (трава), лопух большой (листья), чистотел большой (трава), коровяк скипетровидный (цветки, листья), коровяк метельчатый (цветки, листья), кипрей узколистный (листья), кипрей узколистный (цветки), хвощ полевой (трава), череда трехраздельная (трава), будра плющевидная (трава), аир обыкновенный (корни), богульник болотный (трава), вероника лекарственная (трава), береза бородавчатая (листья), душица обыкновенная (трава), марьянник ...

СБОР ЛЕКАРСТВЕННЫХ РАСТЕНИЙ "АННА", ИСПОЛЬЗУЕМЫЙ ПРИ ГОЛОВНЫХ БОЛЯХ

Использование: в медицине, а именно при создании лекарственных средств растительного происхождения. Сущность: предлагаются сборы для лечения головных болей "Анна-1" содержит мяту перечную или котовник и зверобой продырявленный при соотношениия 1 : 1, "Анна-2" - мяту перечную или котовник, зверобой продырявленный или элеутерококк колючий и клевер луговой при соотношении 1 : 1 : 2; "Анна-3" - мяту перечную или котовник, зверобой и элеутерококк, клевер, пижму и крапиву при соотношении 1 : 1 : 2 : 1 : 2. 1 з.п. ф-лы.

СРЕДСТВО ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ОПОРНО-ДВИГАТЕЛЬНОГО АППАРАТА

Изобретение относится к химико-фармацевтической промышленности, а именно к созданию средства для профилактики и лечения заболеваний опорно-двигательного аппарата. Средство для профилактики и лечения заболеваний опорно-двигательного аппарата содержит яд гадюки обыкновенной, камфору, скипидар живичный, спиртовую настойку перца стручкового, масло кедрово-стланиковое, масло мяты перечной, масло эвкалиптовое, тимол, а в качестве водно-эмульсионной основы - комплекс воска эмульсионного, масло касторовое, ланолин, моноглицериды дистиллированные и воду очищенную. Средство обладает высокой терапевтической эффективностью, биологической доступностью и низким процентом противопоказаний.

БАЛЬЗАМ РАЛЬЧЕНКО, ОБЛАДАЮЩИЙ АНТИСЕПТИЧЕСКИМ, ПРОТИВОВОСПАЛИТЕЛЬНЫМ, ОБЕЗБОЛИВАЮЩИМ, ИММУНОСТИМУЛИРУЮЩИМ, КЕРАТОЛИТИЧЕСКИМ И РЕГЕНЕРИРУЮЩИМ ДЕЙСТВИЕМ

Изобретение относится к медицине, а именно к лекарственным средствам на основе природного сырья. Бальзам представляет собой масляный экстракт травы чистотела, мяты перечной, болиголова пятнистого, синюхи голубой, белены, корней акенита джунгарского, молочая Палласа, аира болотного, цветы коровяка и спор страусопера германского, взятые в определенном соотношении. Бальзам Ральченко имеет широкий спектр фармакологического действия при отсутствии противопоказаний.

МАЗЬ ПРОТИВОВОСПАЛИТЕЛЬНОГО, ОБЕЗБОЛИВАЮЩЕГО И РАНОЗАЖИВЛЯЮЩЕГО ДЕЙСТВИЯ (ВАРИАНТЫ)

Изобретение относится к медицине и касается создания лечебных средств, обладающих противовоспалительным обезболивающим и ранозаживляющим действием. Мазь может быть использована для лечения седалищного нерва, инсульта, остеохондроза, ревматоидного артрита, полиартрита, радикулита, подагры, миозита, заболеваний верхних дыхательных путей, дерматита, ожогов, ушибов и угревой сыпи. Мазь 1 содержит, мас.%: пихтовое масло 17; вазелин 23; ланолин остальное. Мазь 2 содержит, мас. %: пихтовое масло 5; камфорное масло 5; багульниковое масло 5; масло корня мандрагоры 5; масло плодов можжевельника 5; мед 5, мумие 5; медвежий жир 10; ланолин остальное. Мазь 3 содержит, мас.%: пихтовое масло 5; гвоздичное масло 0,6; масло корицы 0,6; эвкалиптовое масло 0,6; мятное масло 0,6; масло донника 5; масло алое 5; масло корня мандрагоры 5; масло подорожника 5; мед 5; лосиный жир 5; медвежий жир 5; ланолин остальное. Мазь 4 содержит, мас.%: пихтовое масло 12, масло перца красного 12; мед 24, медвежий жир 4; ланолин ...

СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ХРОНИЧЕСКОГО ГЕПАТИТА НЕИНФЕКЦИОННОЙ ЭТИОЛОГИИ, ОСЛОЖНЕННОГО ХРОНИЧЕСКИМ ПАНКРЕАТИТОМ

Изобретение относится к медицине, а именно к фитотерапии для лечения хронического гепатита неинфекционной этиологии, осложненного хроническим панкреатитом. Сущность изобретения состоит в том, что предложен сбор, состоящий из 19 лекарственных растений, взятых в определенном соотношении. Лечение данным сбором приводит к отсутствию побочных эффектов (токсического воздействия на печень, желчеотделения, аллергических реакций) по сравнению с известными ферментными препаратами и, кроме того, происходит стойкая ремиссия в состоянии больного. 2 табл.

СПОСОБ ПОВЫШЕНИЯ ЭФФЕКТИВНОСТИ ЛУЧЕВОЙ ТЕРАПИИ

Изобретение относится к области медицины, а именно к радиобиологии и может быть использовано при лучевой терапии болезненных злокачественных новообразований у больных раком различных локализаций. Положительный результат изобретения состоит в пролонгировании времени появления и степени выраженности лучевых реакций, повышении радиорезистентности, обеспечение быстрого клинического эффекта в связи с возможностью проведения лучевой терапии без перерыва, а также использование нового средства, обладающего радиопротекторными свойствами и низкой токсичностью. Это достигается тем, что в способе лучевой терапии, включающем нанесение на ткань в зоне облучения лекарственного препарата, в качестве такого препарата используют препараты, содержащие масло "Витаон", которые наносят непосредственно до и после каждого сеанса облучения на протяжении всего курса лучевой терапии, при этом нанесение препарата после сеанса облучения повторяют неоднократно до исчезновения лучевой реакции. 1 з. п. ф-лы.

Фармацевтическая композиция противодиабетического действия в виде саше

Изобретение относится к химико-фармацевтической промышленности, медицине, фармакологии. Композиция противодиабетического действия содержит компоненты в г/саше (мас.%): гликлазид 0,06 (1,6), сухой экстракт травы галеги лекарственной 0,10 (2,6), сухой экстракт корня солодки 0,60 (16,0), сухой экстракт травы мяты перечной 0,30 (8,0), пектин яблочный 2,00 (53,2), гидроксиэтилцеллюлоза 0,50 (13,3), раствор коллидона К-30 в спирте этиловом 0,20 (5,3). Изобретение обеспечивает создание фармацевтической композиции противодиабетического действия комплексного состава, выполненной в виде саше, содержащей гликлазид и смягчающие его побочные действия сухие экстракты галеги лекарственной, корня солодки, мяты перечной. 3 табл., 3 пр.

Фармацевтическая композиция противодиабетического действия в твердой лекарственной форме в виде таблеток

Изобретение относится к химико-фармацевтической промышленности, а именно к производству средств противодиабетического действия. Предложена твердая дозированная лекарственная форма пролонгированного действия, выполненная в виде таблеток, с противодиабетической активностью, содержащая гликлазид и микрокапсулированные сухие экстракты галеги лекарственной, солодки голой и мяты перечной, а также полиэтиленгликоль 6000, при определенном соотношении компонентов. Предложенная лекарственная форма характеризуется пролонгированным высвобождением гликлазида и фармакологически активных веществ, содержащихся в сухих экстрактах, обеспечивает повышение эффективности и безопасности лечения сахарного диабета за счет контролирования скорости высвобождения гликлазида и поддержания равномерной концентрации его в крови, а также сглаживания побочных эффектов растительными компонентами композиции. 3 табл.

ЭЛИКСИР, ОБЛАДАЮЩИЙ СЕДАТИВНЫМ И ОБЩЕУКРЕПЛЯЮЩИМ ДЕЙСТВИЕМ

Изобретение относится к медицине, к созданию спиртосодержащих комплексных препаратов природного происхождения на основе растительного сырья. Эликсир представляет собой спиртоводное извлечение из плодов аниса обыкновенного, боярышника, кориандра, тмина обыкновенного и шиповника, травы кипрея, пустырника, тысячелистника обыкновенного и череды, цветков ноготков и ромашки аптечной; семян сосны кедровой сибирской, листьев мяты перечной и подорожника большого, корней солодки голой, корневищ и корней элеутерококка, шишек хмеля обыкновенного и чаги с добавлением к полученному извлечению меда натурального, эликсирного колера, сахара, спирта этилового 95%-ного и воды до получения 1000 мл целевого продукта при следующем соотношении компонентов, г: Водно-спиртовое извлечение, мл - 250-300 Мед натуральный - 33-35 Эликсир колерный - 30 -35 Сахар - 18-20 Спирт этиловый 95%-ный, мл - 70 Вода очищенная, мл - До 1000 Водно-спиртовое извлечение содержит метоксибензальдегид в количестве 20 мг/л, в готовом ...

ПРЕПАРАТ ДЛЯ ЛЕЧЕНИЯ МАСТИТА У ЛАКТИРУЮЩИХ ЖИВОТНЫХ

Изобретение относится к области сельского хозяйcтва, в частности к ветеринарии. Может быть использовано для профилактики и лечения мастита у лактирующих животных. Препарат представляет собой эмульсию на основе экстракта из биологически активных веществ растительного происхождения. Экстракт готовят из смеси растений: календулы цветов, крапивы двудомной, подорожника большого, душицы обыкновенной, зверобоя продырявленного, чaбреца обыкновенного, липы мелколистной, пустырника сердечного, чистотела большого, тысячелиcтника, березы листа, кориандра семени, брусники листа, кипрея обыкновенного цветов, смородины листа, ромашки аптечной, мяты перечной, взятых в равных частях. Препарат вводят в подогретом виде 2 раза в день в дозе 5-7 мл после доения с помощью шприца и выменного катетера в больную четверть вымени. 1 табл.

СПОСОБ ПРОФИЛАКТИКИ ПОЛЛИНОЗОВ

Изобретение относится к медицине и касается способа профилактики полинозов - аллергических реакций, вызываемых пыльцой цветущих растений, в котором применяют эфирные масла, получаемые из группы растений, внесенных в Государственную фармакопею СССР или используемые как пищевые. Эфирные масла переводят в водную эмульсию при соотношении масло : вода 1 : 1000. Водная эмульсия посредством гидроаэроионизатора механически раздробляется и подается в воздух помещения для отпуска процедур в виде мелкодисперсного электрически заряженного аэрозоля (фитоаэроионов). Сеанс фитоаэроионизации продолжают 25 - 30 мин, отпуская процедуры ежедневно курсом в 25 - 30 раз. В течение года проводят 3 - 4 курса с равными промежутками между ними. При начале аллергических реакций фитоаэроионизация дает выраженное улучшение в 96 - 97% больных, наступающее не позже 3 - 5 сеансов. 2 з. п. ф-лы. 3 табл.

СБОР УРОЛОГИЧЕСКИЙ

Использование: Изобретение относится к химико-фармацевтической промышленности, а именно, к созданию лекарственных сборов. Сущность изобретения: предложен сбор урологический, содержащий лист толокнянки или брусники, плоды укропа огородного, корневище и корни элеутерококка или левзеи сафлоровидной, лист мяты перечной, цветки календулы. Технический результат: применяют настой из сбора в качестве противовоспалительного, мочегонного, антимикробного, спазмолитического и общеукрепляющего средства при острых и хронических заболеваниях почек и мочевыводящих путей.

СБОР N 2 ЛЕКАРСТВЕННЫХ ТРАВ, ОБЛАДАЮЩИЙ ОБЩЕУКРЕПЛЯЮЩИМ ДЕЙСТВИЕМ

Изобретение относится к медицине и касается создания лекарственного сбора из растительного сырья. Сбор содержит крапиву, мяту афганскую, брусничник, золотую розгу, рябину и шикшу. Сбор одновременно обладает тонизирующим, противовоспалительным, действиями желчегонной и мочегонной активностями.

КОМБИНАЦИЯ КОМПОНЕНТОВ ДЛЯ УЛУЧШЕНИЯ ФИЗИЧЕСКИХ ПОКАЗАТЕЛЕЙ У ЛИЦ, ЗАНИМАЮЩИХСЯ ТЯЖЕЛЫМИ ФИЗИЧЕСКИМИ НАГРУЗКАМИ

Изобретение относится к фармацевтической промышленности и представляет собой композицию для поддержания и/или восстановления организма во время и/или после тяжелых физических нагрузок, содержащую L-таурин, L-лейцин, L-изолейцин, L-валин, экстракт листьев зеленого чая, йохимбин гидрохлорид, элеутерококка колючего корневищ и корней экстракт, левзеи сафлоровидной корневищ с корнями экстракт, родиолы розовой корневищ с корнями экстракт, экстракт кожуры горького апельсина, рибофлавина натрия фосфат, холина альфосцерат, пантотенат кальция, пиридоксина гидрохлорид, фолиевую кислоту, цианокобаламин, биотин, никотинамид, L-карнитин, бета-аланин, калия оротат, метилурацил, инозин, кофеин, экстракт листьев, соцветий и корневищ иван-чая, креатина моногидрат, L-тирозин, аскорбиновую кислоту, магний в форме бис-глицината, медь в форме бис-глицината, цинк в форме бис-глицината, L-глутамин, тиамина гидрохлорид, холекальциферол 5000 МЕ, кальция малат, натрия дигидрофосфат, альфа-токоферола ацетат, L-селенметионин ...

СРЕДСТВО "АНТИНИК" ДЛЯ ОБЛЕГЧЕНИЯ ОТВЫКАНИЯ ОТ ТАБАКОКУРЕНИЯ И ЛЕЧЕНИЯ ХРОНИЧЕСКИХ БРОНХОЛЕГОЧНЫХ ЗАБОЛЕВАНИЙ КУРИЛЬЩИКОВ

Изобретение относится к медицине, а именно к созданию лекарственных средств для отвыкания от курения на растительной основе. Предложенное средство включает две композиции сборов лекарственных растений для приема в разное время суток - утром и вечером. Один сбор содержит аир болотный, спорыш, крапиву двудомную, подорожник большой, хвощ полевой, исландский мох, солодку голую, мальву лесную, пикульник ладанниковый, посконник и мачок желтый. Второй сбор содержит синюху голубую, эвкалипт, багульник болотный, золотарник обыкновенный, лаванду, зизифору бунге, тимьян Маршала, дягиль лекарственный, мяту перечную и баранец обыкновенный.

БИОЛОГИЧЕСКИ-АКТИВНАЯ КОМПОЗИЦИЯ "ФИТАОН-2" И СПОСОБ ЕЕ ПОЛУЧЕНИЯ

Использование: лечебно-профилактические разделы медицины - физиотерапия, дерматология, терапия. Сущность изобретения: бальзамическое биологически активное средство содержит экстракты растений - листа мяты перечной, почек сосны обыкновенной, корня солодки, цветков календулы лекарственной, трав тысячелистника обыкновенного, зверобоя обыкновенного, чистотела, чабреца обыкновенного, сушеницы топяной, душицы, плодов черного перца и кориандра в дистиллированной воде; эфирные масла - мятное, кориандровое, анисовое, пихтовое, камфарное - в качестве ароматизирующего компонента, а также глицерин и водный раствор аммиака. Ароматизирующий компонент использован с тонизирующими добавками в количестве не более 0,1% от веса основы. Средство допускает различные комбинации ингредиентов и их содержания. Предложен также способ получения средства. 2 с.п. ф-лы.

СПОСОБ ЛЕЧЕНИЯ СПАСТИЧЕСКОГО ЭНТЕРОКОЛИТА

Изобретение относится к медицине, а именно - к гастроэнтерологии, и может быть использовано при лечении спастического энтероколита. Способ лечения основан на комплексном воздействии на организм больного и заключается в проведении курса рефлекторно-коррегирующей терапии (РКТ) путем механического сдавливающего и разминающего воздействия на корешковые и рефлекторные зоны спины в области нижегрудного отдела позвоночника. Курс РКТ сочетают с курсом упражнений йоги, с курсом дыхательных упражнений, с приемом горячего настоя лекарственных растений. Дополнительно осуществляют прием биостимулирующей смеси на основе сока алоэ и меда, прием сока трав, периодическое промывание желудка и курс упражнений для живота. 5 з.п.ф-лы.

ПРЕПАРАТ ДЛЯ ПРОФИЛАКТИКИ БРОНХОПНЕВМОНИИ ТЕЛЯТ "ЭВКАЗОЛЬ"

Использование: сельское хозяйство, ветеринария, а именно для лечения бронхопневмонии телят. Сущность изобретения заключается в том, что препарат эвказоль содержит пихтовое и мятное или шалфейное масла, твин - 80 и спирт этиловый при определенном соотношении компонентов. Может содержать также хладон 12 или хладон 22. 1 з. п. ф-лы.

ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКОЕ СРЕДСТВО, СПОСОБ И УСТРОЙСТВО ДЛЯ КОРРЕКЦИИ НАРУШЕНИЙ ФУНКЦИОНАЛЬНОГО СОСТОЯНИЯ ОРГАНИЗМА

Изобретение относится к созданию лечебно-профилактического средства, к способу и устройству для коррекции нарушений функционального состояния организма. Лечебно-профилактическое средство для коррекции нарушений функционального состояния организма содержит измельченный минерал шунгит и в качестве сухой измельченной субстанции мяту, ромашку, зверобой, валериану, взятые в весовых частях 1:2,25:2,25:2,25:2,25 соответственно. Способ коррекции нарушений функционального состояния организма путем воздействия на рефлексогенные зоны организма растительным аппликатором, содержащим измельченные мяту, ромашку, зверобой, валериану и измельченный минерал шунгит, в количестве 20-40 г, при этом время воздействия составляет не менее б часов в сутки в течение 15-20 дней. Устройство для коррекции нарушений функционального состояния организма включает заготовку из слоистого материала, которая имеет эластичную тканевую основу и дополнительно содержит вкладыш с лечебно-профилактическим средством, указанным выше ...

ЛЕКАРСТВЕННОЕ СРЕДСТВО СЕДАТИВНОГО ДЕЙСТВИЯ И СПОСОБ ПОЛУЧЕНИЯ ЭФИРНОГО МАСЛА ДУШИЦЫ МЕДИЦИНСКОГО НАЗНАЧЕНИЯ

Изобретение относится к области медицины и касается лекарственных средств седативного действия. Целью изобретения является повышение качества седативных средств. С этой целью лекарственное средство седативного действия включает этиловый эфир альфа-бромизовалериановой кислоты, фенобарбитал, эфирное масло мяты перечной, эфирное масло душицы, полученное реэкстракцией 70%-ным этанолом товарного углекислотного экстракта травы душицы, и 50%-ную спиртоводную смесь при следующем соотношении компонентов (в г на 100 г средства): этиловый эфир альфа-бромизовалериановой кислоты - 2,0, фенобарбитал - 2,0, эфирное масло мяты перечной - 0,14, эфирное масло душицы - 0,02, спирт этиловый 50%-ный - до 100. Способ получения эфирного масла душицы медицинского назначения путем его извлечения из травы душицы, характеризуется тем, что товарный углекислотный экстракт травы душицы реэкстрагируют 70%-ным этанолом и освобождают от взвешенных частиц, получая этанольный раствор эфирного масла душицы. При этом способ ...

СПОСОБ ВЫВЕДЕНИЯ ЖЕЛЧНЫХ КАМНЕЙ ИЗ ЖЕЛЧНОГО ПУЗЫРЯ

Изобретение относится к медицине, в частности к способам удаления желчных камней из желчного пузыря с использованием растительного сырья без оперативного вмешательства. Способ включает прием в терапевтических дозах настоя лекарственных трав, взятых в равных пропорциях по массе, в течение 0,5-2 мес совместно с энтеросорбентом. Травяной сбор содержит цветы бессмертника песчаного, траву душицы обыкновенной, траву зопника, траву крапивы двудомной, цветы календулы лекарственной, корень лапчатки лесной, лист мяты перечной, семена моркови дикой, траву мать-и-мачехи, траву полыни горькой, цветы ромашки аптечной, траву тысячелистника обыкновенного, семена укропа огородного, шишки хмеля, лист шалфея лекарственного, лист трилистника водяного, траву эрвы шерстистой, плоды шиповника и семена кориандра. В случаях застарелой ЖКБ дополнительно проводят очищение желчных путей с использованием растительного масла, при этом до приема его пациент последовательно принимает энтеросорбент и спазмолитик, а после ...

МАЗЬ БЕЛОВА ДЛЯ ЛЕЧЕНИЯ ХИМИЧЕСКИХ, ТЕРМИЧЕСКИХ ОЖОГОВ И ОТМОРОЖЕНИЙ

Изобретение относится к фармации и может быть использовано для лечения химических, термических ожогов и отморожений. Сущность: мазь для лечения термических, химических ожогов и отморожений содержит спиртовые экстракты растительного сырья и растительное масло, при этом соотношение спиртового экстракта растительного сырья и масла 1 : 5 - 7. 2 з.п. ф-лы.

ЛЕКАРСТВЕННЫЙ СБОР ДЛЯ СНЯТИЯ СИНДРОМА ПОХМЕЛЬЯ И ТЯГИ К АЛКОГОЛЮ

Изобретение относится к медицине, а именно к созданию лекарственных средств, и может быть использовано для лечения и профилактики алкоголизма, а также ОРВИ, простудных заболеваний, а также как противолихорадочное, общеукрепляющее, антистрессовое средство. Сбор на основе растительного сырья и содержит компоненты: имбирь, кардамон, мяту, мелиссу, мускат, ферулу, гвоздику, лимонную кислоту, корицу при следующем соотношении, мас.ч.: имбирь 0,2 - 0,7; кардамон 0,1 - 0,6; мята 0,3 - 0,8; мелисса 0,05 - 0,1; мускат 0,6 - 0,9; ферула 0,04 - 0,09; гвоздика 1,5 - 1,8; лимонная кислота 0,1 - 0,5; корица 0,2 - 0,6. Сбор ускоряет метаболизм алкоголя в организме, при длительном приеме снимает усталость, тяжесть, депрессивное состояние, устраняет боли в сердце.

ПРОТИВОВОСПАЛИТЕЛЬНЫЙ ЛЕКАРСТВЕННЫЙ СБОР ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ РАССТРОЙСТВ МОЧЕПОЛОВОЙ СИСТЕМЫ

Изобретение относится к фармакологии, а именно к лекарственным препаратам из растительного сырья, и может быть использовано при лечении урологических заболеваний, осложненных снижением половой функции. Лекарственный сбор содержит листья подорожника, листья мяты перечной, траву полыни горькой, траву тимьяна и плоды шиповника в равных соотношениях. Сбор нормализует половую функцию, улучшает общее самочувствие.

ЖЕЛУДОЧНО-КИШЕЧНЫЙ СБОР "ФИТОВИТ"

Изобретение относится к медицине, а именно к растительным сборам, которые могут быть использованы при лечении заболеваний желудочно-кишечного тракта. Желудочно-кишечный сбор "ФИТОВИТ" включает подорожник большой (лист), мяту перечную (траву), ромашку аптечную (цветки), календулу лекарственную (цветки), тысячелистник обыкновенный (траву), горец птичий (траву), а также аир болотный (корень), бессмертник песчаный (цветки), валериану лекарственную (корни), горец змеиный (корни), душицу обыкновенную (траву), зверобой продырявленный (траву), крапиву двудомную (траву), лен обыкновенный (семя), лимонник китайский (плоды), облепиху крушиновидную (лист), солодку голую (корни), сушеницу топяную (траву), укроп обыкновенный (семя), череду трехраздельную (траву). Желудочно-кишечный сбор может быть применен при острых и хронических заболеваниях желудочно-кишечного тракта, язвенной болезни желудка и 12-перстной кишки, гастритах, колитах, неспецифических язвенных колитах. Кроме того, заявляемый сбор способствует ...

НАБОР АНТИАЛКОГОЛЬНЫХ СРЕДСТВ

Изобретение относится к медицине, а именно к биологически активным добавкам, используемым в наркологии, для купирования и лечения состояния похмелья после острой алкогольной интоксикации, а также для профилактики и лечения алкоголизма. Набор антиалкогольных средств комплексно решает проблему отрицательного влияния алкоголя на организм человека. Набор включает антиалкогольное средство для снятия постинтоксикационного синдрома при острой алкогольной интоксикации и второе антиалкогольное средство для снятия синдрома психоэмоционального напряжения при хроническом алкоголизме. Набор антиалкогольных средств нетоксичен и может быть применен для лечения и профилактики психоэмоционального напряжения или хронического психического стресса. 2 з.п. ф-лы, 1 табл.

СПОСОБ ЛЕЧЕНИЯ ЭРОЗИВНОГО ГАСТРИТА

Изобретение относится к медицине, а именно, к гастроэнтерологии, может быть использовано при лечении эрозивного гастрита. Сущность изобретения: при эрозивном гастрите производят промывание желудка по дуоденальному зонду с использованием лекарственных веществ. При этом, полая олива зонда содержит 16 отверстий диаметром 1 мм, которые расположены равномерно по всей поверхности оливы. Олива дуоденального зонда содержит вогнутую пластинку, занимающую 2/3 просвета оливы и ориентированную вогнутостью к трубке. Затем проводят орошение слизистой желудка при температуре вводимой жидкости 39-40oC под давлением 40 мм вод. ст. ежедневно 7-10 дней. 1 табл.

Фитокомплекс для профилактики развития игровой зависимости (варианты)

Изобретение относится к фармацевтической промышленности, а именно к фитокомлексам для приготовления настоя для профилактики развития игровой зависимости (варианты). Фитокомплекс для приготовления настоя для профилактики развития игровой зависимости, характеризующийся тем, что содержит цветы, лист и стебель кипрея, цветы красного клевера, корень аира, траву пустырника, цветки и листья таволги, траву мяты, лист березы, лист брусники, цветы бессмертника, цветы липы, корень алтея, корень элеутерококка, корень солодки, плоды шиповника, цветы зверобоя при следующем соотношении 5:3:2:2:1:2:2:2:2:2:2:1:2:2:2 соответственно, для возрастной категории от 7 до 14 лет. Фитокомплекс для приготовления настоя для профилактики развития игровой зависимости, характеризующийся тем, что содержит цветы, лист и стебель кипрея, цветы красного клевера, корень аира, траву пустырника, цветки и листья таволги, траву мяты, лист березы, цветы бессмертника, цветы липы, корень алтея, корень элеутерококка, корень левзеи ...

КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ И ПРЕДУПРЕЖДЕНИЯ ОСТЕОАРТРИТА, ОСТЕОПОРОЗА И ОСТЕОАРТРОЗА СУСТАВОВ

Изобретение относится к фармацевтической промышленности, а именно к композиции для улучшения функционального состояния опорно-двигательного аппарата. Композиция для лечения и предупреждения остеоартрита и остеартроза суставов, которая содержит порошок или экстракт высушенного растения, выбранного из группы: лопух, одуванчик, сабельник болотный, береза, зверобой, золотарник, крапива, мята, солодка, лапчатка белая, лапчатка прямостоячая, шиповник, синюха голубая, валериана, кукуруза, расторопша, овес, репешок, бессмертник, женьшень, шалфей, звездчатка, тыква, ива, земляника, цикорий, пырей, топинамбур, черника, календула, хрен, чеснок, осина, горец птичий (спорыш), подорожник, девясил, красностебельная гречиха, цветки ромашки, мелисса, василек синий, сушеница, череда трехраздельная; лиофилизат трутневого расплода и порошок кверцетина, или дигидрокверцетина, или рутина, при определенном соотношении компонентов. Вышеописанная композиция эффективна для лечения и предупреждения остеоартрита и ...

СБОР ЛЕКАРСТВЕННЫХ РАСТЕНИЙ ДЛЯ ПРОФИЛАКТИКИ И КОМПЛЕКСНОГО ЛЕЧЕНИЯ ДИСБАКТЕРИОЗА КИШЕЧНИКА

Изобретение относится к химико-фармацевтической промышленности, а именно к фармации, и касается создания сбора лекарственных растений для профилактики и комплексного лечения дисбактериоза кишечника. Сбор лекарственных растений содержит корневище лапчатки, листья шалфея, траву тысячелистника, траву зверобоя, корневище с корнями девясила, траву череды, листья мяты, плоды фенхеля и кору крушины при соотношении компонентов 2:2:2:2:2:2:2:2:1 соответственно. Использование сбора расширяет арсенал лекарственных средств для профилактики и комплексного лечения дисбактериоза кишечника для санации от условно-патогенной микрофлоры кишечника. 1 табл.

СБОР ЛЕКАРСТВЕННЫХ РАСТЕНИЙ ДЛЯ ЛЕЧЕНИЯ ФУНКЦИОНАЛЬНОГО РАССТРОЙСТВА ЖЕЛЧНОГО ПУЗЫРЯ ПРИ ГИПЕРТОНИЧЕСКИ-ГИПЕРКИНЕТИЧЕСКОМ ТИПЕ ДИСКИНЕЗИИ

Изобретение относится к фармацевтической промышленности. Сбор для лечения функционального расстройства желчного пузыря при гипертонически-гиперкинетическом типе дискинезии, содержащий листья мяты перечной, отличается тем, что дополнительно содержит цветки ромашки, цветки пижмы, листья подорожника большого, семена льна и плоды шиповника при равном соотношении компонентов. Вышеописанное средство улучшает обменные процессы гепатоцитов, нормализует вегетативную регуляцию, увеличивает продолжительность ремиссии. 1 табл., 4 пр.

СПОСОБ ПОЛУЧЕНИЯ ТВЕРДОЙ ФОРМЫ ЛЕКАРСТВЕННОГО СРЕДСТВА СЕДАТИВНОГО И СПАЗМОЛИТИЧЕСКОГО ДЕЙСТВИЯ

Изобретение относится к фармацевтической промышленности, а именно к способу получения твердой формы лекарственного средства седативного и спазмолитического действия путем создания комплекса бета-циклодекстрина со смесью этилового эфира альфа-бромизовалериановой кислоты и масла мяты перечной (смесью ЭБК-масло). Средство, полученное заявленным способом, является стабильным. 3 з.п. ф-лы, 2 табл., 11 пр.

СБОР "КАСМИН" ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ТРОМБОЗОВ

Изобретение относится к медицине, а именно к созданию лекарственных средств растительного происхождения, и может найти применение для профилактики лечения тромбозов и тромбоэмболий различной этиологии. Сбор содержит (мас. %) семена конского каштана обыкновенного (7-12), корни солодки голой (12-17), литья мяты перечной или траву мелиссы лекарственной (20), плоды боярышника (20) и плоды шиповника остальное. Сбор влияет не только на собственно систему гемостаза, но и на сердечно-сосудистую систему в целом, нервную систему, липидный углеводный обмен. 8 табл.

БАЛЬЗАМИЧЕСКОЕ БИОЛОГИЧЕСКИ АКТИВНОЕ СРЕДСТВО - ФИТАОН-4 И СПОСОБ ЕГО ПОЛУЧЕНИЯ

Изобретение относится к медицине, а именно к лечебно-профилактическому разделу медицины, физиотерапии, терапии. Бальзамическое биологически активное средство содержит спиртовые экстракты растений, растительные масла в качестве ароматизирующего компонента, консервант, растворитель, перец черный душистый и тонизирующие добавки. Предложен также способ получения средства. Средство обладает широким спектром действия. 2 с. и 3 з.п.ф-лы.

ОЗДОРОВИТЕЛЬНО-ПРОФИЛАКТИЧЕСКОЕ СРЕДСТВО И СПОСОБ ЕГО ПОЛУЧЕНИЯ

... 1. Оздоровительно-профилактическое средство, содержащее биологически активные вещества - воск пчелиный, прополис и экстракт лекарственного растительного сырья, заключенные в капсулу открытую с одной стороны, отличающееся тем, что оно дополнительно содержит кварцевый песок и спиртовой раствор лекарственного растительного сырья, включающий шалфей, зверобой, полынь, алоэ древовидное, бессмертник, кору дуба, чагу, мяту перечную, любисток при следующем соотношении компонентов, мас.%: Воск пчелиный 65-70 Прополис 10-15 Кварцевый песок 10-15 Спиртовой экстракт лекарственного растительного сырья 5-10. 2. Оздоровительно-профилактическое средство по п.1, отличающееся тем, что спиртовой экстракт содержит лекарственное растительное сырье в следующем соотношении, мас.%: шалфей 0,8-1,0 зверобой 1,3-1,5 полынь 1,3-1,5 алоэ древовидное 1,8-2,0 бессмертник 0,8-1,0 кора дуба 1,3-1,5 чага 1,8-2,0 мята перечная 2,8-3,0 любисток 1, 8-2,0. 3. Способ получения оздоровительно-профилактического средства, включающий ...

ПРЕПАРАТ ИЗ МАСЕЛ ДЛЯ КОРРЕКЦИИ СОСТАВА МИКРОБИОТЫ КИШЕЧНИКА В ФОРМЕ КАПСУЛЫ С КИШЕЧНОРАСТВОРИМОЙ ОБОЛОЧКОЙ

Изобретение относится к области химико-фармацевтической, нутрицевтической промышленности и медицины и касается средства, корректирующего нарушения функционирования микробиоты. Препарат для коррекции состава микробиоты кишечника в форме мягкой капсулы, характеризующийся тем, что содержит оболочку, включающую желатин пищевой, глицерин, альгинат натрия, гидроксипропилметилцеллюлозу, стеариновую кислоту и аммония гидроксид, в которую заключено действующее начало в виде комплекса из масла листьев мяты перечной, эфирного масла корневищ имбиря, токоферола или смеси токоферолов, а также масла, выбранного из оливкового масла рафинированного, масла периллы или их смеси, при следующем содержании компонентов в мг на капсулу: желатин пищевой 110-130, глицерин 43-50, гидроксипропилметилцеллюлоза 22,5-27,5, альгинат натрия 4,7-5,3, аммония гидроксид 0,9-1,1, стеариновая кислота 0,3-0,7, эфирное масло корневищ имбиря 10-500, мяты перечной листьев масло 10-500, токоферол или смесь токоферолов 0,04-0,06, ...

СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ КОСТНО-МЫШЕЧНОЙ СИСТЕМЫ НА ОСНОВЕ КОМПОЗИЦИИ "ИЗУМРУДНАЯ"

Изобретение относится к созданию лекарственных средств, которые могут быть использованы для комплексного лечения заболеваний костно-мышечной системы, в том числе суставов и позвоночника в санаторно-курортных условиях. Композиция "Изумрудная" содержит, в заданных количествах, следующие активные ингредиенты: аир (корень), осину (кора), чабрец (трава), шалфей (соцветия), мяту блошиную (трава), девясил (корни), лавр благородный (листья), азалию (цветки), бузину черную (цветки), агримонию (трава), лопух (корни), полынь (трава), сосну (хвоя), донник лекарственный (трава), багульник, а также целевую добавку: масло подсолнечное, масло беленное, масло камфорное, анестезина порошок, раствор аммиака, раствор димексида, порошок глины голубой. Из указанного состава композиции задают отдельные составы и применяют их для каждого отдельного этапа лечения заболеваний костно-мышечной системы. Все этапы лечения входят в единый лечебный процесс, при котором на первом этапе тело больного прогревают в лечебной ...

СПОСОБ ПАППАС Е.А. ДЕТОКСИКАЦИИ И ОМОЛОЖЕНИЯ ОРГАНИЗМА

Изобретение относится к области медицины, касается немедикаментозного лечения и профилактики заболеваний, оздоровительных и омолаживающих мероприятий. Способ включает очищение кишечника на первом этапе и печени - на втором. При этом очищение кишечника осуществляют путем его орошения раствором, содержащим 5-10 доз бифидобактерий на 10-12 литров профильтрованной воды, а очищение печени проводят путем приема гомогенной массы из масла расторопши с обезжиренным кефиром и чередуют в течение дня прием этой массы с приемом настоев желудочно-кишечных, печеночных и почечных фитосборов. Настой фитосбора запивают лечебным чаем, приготовленным из 25,0-35,0 г зеленого чая, 25,0-35,0 г мелиссы или мяты, 25,0-35,0 г меда, 45,0-55,0 г сока лимона и 1,1-1,3 литра кипятка. Способ позволяет очистить детоксикационные органы - кишечник, печень, почки, снизить «биологический возраст» на 4-5 лет, улучшает мозговое и периферическое кровообращение, иммунитет, является удобным для пациента за счет сокращения сроков ...

СПОСОБ ЛЕЧЕНИЯ АЛКОГОЛИЗМА "ТРОЙНАЯ ЗАЩИТА"

Изобретение относится к медицине, в частности к наркологии. Сущность изобретения: лечебное воздействие направлено на три точки этиопатогенеза алкоголизма, а именно лечение синдрома патологического влечения к алкоголю, металкогольного токсикоза, системной алкогольной энцефалопатии и висцеропатии, психических нарушений. Способ лечения состоит в последовательном комплексном лечебном воздействии. На первом этапе принимают препарат "эспераль" по 0,25 г 2 раза в день 5 - 10 дней. На втором этапе проводят психосуггестивное воздействие в состоянии бодрствованиям. На третьем этапе принимают настой из лекарственных трав в течение 21 дня по 100 мл 3 раза в день за 20 мин до еды. Предложенный способ рекомендуется для больных алкоголизмом второй и третьей стадии заболевания.

СРЕДСТВО "АНТИНИК" ДЛЯ ОБЛЕГЧЕНИЯ ОТВЫКАНИЯ ОТ ТАБАКОКУРЕНИЯ И ЛЕЧЕНИЯ ХРОНИЧЕСКИХ БРОНХОЛЕГОЧНЫХ ЗАБОЛЕВАНИЙ КУРИЛЬЩИКОВ

Изобретение касается создания лекарственных средств на растительной основе для отвыкания от курения. Предложенное средство включает две композиции сборов лекарственных растений для приема в разное время суток - утром и вечером. Один сбор содержит аир болотный, спорыш, крапиву двудомную, подорожник большой, хвощ полевой, исландский мох, солодку голую, мальву лесную, пикульник ладанниковый, посконник и мачок желтый. Второй сбор содержит - синюху голубую, эвкалипт, багульник болотный, золотарник обыкновенный, лаванду, зизифору бунге, тимьян Маршала, дягиль лекарственный, мяту перечную и баранец обыкновенный.

Способ профилактики геморрагического инсульта

БИОЛОГИЧЕСКИ АКТИВНАЯ КОМПОЗИЦИЯ "ФИТАОН-2,2" И СПОСОБ ЕЕ ПОЛУЧЕНИЯ

Использование: лечебно-профилактические разделы медицины - хирургия, урология, дерматология, стоматология, отолорингология, гинекология, проктология, физиотерапия. Сущность изобретения: бальзамическая биологически активная композиция содержит водные экстракты растений - травы сушеницы топяной, тысячелистника, чистотела, чабреца, душицы и зверобоя, листья мяты, почки сосны, цветки ноготков, ромашки, плоды и/или листья конского каштана и корень солодки, эфирные масла из ряда: мятное, кориандровое, анисовое пихтовое и камфорное - в качестве ароматизирующего компонента, аммиак водный - в качестве консерванта, глицерин, олеиновая кислота - в качестве косметического средства, вода дистиллированная - в качестве экстрагента. Ароматизирующий компонент использован с тонизирующими добавками в количестве не более 0,2% по весу основы. Композиция допускает различные комбинации ингредиентов и их содержание. Предложен также способ получения средства.

ЛЕЧЕБНАЯ МАЗЬ БЕЛОВА

Изобретение относится к фармации и может быть использована для лечения химических, термических ожогов и отморожений. Сущность изобретения: мазь для лечения термических, химических ожогов и отморожений содержит спиртовые экстракты растительного сырья и растительное масло, при этом соотношение спиртового экстракта растительного сырья и масла 1:5-7.

СПОСОБ ЛЕЧЕНИЯ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ И СРЕДСТВО ДЛЯ ИХ ЛЕЧЕНИЯ

Изобретение относится к области фитотерапии, в частности к способам лечения сердечно-сосудистых заболеваний и средствам для их лечения. Для улучшения эффективности лечения в сборе лекарственных трав использованы мелисса - 560 г и мята гречишная - 560 г.

СПОСОБ ПОВЫШЕНИЯ РЕЗИСТЕНТНОСТИ ОРГАНИЗМА ЧЕЛОВЕКА ПОСРЕДСТВОМ ПРИМЕНЕНИЯ ФИТОАЭРОИОНОВ

Способ повышения резистентности организма человека посредством введения ингаляционным путем фитоаэроионов, представляющих из себя мелкодисперсный электрически заряженный аэрозоль, в котором материальным носителем электрического заряда являются водные эмульсии эфирных масел или водные отвары различных безалколоидных растений, не входящих в группу адаптагенов. Эфирные масла переводятся в эмульсию в соотношении масловода 1:1000. Водные отвары готовятся при соотношении растительное сырье-вода 1:50. Эмульсия или отвар механически переводятся в мелкодисперсный аэрозоль и при выходе из фитоаэроионизатора дополнительно получают электрический заряд. Концентрации биологически активных веществ в воздухе помещения, в котором отпускают процедуры, находится в пересчете на эфирное масло 1-2 мг/мвоздуха. Длительность процедуры в пределах 30-40 мин. Количество процедур на один курс 25-30 принимаемых ежедневно. При необходимости профилактического проведения курсов фитоаэроионизации их повторяют спустя 2- ...

Средство для профилактики суставов

Способ профилактики суставов

СПОСОБ КОЛИЧЕСТВЕННОГО ОПРЕДЕЛЕНИЯ РОЗМАРИНОВОЙ КИСЛОТЫ В ЛИСТЬЯХ МЯТЫ ПЕРЕЧНОЙ

Изобретение относится к области химико-фармацевтической промышленности, а именно к способу количественного определения содержания розмариновой кислоты в листьях мяты перечной. Способ осуществляют путем экстракции сырья органическими растворителями с последующей пробоподготовкой и определением оптической плотности методом ВЭЖХ, при этом экстракцию сырья осуществляют этиловым спиртом в концентрации 60% в соотношении «сырье-экстрагент» - 1:50, время экстракции – извлечение на кипящей водяной бане в течение 60 мин, степень измельчения сырья – 2 мм; количественное определение розмариновой кислоты в листьях мяты перечной проводят при длине волны 330 нм; содержание розмариновой кислоты X в процентах в абсолютно сухом сырье вычисляют по формуле: где H – среднее значение высоты пика розмариновой кислоты испытуемого раствора, вычисленное из хроматограмм раствора испытуемого образца; H0 – среднее значение высоты пика раствора СО розмариновой кислоты, вычисленное из хроматограмм раствора РСО розмариновой ...

Способ лечения желчно-каменной болезни

Изобретение касается медицины, в частности способа лечения желчно-каменной болезни с использованием смеси растительного сырья. Целью изобретения является сокращение сроков лечения. Способ осуществляется путем приема смеси лекарственных растений следующего состава, г: корень ревеня 0,4; корень одуванчика 0,2; корень цикория 0,1; лист сенны 0,4; лист мяты перечной 0,2; листья молодых побегов или цветы бузины 0,2; лист трилистника водяного 0,1; лист репяшка 0,1; цветы ромашки аптечной 0,2; цветы бессмертника песчаного 0,1; плоды жостера слабительного 0,3; трава зверобоя продырявленного 0,1; кора крушины ломкой 0,3; кора барбариса 0,2; семена укропа огородного 0,1. Порошок принимают 5 раз/ каждый раз запивая настоем травы хвоща полевого с последующим приемом оливкового масла, сока лимона и наложением грелок в области печени.

METHOD FOR CONTROL OF HONEY BEE VARROATOSIS

"Сбор лекарственных трав для профилактики и лечения дисбактериоза "Фекла-6""

Изобретение относится к химико--фармацевтической промышленности и касается создания сбора дмя профилактики и лечения дисбактериоза Сбор содержит ромашку, мяту дикую (котовник). зверобой крапиву, пастушью сумку, кору дуба и плоды укропа при соотношении компонентов 2 2 2 1 1 2 1 Сбор обладает антимикробным, иммуностимулирующим спазмолитическим и ветрогонным действием ...

ГИПOTEHЗИBHЫЙ CБOP " BAЛEHTИHA

Сбор для профилактики и лечения заболеваний желудочно-кишечного тракта

Использование: в химико-фармацевтической промышленности для создания лекарственных сборов из лекарственного сырья, которые, могут быть использованы в качестве средств для лечения заболеваний желудочно-кишечного тракта Сущность сбор содержит бессмертник итальянский, мяту английскую, котовник лимонный и розу эмиро- масличную при следующем соотношении компонентов , мзс.% мята английская 10-15, бессмертник итальянский 15-20, котовник лимонный 20 - 25. роза эфиромасличная - остальное Техниче с- кий результат, сбор расширяет арсенап средств растительного происхождения, используемых в качестве средств для лечения заболеваний желудочно-кишечного тракта. 1 табл ...

Способ лечения калькулезных холециститов по Фузайлову Б.Н. и лекарственный препарат для его осуществления

Способ лечения калькупезных холециститов и лекарственный препарат для его осуществления относятся к области медицины. Для растворения калькулезов при отсу ствии побочных вредных воздействий на организм больных принимается настой сбора лекарственных трав на фоне общей диеты с включением растительного масла морковно-све- кольного сока, кефирного настоя и кашицы хрена особым образом приготовленных и назначенных в заданном режиме. Предлагается два варианта лечебного сбора содержащих, мас.%: первый состав трава полыни горькой 10 - 15; корень одуванчика 10 - 15; лист мяты перечной 10 - 12; цветки бессмертника 20 - 23; кора крушины 8 - 12 и корни мзрены красильной 35 - 48; второй состав- кукурузные рыльца 15-25; корень одуванчика 15 - 25; цветки ромашки аптечной 10-20; лист и корень земляники лесной 15-25, трава тысячепистника 20 - 25 и трава чистотела 20-25 2 с и 1 з.п ф-лы ...

Способ получения флавоноидов,ОблАдАющиХ жЕлчЕгОННыМ дЕйСТВиЕМ

Способ получения средства, обладающего спазмолитической активностью

Использование: изобретение относится к; медицине, а именно к фитотерапии, и касается получения из растительного сырья средства, обладающего спазмолитической активностью. Цель изобретения - расширение спектра действия за счет диуретической. активности. Сущность изобретения: в экстракции водой на кипящей водяной бане в течение 25 мин, сбора лекарственных растений , включающего корневища с корнями валерианы 1 ч, траву пустырника 2ч, плоды боярышника 6 ч, траву астрагала 2 ч, траву сушеницы 2 ч, лист подорожника 1 ч, лист мяты 1 ч, траву горца птичьего 1 ч, а после фильтрации охлаждают в течение 25 мик. Положительный эффект заключается в появлении диуретической активности, эффект выражен в дозе 0,1-1,0 г/кг веса. СП с ...

BIOSTIMULANT

Способ борьбы с варроатозом пчел

Использование: в ветеринарии. Сущность изобретения: способ борьбы с варро- атозом пчел путем использования отвара мяты полевой для опрыскивания им сотора- мок и внутренних поверхностей ульев.

Medicine for treating a disease which occur internally e.g. symptoms of inflammation of the stomach and for treating a disease occurring externally e.g. nail fungal infections

Medicine for treating a disease which occur internally e.g. symptoms of inflammation of the stomach and for treating a disease occurring externally e.g. nail fungal infections, is claimed. ACTIVITY : Antiinflammatory; Fungicide. No biological data given. MECHANISM OF ACTION : None given.

ABFUEHRMITTEL AUF DER BASIS VON PLANTAGOSAMEN UND SENNAFRUECHTEN UND VERFAHREN ZUR HERSTELLUNG DESSELBEN

Mittel zum Auftragen auf eine überwärmte Körperregion

NEUE DOSISFORMEN VON SUBSTITUIERTEN BENZIMIDAZOLEN UND VERFAHREN ZUR DEREN VERWENDUNG

An Improvement in Cough Mixture for the Cure of Cough and Colds and for Bronchitis in its Early Stages.

... 29,543. Sinclair, E. J. C. Dec. 20. Medicines for internal use.-A cough mixture consists of a syrup of sugar and molasses, oil of peppermint, oil of aniseed, paregoric, ipecacuanha wine, and laudanum.

Compositions containing fructose and plant extracts

Compositions containing an extract of puerariae radix, phaseoli radiati semen, small red bean, crataegi fructus, malt, cnidii rhizoma, atractylodes rhizoma, cassiae semen, amomi semen and menthae folium plus fructose have activity in prophylaxis and treatment of the after effects of excessive alcohol intake.

Anti-snoring treatment

An anti-snoring treatment comprises the use of a water-based gargle before retiring to sleep. The gargle is prepared by adding a few drops of an emulsion containing oil of sage and oil of eucalyptus to warm water. The emulsion may also contain oils from fennel, dwarf pine, peppermint, lemon, lavender, cloves, thyme, balm and/or mastic.

Compositions for intranasal administration

The present invention relates to pharmaceutical compositions for administration to the nasal tract. In particular, the invention relates to dry powder compositions comprising cellulose, and in particular hyroxypropylmethylcellulose (HPMC), and one or more therapeutic agents. It has been shown that administration of HPMC to the nasal cavity is capable of enhancing natural mucus. These powders, and the gel that forms when they are administered to the nasal tract, have now surprisingly been found to be a very effective way of intranasally administering therapeutic agents, and in particular, herbal or homeopathic agents.

BETEL NUT AND NICOTINE CHEWING GUM

A gum based chewing product, particularly a chewing or bubble gum, containing a synthetic or natural betel nut source, and nicotine. Each gum piece may contain between 1 and 12.6 mg of nicotine. The product may contain taste enhancers such as catechu and lime. A process for the preparation of the gum is also outlined.

Antimicrobial composition

Compositions for the preservation of foodstuffs, for the sterilization and hygiene ofair in confined spaces and for cosmetic and pharmaceutical purposes

A composition for the preservation of foodstuffs, for the sterilization of air in confined spaces and for cosmetic and pharmaceutical purposes comprising an essential oil having bacteriostatic and/or bactericidal properties or a bacteriostatically and/or bactericidally active compound extracted from such an oil, acetic or citric acid and ethanol or ispropyl alcohol. The composition may comprise oil of cloves, cinnamon oil, peppermint oil, oil of thyme, oil of rosemary, mustard oil, thymol, cinnamic aldehyde, polyoxyethylene oleate or stearate, polyoxyethylene sorbitan mono-palmitate, mono- or tri-oleate, or mono- or tri-stearate, and mucilages of animal, vegetable or synthetic origin (e.g. tragacanth or agar-agar). The composition may be in the form of an aqueous concentrate. The composition may be applied to the food by steeping or spraying. Sheep's guts, pigs' intestines, fish, shellfish, sausages, cheese and pastry goods may be treated. The composition may be sprayed or vapourized in ...

Gum based chewing product and process for preparing the same

Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases

Antimicrobial treatment for herpes simplex virus and other infectious diseases

Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases.

An improved medical treatment and medicine is provided to quickly and safely resolve hiv and other microbial infections. The inexpensive medicine can be self administered and maintained for the prescribed time. The attractive medicine comprises an antimicrobial concentrate comprising microbe inhibitors, phytochemicals or isolates. Desirably, the effective medicine comprises a surfactant and an aqueous carrier or solvent and a nutrient. In the preferred form, the medicine comprises: echinacea and commiphora myrrha phytochemicals, benzalkonium chloride, a sterile water solution, and folic acid.

Antimicrobial treatment for herpes simplex virus and other infectious diseases.

An improved medical treatment and medicine is provided to quickly and safely resolve herpes and other microbial infections. The inexpensive user-friendly medicine can be applied and maintained on the infected region unitl the physical symptoms of the disease disappers and the patient is comfortable and has a normal appearance. The attractive medicine comprises an antimicrobial concentrate comprising microbe inhibitors, phytochemicals or isolates. Desirably, the effective medicine comprises a surfactant and an aqueous carrier or solvent. In the preffered form, the medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution.

Antimicrobial treatment for herpes simplex virus and other infectious diseases

Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases

Method of assisting with digestive upsets using a confection-based delivery of peppermint oil and ginger

A confection for assisting with the relief of common digestive complaints is provided. The confection includes a carbohydrate base and an active agent infused into the carbohydrate base. The active agent includes at least one of ginger extract or peppermint oil.

NASAL SPRAY

The invention relates to a medicinal product which is free from sympathomimetics, has an advantageous effect on the nasal mucosa in case of common colds, hay fever, dry nose and sympathomimetic dependencies, and is provided in the form of a nasal spray, a nasal douche or nasal drops. 1. A sympathomimetic-free medicinal product in the form of drops , spays , and/or rinses for use for preparing an agent for treating irritations of the nasal mucosa by a cold , by hay fever , a dry nose and/or sympathomimetic dependence , characterized by comprising menthol , mint oil and/or camphor as well as at least one humectant comprising water-soluble or water-dispersible natural or synthetic polymers that form gels or viscous solutions in aqueous systems , polyhydric alcohols , mono- , di- and/or polysaccharides.2. The sympathomimetic-free medicinal product according to claim 1 , characterized in that said polymers are selected from collagen derivatives claim 1 , polyalkylene glycols claim 1 , especially polyethylene glycols claim 1 , polyglycerols claim 1 , alginates claim 1 , carrageenan claim 1 , pectins claim 1 , gums claim 1 , cellulose derivatives claim 1 , polyvinyl alcohols claim 1 , polyvinyl pyrrolidones and derivatives thereof claim 1 , and/or dextran.3. The sympathomimetic-free medicinal product according to claim 1 , characterized by further containing panthenol.4. The sympathomimetic-free medicinal product according to claim 1 , characterized by containing said humectant in an amount of from 0.1 to 5% by weight.5. The sympathomimetic-free medicinal product according to claim 1 , characterized by further additionally containing common salt and/or sea salt.6. The sympathomimetic-free medicinal product according to claim 1 , characterized by additionally containing essential oils.7. The sympathomimetic-free medicinal product according to claim 1 , characterized by further containing pH control agents and/or tonicizing agents.8. The sympathomimetic-free medicinal ...

Method of Altering Perception of Time

Methods and compositions for modifying an individual's perception of an interval of time are disclosed. 1. A method of modifying a person's defective or impaired time processing , comprising administering to the person by inhalation an effective amount of a composition comprising a coffee odorant such that the person's estimate of the length of a time interval is shorter than the person's estimate of the same time interval made without inhalation of the composition.2. The method of claim 1 , wherein the composition consists essentially of the coffee odorant in a carrier claim 1 , and optional additives.3. The method of claim 1 , wherein the composition comprises a mixture of the coffee odorant with at least one of a peppermint odorant or a vanilla odorant as a secondary odorant that complements and does not mask the coffee odorant.4. The method of claim 3 , wherein the composition comprises a suprathreshold and non-irritant concentration of the coffee odorant and a less than suprathreshold concentration of the secondary odorant.5. A method of modifying a person's defective or impaired time processing claim 3 , comprising administering to the person by inhalation an effective amount of a composition comprising a baby powder odorant such that the person's estimate of the length of a time interval is longer than the person's estimate of the same time interval made without inhalation of the composition.6. The method of claim 6 , wherein the composition consists essentially of the baby powder odorant in a carrier claim 6 , and optional additives.7. The method of claim 1 , wherein the composition comprises a mixture of the baby powder odorant with a vanilla odorant as a secondary odorant that complements and does not mask the baby powder odorant.8. The method of claim 7 , wherein the composition comprises a suprathreshold and non-irritant concentration of the baby powder odorant and a less than suprathreshold concentration of the vanilla odorant.9. A method of treating a ...

Composition and method for minimizing bulling behavior of cattle

A method and composition for treating feedlot cattle in order to mask odor or pheromones given by cattle that trigger other cattle to mount them in a behavior pattern known as Buller Steer Syndrome, or to at least provide a scent which neutralizes that behavior.

TOPICAL THERAPEUTIC COMPOSITION AND PALLIATIVE TREATMENT METHOD

Disclosed herein is a topical therapeutic composition and method for the palliative treatment of irritated or inflamed perianal tissue. The therapeutic composition comprises olive oil and tea tree oil. The palliative treatment of the invention involves application of the composition to irritated or inflamed perianal tissue. The composition and method of the invention can be employed in the palliative treatment of such human maladies as hemorrhoids, fissures and pruritis ani. 1. A topical therapeutic composition comprising olive oil and between about 0.001 and about 10% by volume of tea tree oil.2. The topical therapeutic composition of comprising about 5% by volume of tea tree oil.3. The topical therapeutic composition of wherein said olive oil is virgin olive oil.4. The topical therapeutic composition of in the form of an aqueous emulsion.5. The topical therapeutic composition of in the for of a form stable solid.6. A method for the palliative treatment of perianal irritation or inflammation which comprises applying to irritated or inflamed perianal tissue a composition comprising olive oil and between about 0.001 and about 10% by volume of tea tree oil.7. The method of wherein said composition comprises about 5% by volume of tea tree oil.8. The method of wherein the olive oil of said composition is virgin olive oil.9. The method of wherein said composition is applied as an aqueous emulsion thereof.10. The method of wherein said composition is applied as a form stable suppository. This application is a Divisional of U.S. patent application Ser. No. 13/507,719, filed Jul. 21, 2012, and claims the benefit of U.S. Provisional Application Ser. No. 61/628,217, filed by the present applicant on Oct. 26, 2011. The disclosure of U.S. patent application Ser. No. 13/507,719 is expressly incorporated by reference herein in its entirety.The present invention relates broadly to a topical therapeutic composition and is more particularly concerned with a composition which is ...

Method For Producing Articles of Plant Origin Impregnated With a Liquid Plant Substance

The present invention relates to a method for producing articles impregnated with at least one plant substance from at least one plant, characterized in that it comprises the following steps: 1. A method for producing articles impregnated with at least one plant substance from at least one plant comprising ,{'b': 1', '1', '1, 'a) Extraction and/or pressing of at least one plant (V), or at least one part of said plant, thereby producing a liquid plant extract (E) and a solid fibrous residue (R), then'}{'b': 1', '1, 'b) Separation of said plant extract (E) from said fibrous residue (R), and'}{'b': '1', 'c) Destructuring of said fibrous residue (R),'}{'b': '1', 'd) Production of a fibrous web or of an article made from the fibrous residue (R) obtained in step c), and'}{'b': 1', '1', '1', '1', '2', '2', '2', '1, 'e) Impregnation of said fibrous residue (R) with (i) at least said plant extract (E), which is optionally concentrated, purified, flavored and/or fragranced, with (ii) at least one water-soluble or liposoluble plant substance isolated from said plant extract (E), with (iii) at least one composition comprising at least one optionally concentrated, purified, flavored and/or fragranced water-soluble or liposoluble substance of said plant extract (E), or with (iv) at least one plant extract (E) or at least one composition comprising at least one optionally concentrated, purified, flavored and/or fragranced water-soluble or liposoluble substance of said plant extract (E), resulting from an extraction or pressing of a plant (V) different from said plant (V).'}2. The method according to claim 1 , wherein steps c) claim 1 , d) and e) may occur in the following order:step c) precedes step d), which in turn precedes step e), orstep c) precedes step e), which precedes step d).3. The method according to claim 1 , wherein:the plant is chosen from among food plants, medicinal plants, aromatic plants and fragranced plants; or whereinthe plant is chosen from among plants ...

EYE TREATMENT

Methods and kits for treating or preventing an eye condition or for cleaning an eye area tissue are provided. A method of the invention includes administering an isoprenoidal essential oil to eye area tissue, chafing eye area tissue with an abrasive, and removing the abrasive. A kit according to the invention includes an isoprenoidal essential oil, an abrasive for chafing eye area tissue, and in instruction for use for treating an eye condition or cleansing an eye area tissue. The invention also includes a composition of matter comprising an isoprenoidal essential oil and a plurality of abrasive particles in ophthamologically acceptable base. 1. A method of treating or preventing an eye condition in eye area tissue comprising:administering an isoprenoidal essential oil to eye area tissue;chafing eye area tissue with an abrasive; andremoving the abrasive.2DemodexDemodex. The method of wherein treating an eye condition comprises treating a condition selected from the group consisting of: anterior blepharitis claim 1 , posterior blepharitis claim 1 , induced blepharitis claim 1 , conjunctivitis claim 1 , dry eye claim 1 , meibomitis claim 1 , ocular infestation claim 1 , and ocular rosacea.3. The method of wherein administering an isoprenoidal essential oil to eye area tissue comprises administering tea tree oil.4. The method of wherein the concentration of tea tree oil is about 0.5% (w/w) to about 4% (w/w).5. The method of about the concentration of tea tree oil is about 5% (w/w) to about 50% (w/w).6. The method of wherein chafing eye area tissue comprises chafing a tissue selected from the group consisting of: upper eyelid tissue claim 1 , lower eyelid tissue claim 1 , eyelid margin tissue claim 1 , anterior eyelid margin tissue claim 1 , posterior eyelid margin tissue claim 1 , and eyelash follicle.7. The method of wherein chafing eye area tissue with an abrasive comprises chafing with abrasive particles having a size from about 1 μm to about 600 μm in a longest ...

Antifungal serum

The subject invention is based upon the discovery that an antifungal agent can be delivered through the fingernail or the toenail of an infected human to treat onychomycosis by dissolving or dispersing the antifungal agent in a solvent system which is comprised of a combination of an alkyl lactate and Simmondsia chinesis seed oil. In accordance with this invention the antifungal agent is absorbed by and incorporated into the nail matrix by diffusing through the epithelium of the nail bed to reach the nail bed hyperkeratosis. The antifungal agent additionally penetrates into the ventral surface of the nail plate. The subject invention more specifically discloses an antifungal serum which is comprised of (1) an alkyl lactate, such as isoamyl lactate, (2) Simmondsia chinesis seed oil, and (3) an antifungal agent, such as tolnaftate or undecylenic acid.

ENTERIC COATED MULTIPARTICULATE CONTROLLED RELEASE PEPPERMINT OIL COMPOSITION AND RELATED METHODS

A multiparticulate composition is formed from a plurality of individual cores including a hydrophobic phase containing peppermint oil dispersed in a microcrystalline cellulose-based gel and a hydrophilic phase containing a hydrogel. An enteric coating is over the individual cores. The multiparticulate composition can be used to treat gastrointestinal disorders. 1. A multiparticulate composition comprising a plurality of individual enteric coated cores , the cores including a hydrophobic phase containing peppermint oil dispersed in a microcrystalline cellulose-based gel and a hydrophilic phase containing a hydrogel.2. The multiparticulate composition of claim 1 , further comprising a continuous proteinaceous subcoating layer covering the individual cores and separating the individual cores from their respective enteric coatings.3. The multiparticulate composition of claim 2 , wherein the continuous proteinaceous subcoating comprises a gelatin film adhered to the core.4. The multiparticulate composition of claim 2 , wherein the continuous proteinaceous subcoating comprises a dried proteinaceous gel.5. The multiparticulate composition of claim 2 , wherein the continuous proteinaceous subcoating is adapted to prevent the peppermint oil from mixing with the enteric coating.6. The multiparticulate composition of claim 2 , wherein the enteric coating has a glass transition temperature higher than a standard boiling point of the peppermint oil.7. The multiparticulate composition of claim 1 , wherein the enteric coated cores release no more than about 20% of the peppermint oil within about two hours of being placed in a 0.1 N HCl solution and claim 1 , subsequently claim 1 , no less than about 85% of the peppermint oil within about eight hours of being placed in a substantially neutral pH environment.8. The multiparticulate composition of claim 1 , wherein the enteric coated cores are spheroidal and not more than 3 mm in diameter.9. A multiparticulate composition comprising ...

Natural - Topical analgesic and anti-inflammatory composition F2

This invention replaces the practice of utilizing synthesized salicin compounds for use as anti-inflammatory components in topical pain relief compositions through the use of naturally occurring salicin in the form of (white willow bark) botanicals. This invention is a compound of naturally occurring botanicals identified in the Natural Pharmacopeia as individually exhibiting anti-inflammatory and/or analgesic properties. 1Helicrysum GymnocephalumSalix AlbaEucalyptus GlobulesLavandula AngustifoliaPelargonium GraveoleusMentha viridisMentha Avrensis,. As described in U.S. patient application Ser. No. 13/565 ,676 filed on Aug. 2 , 2012 , the combination of essential oil and extract when combined with essential oil , essential oil , essential oil , essential oil , Camphor , and incorporated into a cosmetic cream substrate , together constitute a unique and effective topical pain relief product.2Pimenta Racemosa,Cymbopogon flexuosus. It has been found that the effects of the compound described in above are enhanced by the addition (Dominican Bay Leaf) claim 1 , (Lemon Grass) to said compound. Test subjects reported that the enhanced compound provides a higher level of temporary pain relief claim 1 , that it is longer lasting. This is a continuation of U.S. patent application Ser. No. 13/565,676 dated 2013 Aug. 2.This invention is intended provide an alternative to synthetic topical pain relief preparations. This invention contains natural, botanical extracts and essential oils in lieu of synthetic analgesics and fragrance, replacing synthetic salicin based anti-inflammatory preparations.The invention is an emulsion of natural trans-dermal carriers and analgesic and anti-inflammatory components including (White Willow Bark) extract. The cream is compounded by combining the jojoba oil base with (White Willow Bark), the natural botanical extracts (Lavender), (Egyptian ), (Spearmint), (), (Rosemary), (Dominican Bay Leaf), (Lemon Grass), crystaline menthol and crystaline ...

Plant Extracts for Improving Cognitive Health and Function

Extracts of plants of the Lamiaceae family are shown to improve cognitive health and function. 1. A method to enhance , improve or sustain cognitive health and/or function in mammals , comprising oral administration of an efficacious amount of an extract of a plant of the Lamiaceae family.2. A method of claim 1 , wherein said mammals are selected from the list consisting of humans and companion animals.3. A method of claim 2 , wherein said efficacious amount of said extract is between 0.01 and 50 mg/kg/day.4. A method of claim 1 , wherein said extract comprises carnosic acid.5. A method of claim 4 , wherein cognitive health and/or cognitive function refers to procedural learning (through improvement of focus claim 4 , attention claim 4 , and alertness) and memory claim 4 , and wherein memory is selected from the group consisting of reference memory claim 4 , recognition memory claim 4 , short-term memory claim 4 , long-term memory and associative memory which have both declarative and procedural components.6. A method of claim 4 , wherein cognitive health and/or cognitive function refers to executive function7. A method of claim 2 , wherein said extract comprises rosmarinic acid.8. A method of claim 7 , wherein said efficacious amount of said extract is between 0.01 and 50 mg/kg/day.9. A method of claim 7 , wherein cognitive health and/or cognitive function for rosmarinic acid refers to declarative learning through improvement of focus claim 7 , attention claim 7 , and alertness.10. A method of claim 7 , wherein cognitive health and/or cognitive function for rosmarinic acid refers to declarative memory claim 7 , both short-term and long-term memory.11. A method of claim 7 , wherein cognitive health and/or cognitive function refers to executive function.12. A method of claim 1 , wherein said extract comprises carnosic acid and rosmarinic acid.13. A method of claim 12 , wherein to enhance claim 12 , improve and sustain cognitive health and/or function comprises ...

COMPOSITIONS CONTAINING RESVERATROL AND ESSENTIAL OIL OF CLOVES FOR THE TREATMENT OF ITCHING

The present invention relates to a patch or sticking plaster formulation containing a combination of resveratrol or derivatives thereof and essential oil of cloves () for the treatment of itching. 16-. (canceled)7. A method for the treatment of itching in a subject in need thereof comprising the topical administration to said subject of a formulation comprising an effective amount of:a) resveratrol of a derivative thereof;{'i': 'Eugenia caryophyllata', 'b) essential oil.'}8. Methods according to claim 7 , wherein the formulation comprises the active ingredients within the following weight/volume percentages:a) resveratrol or a derivative thereof: 0.01% to 10%;{'i': 'Eugenia caryophyllata', 'b) essential oil: 0.01% to 2%.'}9. Methods according to claim 8 , wherein the formulation comprises the active ingredients within the following weight/volume percentages:a) resveratrol or a derivative thereof: 0.05 to 1%;{'i': 'Eugenia caryophyllata', 'b) essential oil: 0.02% to 0.2%.'}10. Methods according to claim 7 , wherein the formulation is in the form of a patch claim 7 , cream claim 7 , cream-gel claim 7 , gel claim 7 , spray or powder.11. Methods according to claim 10 , wherein the formulation is in the form of a patch. In a general aspect thereof, the present invention relates to a composition in patch or sticking plaster form containing a combination of resveratrol or derivatives thereof and essential oil of cloves, for the treatment of itching.Itching is an unpleasant, complex skin sensation which evokes the reflex response of scratching or the desire to scratch. The act of scratching arises as a protective reflex, and leads to the formation of a skin lesion. Itching is a frequent disorder, although it is generally considered a benign symptom, and can have adverse effects on the patient's well-being and quality of life, and even become disabling when it is severe (1). As it was long considered to be a sub-type of pain, no attention was paid to its neurobiological ...

Medicinal tea

The medicinal tea includes a natural, herbal composition for treating female menstrual pains and post-delivery symptoms. The composition eliminates the side effects of common pain relief or sedative remedies. The composition includes Salvia officinalis, cumin, Artemisia herba - alba, Nigella sativa, Pimpinella anisum, coffee husk, Carum copticom, cinnamon, Achillea fragrantissima, and mint in specific amounts which together provide diuretic, sedative, menstrual and digestive benefits. This composition is easily digestible and provides immediate benefits without any harmful side effects.

OXIDIZED PROTEIN HYDROLASE ACTIVITY ENHANCING AGENT

The present invention provides a novel oxidized protein hydrolase activity enhancing agent. The oxidized protein hydrolase activity enhancing agent of the present invention contains at least one kind of plant extract obtained from a plant selected from the group consisting of water chestnut, stevia, rosemary, thyme, chrysanthemum, savory, mugwort, chestnut, spearmint, marjoram, peppermint, lemon balm, allspice, perilla, basil, and caraway. 1. (canceled)2. (canceled)3. A method for enhancing activity of oxidized protein hydrolase in a sample , comprising:adding oxidized protein hydrolase activity enhancing agent to the sample.4. A method for accelerating protein degradation in a sample comprising:{'claim-ref': {'@idref': 'CLM-00003', 'claim 3'}, 'adding an oxidized protein hydrolase activity enhancing agent according to to the sample.'}5. (canceled)6. A method for treating senescence of tissues caused by accumulation of AGEs in a subject , the method comprising:{'claim-ref': {'@idref': 'CLM-00003', 'claim 3'}, 'administering an oxidized protein hydrolase activity enhancing agent according to .'}7. A method for treating hypofunction of tissues caused by accumulation of AGEs in a subject , the method comprising:{'claim-ref': {'@idref': 'CLM-00003', 'claim 3'}, 'administering an oxidized protein hydrolase activity enhancing agent according to .'}8. The method according to claim 3 , wherein the oxidized protein hydrolase activity enhancing agent comprises two or more kinds of plant extracts selected from the group consisting of those obtained from water chestnut claim 3 , stevia claim 3 , rosemary claim 3 , thyme claim 3 , chrysanthemum claim 3 , savory claim 3 , mugwort claim 3 , chestnut claim 3 , spearmint claim 3 , marjoram claim 3 , peppermint claim 3 , lemon balm claim 3 , allspice claim 3 , perilla claim 3 , basil claim 3 , and caraway.9. The method according to claim 4 , wherein the oxidized protein hydrolase activity enhancing agent comprises two or more kinds ...

METHOD FOR OBTAINING AN EXTRACT ENRICHED IN ROSMARINIC ACID FROM FRESH PLANT MATERIAL

Methods for obtaining an extract enriched in rosmarinic acid from fresh plant material selected from the fresh aerial parts, flowering tops, flowers and/or leaves of plants from the family Lamiaceae, Araliaceae, Boraginaceae, Apiaceae, Poaceae and Malvaceae. The methods include steam bleaching the plant material followed by continuous expression with at least one compression screw, under pressure of between 4 and 10 bar from which the sap (liquid co-product) is recovered. Then, the sap is filtered to produce a clarified sap and is subsequently atomized to obtain a granulated or finely powdered extract containing at least 5% of rosmarinic acid in weight relative to the total weight of the extract. Compositions having such an extract as an active agent are disclosed. The compositions are used in the food, cosmetic, nutraceutical and pharmaceutical fields. 1. A method for obtaining an extract enriched in rosmarinic acid from fresh plant material selected from the fresh aerial parts , flowering tops , flowers and/or leaves of plants from the family Lamiaceae , the method comprising:1) steam bleaching said plant material for less than 2 hours at atmospheric pressure at a temperature of 100° C.;2) continuous expressing with at least one compression screw, under pressure between 4 and 10 bar, of the plant material bleached in 1) with recovery of the sap;3) filtering the recovered sap in 2) to produce a clarified sap; and4) atomizing the clarified sap to obtain a granulated or finely powdered extract containing at least 5% of rosmarinic acid in weight relative to the total weight of the extract.2. (canceled)3. (canceled)4SalviaRosmarinus officinalisOriganum vulgareMentha piperitaSatureja hortensisMelissa officinalis. The method according to claim 1 , wherein the plant material is selected from sage (ssp) claim 1 , rosemary () claim 1 , oregano () claim 1 , mint () claim 1 , summer savory (L.) claim 1 , and lemon balm (L.).5. (canceled)6. The method according to claim 1 , ...

METHOD AND COMPOSITION FOR THE DETECTION OF ARTHROPODS

The present invention relates to a method and a composition for detecting the presence of arthropods, and/or their eggs, in the hair of the body and/or head of a subject. 2. The method according to claim 1 , wherein the fluorescent pigment a) is selected from the group consisting of: black iron oxide claim 1 , yellow iron oxide claim 1 , red iron oxide claim 1 , Acid yellow 23 (CAS Nr. 1934-21-0) claim 1 , Food Yellow 3 (CAS Nr. 2783-94-0) claim 1 , Acid Red 15 (CAS Nr. 16423-68-0) claim 1 , Acid Red 14 (CAS Nr. 3567-69-9) claim 1 , Acid Red 18 (CAS Nr. 2611-82-7) claim 1 , Acid Blue 9 (CAS Nr. 3844-45-9) claim 1 , Acid Blue 74 (CAS Nr. 860-22-00) and mixtures thereof.3. The method according to claim 1 , wherein the at least one starch is selected from the group consisting of corn starch claim 1 , rice starch claim 1 , potato starch claim 1 , tapioca starch and mixtures thereof.4. The method according to claim 3 , wherein the at least one starch is selected from the group consisting of rice starch and corn starch.5. The method according to claim 1 , wherein the composition further comprises at least one of an alcohol claim 1 , a silicone claim 1 , a plasticizer claim 1 , and mixtures thereof.7. A powder composition in the form of a dry spray comprising:a) a fluorescent pigment suitable for selectively binding to the cuticle of arthropods and emitting fluorescence when exposed to visible or ultraviolet light radiation;b) at least one starch or clay, preferably a starch;c) at least one propellant.8. The composition according to claim 7 , wherein the fluorescent pigment a) is selected from the group consisting of: black iron oxide claim 7 , yellow iron oxide claim 7 , red iron oxide claim 7 , Acid yellow 23 (CAS Nr. 1934-21-0) claim 7 , Food Yellow 3 (CAS Nr. 2783-94-0) claim 7 , Acid Red 15 (CAS Nr. 16423-68-0) claim 7 , Acid Red 14 (CAS Nr. 3567-69-9) claim 7 , Acid Red 18 (CAS Nr. 2611-82-7) claim 7 , Acid Blue 9 (CAS Nr. 3844-45-9) claim 7 , Acid Blue 74 (CAS Nr. ...

COMPOSITION AND A METHOD FOR WOUND HEALING

A herbal composition for wound healing is disclosed. The herbal composition comprises an extract of honeysuckle and an extract of mint in a weight ration of 1:2 to 2:1. The herbal composition further comprises a medical acceptable excipient. 1. A herbal composition comprising an extract of honeysuckle and an extract of mint in a weight ratio of 1:2 to 2:1.2. The herbal composition as claimed in claim 1 , wherein the weight ratio of the extract of honeysuckle and the extract of mint is 1:1.3. The herbal composition as claimed in claim 1 , wherein the extract of honeysuckle is an ethanolic extract via 50% ethanol.4. The herbal composition as claimed in claim 1 , wherein the extract of mint is a water extract of mint.5. The herbal composition as claimed in claim 1 , wherein the herbal composition further comprises a medical acceptable excipient.6. The herbal composition as claimed in claim 5 , wherein the herbal composition comprises 5 wt % of the extract of honeysuckle and 5 wt % of the extract of mint.7. The herbal composition as claimed in claim 5 , wherein the medical acceptable excipient is a polyethylene glycol.8. The herbal composition as claimed in claim 7 , wherein the polyethylene glycol has a molecular weight between 200-10000 kDa.9. A method for wound healing claim 5 , said method comprising administrating an effective amount of the herbal composition as claimed in to a target in need thereof.10. A method for wound healing as claimed in claim 9 , wherein the effective amount of the herbal composition is 0.75 kg/per mof wound area. 1. Field of the InventionThe present invention relates to a composition and, more particularly, to a herbal composition for wound healing. The present invention further relates to a method for wound healing by administrating the herbal composition to a target in need.2. Description of the Related ArtWounds comprising crush wounds, cuts, incisions, squeeze wounds, stab wounds or wounds due to surgery, plastic surgery or chronic ...

Composition Comprising Plants Extracts that Synergistically Treat or Inhibit Pathological Conditions and Method of Making

A composition including plant extracts that synergistically treat or inhibit pathological conditions and a method for developing the composition is provided. The composition includes bioactive chemical agents extracted from the plant species including, but not limited to, acetonide, catalpol, hispidulin, loliolide, neptin, rhamnose, and scutellarin, and bioactive chemical agents extracted from the plant species including, but not limited to, cadinol, diosmetin, eugenol, furfural, hesperidin, luteolin, and piperitone. The method includes the steps of washing and plant material, freezing the plant material, cutting the frozen plant material into pieces, heating the plant material in purified water to form a resultant solution containing and plant extracts, cooling the resultant solution, and filtering the and plant material out of the resultant solution to produce the composition. 1Plantago majorMentha spicata) A composition for inhibiting or treating pathological conditions , the composition comprising an effective amount of a plurality of plant extracts from a plant species and an effective amount of plurality of plant extracts from a plant species.2) A composition for inhibiting or treating pathological conditions , the composition comprising an effective amount of a plurality of plant extracts including acetonide , adenine , allantoin , apigenin , apigenin-7-glucoside , asperuloside , aucubin , baicalein , baicalin , benzoic acid , caffeic acid , catalpol , chlorogenic acid , cinnamic acid , D-glucose , D-xylose , ferulic acid , fumaric acid , geniposidic acid , gentisic acid , glucoraphanin , hispidulin , hydroxycinnamic acid , loliolide , luteolin , luteolin-7-O-beta-D-glucoside , neochlorogenic acid , nepetin , oleanolic acid , P-coumaric acid , P-hydroxybenzoic acid , phenolcarbonic acid , rhamnose , saccharose , salicylic acid , scutellarin , sitosterol , succinic acid , sulforaphane , syringic acid , syringin , tyrosol , ursolic acid , vanillic acid , acetic ...

ANALGESIC COMPOSITIONS AND METHODS OF USE

The invention relates to the fields of pharmacology and medicine, and provides anesthetic compositions and methods for the treatment of pain using compositions comprising Tea tree oil and one or more additional agent. The invention relates to analgesic compositions for the treatment of pain associated with a variety of disorders or conditions, particularly oral or dental disorders or conditions such as alveolar osteitis or dental caries. 1. An anesthetic composition comprising a combination of Tea tree oil and one or more additional agent , comprising 0.1 ml to 1.0 ml of Tea tree oil.2. The anesthetic composition of claim 1 , wherein the ratio of Tea tree oil to the one or more additional agent is a 6:1 part by weight relationship.3. The composition of claim 1 , wherein the additional agent is selected from the group consisting of Ginger root oil claim 1 , Peppermint leaf oil claim 1 , Chamomile flower oil claim 1 , Olive leaf extract oil claim 1 , Grape seed oil claim 1 , Clove oil claim 1 , a flavoring syrup claim 1 , and an additional anesthetic agent.4. The composition of claim 3 , wherein the flavoring syrup is Cherry syrup.5. The composition of claim 3 , wherein the additional anesthetic agent is a topical anesthetic agent.6. The composition of claim 5 , wherein the topical anesthetic agent is selected from the group consisting of benzocaine claim 5 , lidocaine claim 5 , and tetracaine.7. The composition of claim 5 , wherein the topical anesthetic is benzocaine.8. The composition of claim 2 , comprising the Tea tree oil claim 2 , Ginger root oil claim 2 , Peppermint leaf oil claim 2 , Chamomile flower oil claim 2 , Olive leaf extract oil claim 2 , Grape seed oil claim 2 , Clove oil claim 2 , the flavoring syrup claim 2 , and an additional anesthetic agent in a ratio of about a 6:1:1:1:1:1:1:1:1 part by weight relationship.9. The composition of claim 1 , wherein the composition further comprises zinc oxide and/or water soluble poly(ethyleneglycol) (PEG).10. The ...

COMPOSITIONS FOR PERIODONTAL ADJUNTIVE THERAPY

The scaling, root planning, and curettage procedure, even without additional treatment, benefits the patient by providing a reduction in pocket depth. The present disclosure provides high pH periodontal adjuvant compositions that, in conjunction with scaling and root planning, can reduce or eliminate a population of bacteria from a site of periodontal treatment. The compositions are applied as a paste and removed by lavage, thereby reducing or removing an active periodontal infection and allowing the periodontium to return to a state of health. 1. A periodontal adjunct composition consisting of potassium hydroxide , a metal salt , a phenolic compound , an Hreceptor antagonist , and an essential oil , wherein the potassium hydroxide is between about 54% and about 95% by weight; the metal salt is between about 0.5% and about 5% by weight; the phenolic compound is between about 0.5% and about 5% by weight; the essential oil is between about 0.5% and about 5% by weight; and the Hreceptor antagonist is between about 0.1% and about 1% by weight , wherein % by weight is % by weight of the final composition weight.2. The periodontal adjunct composition of claim 1 , wherein the composition is admixed with an excipient.3. (canceled)4. The periodontal adjunct composition of claim 1 , wherein the Hreceptor antagonist is selected from the group consisting of: cimetidine claim 1 , nizatidine claim 1 , famotidine claim 1 , and ranitidine.5. (canceled)6. The periodontal adjunct composition of claim 1 , wherein the phenolic compound is selected from the group consisting of thymol claim 1 , carvacrol claim 1 , cresol claim 1 , estradiol claim 1 , eugenol claim 1 , gallic acid claim 1 , guaiacol claim 1 , methyl salicylate claim 1 , raspberry ketone claim 1 , salicylic acid claim 1 , sesamol claim 1 , tumeric claim 1 , phenol claim 1 , bisphenol A claim 1 , BHT claim 1 , 4-nonylphenol claim 1 , orthophenyl phenol claim 1 , phenolphthalein claim 1 , and xylenol.7. The periodontal ...

Enteric Coated Multiparticulate Composition With Proteinaceous Subcoat

A multiparticulate composition includes a plurality of individual enteric coated cores containing one or more terpene-based active ingredients and having a continuous proteinaceous subcoating layer covering the individual cores and separating the individual cores from their respective enteric coatings. The continuous proteinaceous subcoating layer prevents volatile terpene-based active ingredients from leaving the core, even when the core is heated during processing or stored for long periods above room temperature. The multiparticulate composition may be used to treat gastrointestinal disorders. 1. A multiparticulate dosage form comprising a plurality of individual enteric coated particulates having (a) a solid core containing an effective amount of at least one volatile terpene-based active ingredient , (b) a continuous proteinaceous subcoating over the core , and (c) an enteric coating over the subcoating , the subcoating being effective to prevent the volatile terpene-based active ingredient(s) from substantially penetrating the subcoating and contacting the enteric coating when stored at a temperature of 40 degrees C. and 75% relative humidity from between 1 day to 30 days.2. The multiparticulate composition of claim 1 , wherein the at least one volatile terpene-based active ingredient includes L-menthol from an at least 80% pure L-menthol source.3. The multiparticulate composition of claim 1 , wherein the at least one volatile terpene-based active ingredient includes peppermint oil.4. The multiparticulate composition of claim 1 , wherein the at least one volatile terpene-based active ingredient includes L-menthol from an at least 80% pure L-menthol source dissolved in peppermint oil.5. The multiparticulate composition of claim 1 , wherein the at least one volatile terpene-based active ingredient includes both L-menthol and caraway oil.6. The multiparticulate composition of claim 1 , wherein the at least one volatile terpene-based active ingredient includes ...

Enteric Coated Multiparticulate Composition With Proteinaceous Subcoat

A multiparticulate composition includes a plurality of individual enteric coated cores containing one or more terpene-based active ingredients and having a continuous proteinaceous subcoating layer covering the individual cores and separating the individual cores from their respective enteric coatings. The continuous proteinaceous subcoating layer prevents volatile terpene-based active ingredients from leaving the core, even when the core is heated during processing or stored for long periods above room temperature. The multiparticulate composition may be used to treat gastrointestinal disorders. 1. A method of treating a gastrointestinal disorder in a human subject , the method comprising administering to the subject a multiparticulate dosage form composition effective to treat a gastrointestinal disorder in the subject , the composition comprising a plurality of individual enteric coated cores containing one or more terpene-based active ingredients and a continuous proteinaceous subcoating layer covering the individual cores and separating the individual cores from their respective enteric coatings.2. The method of claim 1 , wherein administering is performed enterally.3. The method of claim 2 , wherein administering is performed orally.4. The method of claim 1 , wherein the one or more terpene-based active ingredients include L-menthol from an at least 80% pure L-menthol source dissolved in a terpene-containing essential oil.5. The method of claim 1 , wherein the one or more terpene-based active ingredients include both L-menthol and caraway oil.6. The method of claim 1 , wherein the one or more terpene-based active ingredients include L-menthol from an at least 80% pure L-menthol source dissolved in peppermint oil.7. The method of claim 1 , wherein the one or more terpene-based active ingredients include both peppermint oil and caraway oil.8. The method of claim 1 , wherein the one or more terpene-based active ingredients include both L-menthol and ...

Essential Oil of Kunzea Ambigua and Methods of Use

A method for treating disease includes the steps of obtaining the essential oil from the plant and administering the essential oil obtained to a human to take internally. The essential oil of the plant has been discovered to act positively against parasitic infestation of humans and animals, and also has been found to have high kill rates against various viral and bacterial infections. 1. A method for treating , or improving a condition that adversely affects digestion , comprising the steps of:{'i': 'Kunzea Ambigua', 'obtaining an essential oil of ; and'}{'i': 'Kunzea Ambigua', 'internally administering the essential oil of obtained in said obtaining step to a human or other animal for alleviating the condition that adversely affects digestion.'}2Kunzea AmbiguaKunzea Ambigua.. The method according to claim 1 , wherein the step of internally administering the essential oil of comprises administering 2-15 drops claim 1 , 2-4 times daily claim 1 , of the essential oil of3. The method according to claim 1 , wherein the condition is one of irritable bowel syndrome claim 1 , tick fever claim 1 , bacterial infection or parasitic infestation affecting digestion claim 1 , cancer of the jaw claim 1 , hemorrhoids or mouth or tooth abscess.4Kunzea AmbiguaKunzea AmbiguaKunzea Ambigua. The method according to claim 1 , wherein the step of internally administering the essential oil of is carried out by internally administering one to three drops of the essential oil of per 10 to 15 kilograms of body weight of a patient and repeating treatment with every six to 12 hours for 4 to 7 days.5Kunzea AmbiguaKunzea Ambigua. The method according to claim 3 , wherein said step of internally administering the essential oil of per 10 kilograms of body weight of a patient and repeating treatment with every six hours is performed for at least two days.6Kunzea Ambigua.. The method according to claim 1 , wherein the condition is a tooth abscess and the administration step comprises internally ...

EXTERNAL-USE MEDICAMENT FOR CLEANING AND CARE OF THE OVARIES, VAGINA AND VULVA

An external-use agent for cleaning and caring ovaries, vagina and vulva, which is produced by medical raw materials consisting of propolis extract, zedoary oil, and mint leaf filtrate is provided. On the basis of different properties of each natural Chinese herbal material, using supercritical COtechnology, separation and extraction, and low-temperature centrifugation are carried out respectively, and they are processed for preparation in a proportion, and then the membrane separation is performed, so that a spraying agent or a caring product is manufactured. It may be used alone in a female reproductive system for preventing the repeated infection and for achieving vulval bacteriostatic or antibacterial purposes and cleaning and deodorizing the vagina, eliminating vulval pruritus, and refreshing and moisturizing vulva and vagina etc., with good cleaning and caring functions and achieving a significant effect. 1. An external-use agent for cleaning and caring ovaries , vagina and vulva , characterized in that the external-use agent , is manufactured using raw materials , as active ingredients , based on parts by weight as follows:Propolis extract 1˜10,Zedoary oil 5˜10, andMint leaf filtrate 50˜100,wherein a method for preparing the external-use agent comprises following process steps of:{'sub': 2', '2, 'preparing the propolis extract, including: loading raw propolis into a COextraction tank and circularly adding COliquid to perform extraction with an extraction temperature of 15˜30° C., an extraction pressure of 8˜10 MPa, and extraction time of 1 to 2 hours, to obtain the propolis extract, a propolis content of which is 1% to 3% of amount of the raw propolis;'}{'sub': 2', '2, 'preparing the zedoary oil, including: directly loading zedoary seeds into a COextraction tank and circularly adding COliquid to perform extraction with an extraction temperature of 20˜30° C., an extraction pressure of 2˜7 MPa, and extraction time of 1˜2 hours, to obtain zedoary oil extract ...

Nanoparticle-stabilized microcapsules, dispersions comprising nanoparticle-stabilized microcapsules, and method for the treatment of bacterial biofilms

A stabilized microcapsule includes a liquid hydrophobic core including an essential oil and an aromatic monoaldehyde, and a shell encapsulating the core, the shell including a plurality of amino-functionalized inorganic nanoparticles. Also disclosed is a dispersion including a plurality of the stabilized microcapsules. The microcapsules and dispersions can be particularly useful for treating a bacterial biofilm.

Enteric Coated Multiparticulate Compositions With A Proteinaceous Subcoat

A method of treating a gastrointestinal disorder includes administering to a patient an effective amount of a multiparticulate dosage form including a plurality of individual spheroidal enteric coated cores having a diameter of 0.1 mm to 3 mm. The individual spheroidal enteric coated cores have (a) a core including menthol, (b) a proteinaceous subcoating over the core, and (c) an enteric coating over the proteinaceous subcoating. The multiparticulate dosage form is configured to release most of the menthol in the area of the GI tract where the inflammation is occurring. 1. A method of treating irritable bowel syndrome , the method comprising:administering to a patient having irritable bowel syndrome an effective amount of a multiparticulate dosage form including a plurality of individual spheroidal enteric coated cores having a diameter of 0.1 mm to 3 mm;the individual spheroidal enteric coated cores comprising (a) a core including menthol, (b) a proteinaceous subcoating over the core, and (c) an enteric coating over the proteinaceous subcoating; andwherein the multiparticulate dosage form is configured to release most of the menthol in a small intestine of the patient.2. The method of claim 1 , wherein the multiparticulate dosage form is configured to gradually release the menthol into the small intestine over 4 to 8 hours from passing a pyloric sphincter of the patient.3. The method of claim 1 , wherein the multiparticulate dosage form is configured to release 20% or less of the menthol into a stomach of the patient and 20% or less of the menthol into a colon of the patient.4. The method of claim 1 , wherein the effective amount is effective for relieving symptoms of irritable bowel syndrome including at least one of abdominal pain claim 1 , cramps claim 1 , and diarrhea.5. The method of claim 1 , wherein the individual spheroidal enteric coated cores comprise 10% w/w to 35% w/w menthol claim 1 , 40% w/w to 75% w/w microcrystalline cellulose claim 1 , and 2% w/w ...

SKIN SALVE FOR TREATING INTERTRIGO

The subject patent discloses a method for treating intertrigo on the underside of a female breasts which comprises (1) applying a skin salve to the underside of the female breasts, wherein the female breasts are dry, and wherein the skin salve is comprised of (i) petrolatum, (ii) from 11 weight percent to 60 weight percent beeswax, and (iii) from 0.25 weight percent to 10 weight percent peppermint oil, wherein the skin salve has a viscosity at 25° C. which is within the range of 11 Pa·s to 15 Pa·s at a shear rate of 35 l/s, and (2) allowing the skin salve to remain in contact with female breasts for a period of at least 4 hours. 1. A method for treating intertrigo on the underside of a female breasts which comprises (1) applying a skin salve to the underside of the female breasts , wherein the female breasts are dry , and wherein the skin salve is comprised of (i) petrolatum , (ii) from 11 weight percent to 60 weight percent beeswax , and (iii) from 0.25 weight percent to 10 weight percent peppermint oil , wherein the skin salve has a viscosity at 25° C. which is within the range of 11 Pa·s to 15 Pa·s at a shear rate of 35 l/s , and (2) allowing the skin salve to remain in contact with female breasts for a period of at least 4 hours.2. The method as specified in wherein the skin salve is void of water.3. The method as specified in wherein the beeswax is present in said salve at a level which is within the range of 12 weight percent to 20 weight percent.4. The method as specified in wherein the peppermint oil is present in said salve at a level which is within the range of 1 weight percent to 3 weight percent.5. The method as specified in wherein the beeswax is present in said salve at a level which is within the range of 14 weight percent to 18 weight percent.6. The method as specified in wherein the peppermint oil is present in said salve at a level which is within the range of 1.2 weight percent to 2 weight percent.7. The method as specified in wherein the beeswax ...

MINT MASK AND METHODS OF USE THEREOF

Provided are methods and devices useful for treating a respiratory disease or disorder involving the central or upper airways. The methods and devices deliver to central or upper airways of a subject a vapor or aerosol comprising an effective amount of an active ingredient selected from the group consisting of menthol, menthone, neomenthol, isomenthol, and menthofuran. The methods are useful for treating conditions including cough, asthma, bronchitis, and allergic rhinitis. 1. A method of treating a respiratory disease or disorder involving the central airways , comprising administering to the central airways of a subject in need thereof a vapor or aerosol comprising a therapeutically effective amount of an active pharmaceutical ingredient (API) selected from the group consisting of menthol , menthone , neomenthol , isomenthol , menthofuran , and any combination thereof.2. The method of claim 1 , wherein the API comprises menthol.3. The method of claim 1 , wherein the API is provided as volatile oil of peppermint.4. The method of claim 1 , wherein the API is administered in conjunction with a rebreathing device.5. The method of claim 4 , wherein the rebreathing device comprises a semi-porous substrate impregnated with the API.6. The method of claim 4 , wherein the rebreathing device is a mask comprising a semi-porous substrate impregnated with the API claim 4 , and the mask is constructed and arranged to fit over nose claim 4 , mouth claim 4 , or both nose and mouth of the subject.7. The method of claim 4 , wherein the rebreathing device is breath-activated.8. The method of claim 1 , wherein the vapor or aerosol is delivered to the central airways by inhalation by the subject.9. The method of claim 1 , wherein the respiratory disease or disorder involving the central airways is asthma.10. The method of claim 1 , wherein the respiratory disease or disorder involving the central airways is bronchitis.11. The method of claim 1 , wherein the respiratory disease or ...

HERBAL SUPPLEMENTS AND METHODS OF USE THEREOF

In one embodiment, the present application provides an herbal supplement and method for treating bloating, constipation and/or weight gain in a human subject comprising orally administering to a subject in need thereof an effective amount of the herbal supplement comprising a red quebracho extract. In other embodiments, the supplement may additionally include a triterpenoid saponin, an anti-spasmodic agent, or both. 1. A method for treating bloating , constipation and/or weight gain in a human subject , comprising:orally administering to a human subject in need thereof an herbal supplement comprising condensed tannins in an amount effective to reduce bloating, constipation and/or weight gain in a human subject.2. The method of claim 1 , wherein the condensed tannins are administered from a red quebracho extract in the herbal supplement.3. The method of claim 2 , wherein the herbal supplement further comprises an herbal composition comprising an anti-spasmodic agent.4. The method of claim 3 , wherein the anti-spasmodic agent is provided in the form of a peppermint oil.5. The method of claim 2 , wherein the herbal supplement further comprises an herbal composition comprising a triterpenoid saponin.6AesculusSatindus. The method of claim 5 , wherein the triterpenoid saponin is provided in the form of an or species plant extract.7. The method of claim 5 , wherein the herbal supplement further comprises an herbal composition comprising an anti-spasmodic agent.8Aesculus hippocastanum. The method of claim 7 , wherein the herbal supplement is formulated in a dosage form that comprises between about 20 to 500 mg of red quebracho extract; between about 0.1 to about 2 mg of plant extract; and between about 0.05 to about 1 ml of peppermint oil.9. The method of claim 1 , wherein the herbal supplement further comprises a nutraceutically acceptable carrier.10. The method of claim 1 , wherein the human subject suffers from irritable bowel syndrome claim 1 , functional constipation ...

NASAL DEVICES

A delivery device capable of being mounted or attached outside the nose to a nasal device, wherein said delivery device is adapted to deliver, spread or emit inhalable compositions or substances such as inhalable fumes from said delivery device to the nasal passages of the nose so as to be inhaled by the user, such as during respiration, when in use. Nasal devices such as nasal dilator devices comprising same, and cases for storing and housing same. 1. A nasal device for facilitating or enhancing respiration of a user , comprising:a delivery device for providing an inhalable composition for inhalation by the user, the delivery device comprising a holder for a source of the inhalable composition to be received and/or supported on a frame member of the nasal device such that the source of the inhalable composition, when provided in the holder in use, is located outside of and adjacent to at least one nostril of the user, wherein the source is configured to emit or diffuse the inhalable composition for inhalation by the user.2. A nasal device according to claim 1 , wherein the holder is provided on one or more frame member of the nasal device and comprises at least one of:a receptacle configured to be filled with the source of the inhalable composition;a substrate configured to be filled with the source of the inhalable composition; andmeans for mounting or attaching a receptacle or a substrate configured to be filled with the source of the inhalable composition.3. A nasal device according to claim 2 , wherein the substrate is an absorbent substrate.4. A nasal device according to or claim 2 , wherein the means for mounting or attaching the receptacle or substrate forms a recess for receiving and accommodating or housing the receptacle or substrate on one or more frame members of the nasal device.5. A nasal device according to claim 4 , wherein the means for mounting or attaching the receptacle or substrate forms a recess for removably receiving and accommodating or ...

TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF

The invention is directed to a topical composition comprising one or more topical active ingredients, one or more nonionic surfactants and one or more viscosity enhancers. The invention is further directed to a method of treating topical conditions comprising applying a composition of the present invention to a subject in need thereof. 1. A topical composition comprising one or more topical active ingredients , one or more nonionic surfactants and one or more viscosity enhancers.2. The composition of claim 1 , wherein the one or more topical active ingredients is selected from the group consisting of a topical analgesic claim 1 , a hemorrhoid treatment compound claim 1 , an acne treatment compound claim 1 , an anti-wrinkle compound claim 1 , an anti-scar compound and mupirocin.3. The composition of claim 1 , wherein the one or more topical active ingredients is one or more topical analgesics selected from the group consisting of lidocaine claim 1 , lidocaine hydrochloride claim 1 , menthol claim 1 , camphor claim 1 , methyl salicylate claim 1 , cajuput oil claim 1 , dementholised mint oil and clove oil.4. The composition of claim 1 , wherein the one or more topical active ingredients is one or more hemorrhoid treatment compounds selected from the group consisting of hydrocortisone claim 1 , phenylephrine hydrochloride and pramoxine hydrochloride.5. The composition of claim 1 , wherein the one or more topical active ingredients is one or more acne treatment compounds selected from the group consisting of benzoyl peroxide claim 1 , salicylic acid claim 1 , azelaic acid claim 1 , dapsone claim 1 , resorcinol erythromycin and clindamycin.6. The composition of claim 1 , wherein the one or more topical active ingredients is one or more anti-wrinkle compounds selected from the group consisting of retinol claim 1 , tretinoin claim 1 , isotretinoin claim 1 , alitretinoin claim 1 , etretinate claim 1 , acitretin claim 1 , adapalene and tazarotene claim 1 , vitamin C claim 1 , ...

Compositions and Methods for Joint Health

The present disclosure provides mixtures of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both capable of modulating joint inflammation, joint pain, joint stiffness, cartilage degradation, or improving mobility, range of motion, flexibility, joint physical function, or any combination thereof. Such a mixture of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both can optionally be used in combination with other joint management agents, such as non-steroidal anti-inflammatory agents/analgesics, COX/LOX inhibiting agents, glucosamine compounds, neuropathic pain relief agents, or the like.

Eye-refreshing agent to eliminate and alleviate eye fatigue and discomfort

An eye-refreshing agent, the raw materials of which include mung bean germs, eucalyptus leaves, mint leaves, clove leaves, camphor leaves and borneol. The plant cells thereof are respectively subjected to crushing, low-temperature freezing and centrifugation and sound membrane separation to prepare a water-soluble preparation. The preparation can prevent and alleviate visual fatigue and accelerate metabolism of the eye skin cells, and also has the effect of alleviating and improving eye bags and eye pseudo-wrinkles caused by eye fatigue.

PLANT EXTRACTS FOR IMPROVING COGNITIVE FUNCTION

Extracts of plants of the Lamiaceae family, including the genus, are shown to have a positive impact on overall cognitive health, including improvements in memory, reasoning, attention/concentration, planning, mood, sleep and associated behaviors. 1. A method to enhance , improve or sustain cognitive health and/or function in a mammal , comprising administering an efficacious amount of an extract of a plant of the Lamiaceae family , wherein the primary active ingredients are rosmarinic acid and plant polyphenols.2. (canceled)3. The method of claim 1 , wherein the plant is selected from the group consisting of basil claim 1 , mint claim 1 , sage claim 1 , savory claim 1 , marjoram claim 1 , oregano claim 1 , thyme claim 1 , lavender claim 1 , spearmint claim 1 , and rosemary.4Mentha. The method of claim 1 , wherein the plant is selected from the genus.5. The method of claim 1 , wherein the extract comprises at least 8% rosmarinic acid by weight.6. The method of claim 1 , wherein the efficacious amount is between 0.01 and 50 mg/kg/day.7. (canceled)8. The method of claim 1 , wherein the extract is administered chronically.9. (canceled)10. The method of claim 1 , wherein administration of the extract improves learning claim 1 , executive function claim 1 , memory claim 1 , mood claim 1 , or sleep.11. The method of claim 1 , wherein administration of the extract improves quality of life.12. (canceled)13. (canceled)14. (canceled)15. (canceled)16. (canceled)17. (canceled)18. (canceled)19. (canceled)20. (canceled)21. (canceled)22. (canceled)23. (canceled)24. (canceled)25. A method for improving mood in a mammal comprising administering an efficacious amount of an extract of a plant of the Lamiaceae family claim 1 , wherein the primary active ingredients are rosmarinic acid and plant polyphenols.26. (canceled)27. The method of claim 25 , wherein the plant is selected from the group consisting of basil claim 25 , mint claim 25 , sage claim 25 , savory claim 25 , marjoram ...

Moisturizing gel for preventing or healing injured nipples or areola in my mammalian females

The present invention provides a composition and method for preventing or healing injured nipples or areolas in mammalian females utilizing components of water, peppermint oil and poloxamer in a synergistic ratio 1. A dermatological composition for preventing or healing injured nipples or areolas in mammalian females , comprising:Water;Peppermint Oil;Poloxamer 407; said composition in a synergistic ration ofH2O 1:Poloxamer 407 0.20-0.25:Peppermint Oil 0.0020-0.0027.2. The composition of wherein the synergistic ratio isH2O 1:Poloxamer 407 0.23-0.24:Peppermint Oil 0.0023-0.00253. The composition of wherein the synergistic ratio isH2O 1:Poloxamer 407 0.22-0.24:Peppermint Oil 0.0024-0.00254. A method of preparing a dermatological composition as recited in used as a skin cream or balm claim 1 , said comprising the following steps:placing 10 μm of Poloxamer 407, N.F. into a 4 oz. glass mortar;adding and triturating 20 mL of cold Water for Injection (WATER USP) is with a pestle until uniform;scraping of the pestle will be necessary with the wetted Poloxamer being returned to the mortar;adding and triturating an additional 20 mL of cold WATER USP is added and triturated again until uniform. 2 mL of drawing Peppermint Oil, USP into a glass syringe and adding to the content of the mortar and mixed until uniform;adding an additional 30 ml of cold WATER USP until the mixture becomes smooth and milky in appearance;transferring the mixture to a one liter, wide-mouth bottle with screw cap;adding 60 mL cold WATER USP to the mortar and swirling with the pestle to rinse, subsequently adding to the one liter bottle;adding an additional 700 mL of cold WATER USP is added to the one liter bottle, a cap is secured tightly one the one liter bottle, and shaken vigorously for 30 seconds;adding 220 μm of Poloxamer 407 to the one-liter bottle, the cap secured tightly, and shaken vigorously for 30 seconds;placing the one liter bottle into a 4 degree C. refrigerator for one hour;removing the ...

TOPICAL ANALGESIC

One or more of embodiments of the present invention generally concern a topical analgesic, which can be used to treat painful skin ailments. The topical analgesic can comprise 8 to 40 weight percent of methanol and 0.05 to 5 weight percent of one or more essential oils selected from the group consisting of spearmint essential oil, lavender essential oil, eucalyptus essential oil, lemon essential oil, peppermint essential oil, basil essential oil, and wintergreen essential oil. Furthermore, the topical analgesic can comprise less than 1 weight percent of parabens and less than 1 weight percent of gluten. In addition, the topical analgesic can meet one or more of the following criteria: (i) the topical analgesic comprises less than 10 weight percent of methyl salicylate and (2) the topical analgesic comprises less than 3 weight percent of camphor. 1. A topical analgesic comprising:8 to 40 weight percent menthol; and0.05 to 5 weight percent of one or more essential oils selected from the group consisting of spearmint essential oil, lavender essential oil, eucalyptus essential oil, lemon essential oil, peppermint essential oil, basil essential oil, and wintergreen essential oil,wherein said topical analgesic comprises less than 1 weight percent parabens and less than 1 weight percent gluten,wherein said topical analgesic meets one or more of the following criteria—(i) said topical analgesic comprises less than 10 percent methyl salicylate,(ii) said topical analgesic comprises less than 3 percent camphor.2. The topical analgesic of claim 1 , wherein said topical analgesic comprises menthol in an amount in the range of from 10 to 25 weight percent.3. The topical analgesic of claim 1 , wherein said topical analgesic comprises at least three of the following essential oils: spearmint essential oil claim 1 , lavender essential oil claim 1 , eucalyptus essential oil claim 1 , lemon essential oil claim 1 , peppermint essential oil claim 1 , basil essential oil claim 1 , and ...

CANNABINOID AND MENTHOL GUM AND LOZENGE COMPOSITIONS AND METHODS

The present disclosure relates to chewing gum or lozenge with cannabinoids and menthol including a liquid-filled chewing gum or lozenge with a chewing gum base shell or lozenge candy shell enclosing an internal void therein and a liquid filling in the void, the liquid-filled chewing gum or lozenge including cannabinoids and menthol. 1. A chewing gum or lozenge product , comprising:at least one cannabinoid is in an amount of from about 0.1 wt % to about 10 wt %;an effective amount of menthol.2. The chewing gum or lozenge product of claim 1 , wherein the at least one cannabinoid includes full spectrum hemp oil.3. The chewing gum or lozenge product of claim 1 , wherein the at least one cannabinoid includes less than 0.3 wt % THC.4. The chewing gum or lozenge product of claim 1 , wherein the menthol is in an amount of from about 0.1 wt % to about 14 wt %.5. The chewing gum or lozenge product of claim 1 , further including at least one of an anti-oxidant claim 1 , a colorant claim 1 , a flavoring claim 1 , a flavor enhancer claim 1 , a preservative claim 1 , a salivary stimulating agent claim 1 , a cooling agent claim 1 , a co-solvents claim 1 , an emollient claim 1 , a bulking agent claim 1 , an anti-foaming agent claim 1 , a surfactant claim 1 , a sweetening agent claim 1 , a filler and a taste-masking agent.6. The chewing gum or lozenge product of claim 5 , wherein the filler is in an amount of from about 15 wt % to about 40 wt % and the sweetening agent is in an amount of from about 0.005 wt % to about 5 wt %.7. The chewing gum or lozenge product of claim 5 , wherein the salivary stimulating agent is citric acid in an amount of from about 0.1 wt % to about 10 wt %.8. The chewing gum or lozenge product of claim 1 , further including an exterior sugar coating.9. A filled chewing gum or lozenge product including a shell enclosing an internal void therein and a filling in the void claim 1 , the filled chewing gum or lozenge product comprising:full spectrum hemp oil in an ...

AUTISM IMPROVING AGENT AND AUTISM IMPROVING TEA

Provided is an improving agent that is more suitable to improvement of autism, the agent having reduced side effects thanks to the suppression of the immunological factors. An autism improving agent is provided that is characterized in that the inventive agent contains celery seed, wheat, lemon balm, mint, fenugreek seed, laurel, brown sugar powder and rosemary and that the agent has an effect of improving the symptoms relative to autism. 1stevia,. An autism improving agent characterized in that the inventive agent contains celery seed , wheat , lemon balm , mint , fenugreek seed , laurel , brown sugar powder and rosemary and that the agent has an effect of improving the symptoms relative to autism.2stevia,. The autism improving agent according to claim 1 , characterized in that it contains 2 to 8 grams of celery seed claim 1 , 0.5 to 4 grams of wheat claim 1 , 2 to 8 grams of lemon balm claim 1 , 0.5 to 3 grams of mint claim 1 , 1 to 6 grams of fenugreek seed claim 1 , 0.5 to 4 grams of 1 to 6 grams of laurel claim 1 , 0.1 to 2 grams of brown sugar powder claim 1 , and 1 to 6 grams of rosemary.3stevia,. An autism improving tea characterized in that the inventive agent contains celery seed claim 1 , wheat claim 1 , lemon balm claim 1 , mint claim 1 , fenugreek seed claim 1 , laurel claim 1 , brown sugar powder and rosemary and that the agent has an effect of improving the symptoms relative to autism.4stevia,. The autism improving tea according to claim 3 , characterized in that it contains 2 to 8 grams of celery seed claim 3 , 0.5 to 4 grams of wheat claim 3 , 2 to 8 grams of lemon balm claim 3 , 0.5 to 3 grams of mint claim 3 , 1 to 6 grams of fenugreek seed claim 3 , 0.5 to 4 grams of 1 to 6 grams of laurel claim 3 , 0.1 to 2 grams of brown sugar powder claim 3 , and 1 to 6 grams of rosemary. The present invention relates to an autism improving agent, autism improving tea and a producing method thereof, and in particular, to a more effective autism improving agent ...

Herbal Tea Products and Methods

An herbal tea product is provided to provide relief from lung and breathing conditions such as asthma. The herbal tea product may include oregano, peppermint, OSHA root, lungwort, eucalyptus, plantain leaf, chaparral, elecampane, lobelia, sage, licorice root, and thyme. The herbal ingredients may be included in equal amounts, such as 5 ounces. The OSHA root, elecampane, and/or licorice root may be crushed. Methods of making and using the herbal tea product are also disclosed. The herbal tea product may be placed into tea bags, and prepared for human consumption by placing the tea bag with herbal tea product in hot water that has been brought to a boil. The herbal tea product may be consumed in appropriate amounts, such as 16 ounces, twice a day for two weeks, and then once a day thereafter.

Multiparticulate L-Menthol Formulations and Related Methods

A pharmaceutical dosage form includes an effective amount of L-menthol for treating a gastrointestinal disorder. The L-menthol is within a plurality of particulates having a core including crystalline L-menthol dissolved in a terpene-based essential oil. A proteinaceous coating of a continuous film of proteinaceous material is over the core.

AQUEOUS IONIC SOLUTION CONTAINING SEAWATER AND AT LEAST ONE COMPOUND THAT IS ORIGINALLY IMMISCIBLE WITH SEA WATER

The invention relates to an aqueous ionic solution, particularly for nasal use, including: at least one seawater solution having an osmolality of between 290 mOsm/kg and 400 mOsm/kg in a weight proportion of between about 30 and 98 wt % relative to the total weight of the composition; at least one cationic phospholipid of natural origin in a weight proportion of between about 0.01 and 5 wt % relative to the total weight of the composition; and at least one compound, which is originally immiscible with said seawater solution, in a weight proportion of between 0.01 and 10 wt % relative to the total weight of the composition. 1. Aqueous ionic solution , in particular intended for nasal use , comprising at least:a solution based on seawater having an osmolarity lying, for an isotonic solution, between 250 mOsm/kg and 350 mOsm/kg or, for a hypertonic solution, an osmolarity above 350 mOsm/kg, in a proportion by mass lying between approximately 25% and 98% with respect to the total mass of said aqueous ionic solution,at least one cationic phospholipid of natural origin in a proportion by mass lying between approximately 0.01% and 5% with respect to the total mass of said aqueous ionic solution,at least one compound originally immiscible with said solution based on seawater in a proportion by mass lying between approximately 0.01% and 10% with respect to the total mass of said aqueous ionic solution.2. Aqueous ionic solution according to claim 1 , characterised in that it comprises at least:said solution based on seawater having an osmolarity of between 290 mOsm/kg and 350 mOsm/kg for an isotonic solution or an osmolarity greater than 350 mOsm/kg for a hypertonic solution, in a proportion by mass between approximately 90% and 98% with respect to the total mass of said aqueous ionic solution,said at least one cationic phospholipid of natural origin, in a proportion by mass of between approximately 0.10% and 0.20% with respect to the total mass of said aqueous ionic solution ...

HERBAL SUPPLEMENTS AND METHODS OF USE THEREOF

In one embodiment, the present application provides an herbal supplement and method for treating bloating, constipation and/or weight gain in a human subject comprising orally administering to a subject in need thereof an effective amount of the herbal supplement comprising a red quebracho extract. In other embodiments, the supplement may additionally include a triterpenoid saponin, an anti-spasmodic agent, or both. 1. A method for treating bloating , constipation and/or weight gain in a human subject , comprising:orally administering to a human subject in need thereof an effective amount of a herbal supplement comprisinga red quebracho extract;an herbal composition comprising a triterpenoid saponin; andan anti-spasmodic agent, wherein the red quebracho extract is present in the herbal supplement in an amount between about 0.5% to about 75% by weight of the total supplement, wherein the herbal composition is present in the herbal supplement in an amount between about 10% to about 90% by weight of the total supplement, wherein the anti-spasmodic agent is present in the herbal supplement in an amount between about 2% to about 70% by weight of the total supplement.2. (canceled)3. (canceled)4. The method of claim 1 , wherein the anti-spasmodic agent is provided in the form of a peppermint oil.5. (canceled)6AesculusSatindus. The method of claim 1 , wherein the triterpenoid saponin is provided in the form of an or species plant extract.7. (canceled)8Aesculus hippocastanum. The method of claim 1 , wherein the herbal supplement is formulated in a dosage form that comprises between about 20 to 500 mg of red quebracho extract; between about 0.1 to about 2 g of plant extract; and between about 0.05 to about 1 ml of peppermint oil.9. The method of claim 1 , wherein the herbal supplement further comprises a nutraceutically acceptable carrier.10. The method of claim 1 , wherein the human subject suffers from irritable bowel syndrome claim 1 , functional constipation claim 1 , ...

Method and product for headache relief

A novel product for headache relief and use of the product to treat headaches is disclosed herein. The product may be applied topically, and may be used for acute treatment of headaches to provide a safe, effective, and natural alternative to traditional therapies used to treat acute headache syndromes. The product comprises one or more herbal therapeutic agents. In some embodiments, the one or more herbal therapeutic agents may be combined with allopathic or other traditional headache therapies. In preferred embodiments, the product is applied to select myofascial trigger points. (MTPs) on the temporal, frontal, mastoid, and cervical regions. The product may be available over-the-counter or otherwise may be available without a physician's prescription.

Volatile Distillate By-Product of Mint Oil That Promotes Absorption and/or Bioavailability of Compounds of Bio-Medical and Nutritional Interest

Disclosed is an adjuvant for improving the bioavailability of bioactive compositions. The adjuvant is prepared from a byproduct of mint flavor production. In vitro and in vivo testing confirms effectiveness. The adjuvant contains a mixture of compounds which is effective to improve the oral bioavailability of a bioactive composition normally having limited absorptivity, and it comprises a mixture of nonpolar compounds and compounds with some polar characteristics. In preferred form the nonpolar compounds comprise compounds selected from a group that includes terpene hydrocarbons and terpene derivatives and the compounds with some polar characteristics comprise compounds selected from a group that includes aldehydes, alcohols and ketones. The preferred compositions will have a ratio of nonpolar compounds and compounds with some polar characteristics is within the range of from 5:1 to 20:1. The adjuvants can enhance delivery of CoQ10 and other bioactive compositions, such as carotenoids (e.g., β-carotene), curcuminoids, lycopene, resveratrol, flavonoids and other phenolic compounds, organosulfur compounds, saponins, sterols, stanols, and mixtures of at least two of these, to the interior cellular environment, including organelles, such as the mitochondria.

TOPICAL COMPOSITION

A topical composition is provided that includes at least three plant extracts selected from the group consisting of: lavender, calendula, rosemary, peppermint, myrrh, frankincense, helichrysum and aloe. The plant extracts in are dissolved or suspended in a carrier. The topical composition in some embodiments has each of said at least three plant extracts present in an amount of from 0.1 to 60 total weight percent of an inventive composition, with the total amount of plant extracts being between 2 and 90 total weight percent. A method of treating irradiated skin includes the application of such a composition to skin after medical irradiation, then allowing sufficient time for the skin to heal. A method of inhibiting radiation dermatitis includes the application of such a composition to skin prior to medical irradiation, then irradiating the skin ionizing radiation. 1. A topical composition , comprising:at least three plant extracts selected from the group consisting of: lavender, calendula, rosemary, peppermint, myrrh, frankincense, helichrysum and aloe; anda carrier in which each of said at least three plant extracts are dissolved or suspend.2. The topical composition of claim 1 , wherein said at least three plant extracts are four plant extracts.3. The topical composition of claim 1 , wherein said at least three plant extracts are five plant extracts.4. The topical composition of claim 1 , wherein said at least three plant extracts are six plant extracts.5. The topical composition of claim 1 , wherein said at least three plant extracts are seven plant extracts.6. The topical composition of claim 1 , wherein said at least three plant extracts are eight plant extracts.7. The topical composition of wherein each of said at least three plant extracts is present in an amount of from 0.1 to 60 total weight percent of an inventive composition claim 1 , with the total amount of plant extracts being between 2 and 90 total weight percent.8. The topical composition of wherein ...

Device for diffusing a prescribed mist specific to a user's emotional mental state Rx diffuser

Disclosed is a device and method for diffusing a therapeutic specific to a user's emotional/mental state (EMS), comprising the steps of: selecting (or assessing) at least one EMS, said selected (or assessed) EMS indicating at least one of an emotion, mental, and/or physical state of the user; and activating the ultrasonic membrane of the at least single reservoir (optionally, a plurality of reservoirs) housing the mist specific to the selected/assessed EMS, wherein said activation results in a vibration of the membrane causing an ultra-sonic frequency resulting in the atomization and diffusion of the prescribed mist based on the user-selected (or assessed) EMS. 1. A device for diffusing a therapeutic specific to a user's emotional/mental state (EMS) , said device comprising of:a housing;a reservoir bank within said housing, wherein said bank comprises a plurality of reservoirs;each reservoir comprising an ultrasonic membrane at one end and a diffusion pathway at the opposing end coupled to a diffusion outlet;a mist prescriber;a processor coupled to a memory element with instructions, said processor when executing said memory-stored instructions, configure the device to allow:a user-selected or system-assessed EMS specific to the user, said selected/assessed EMS indicating at least one of an emotion, mental, and/or physical state of the user; andthe mist prescriber activating the ultrasonic membrane of the reservoir housing the mist specific to the selected/assessed EMS, wherein said activation results in a vibration of the membrane causing an ultra-sonic frequency resulting in the atomization and diffusion of the prescribed mist based on the selected/assessed EMS.2. The device of claim 1 , wherein the EMS selected by the user is categorized as at least one of Dopamine claim 1 , Serotonin claim 1 , Epinephrine claim 1 , Norepinephrine claim 1 , Endorphin claim 1 , Acetylcholine claim 1 , Oxytocin claim 1 , or GABA neurotransmitters (NT).3. The device of claim 1 , ...

POWDER FOR DELIVERY TO THE ORAL CAVITY

A powder for delivery to the oral cavity of a user is disclosed. The powder includes at least two populations of particles. A first population of particles includes a stimulant, and a second population of particles includes a flavorant. Also described is a cartridge containing the powder for use in an inhaler device and inhaler device containing the powder. 1. A powder for delivery to the oral cavity of a user comprising:at least two populations of particles, wherein a first population of particles comprises a stimulant, and a second population of particles comprises a flavorant.2. A powder according to claim 1 , consisting of three claim 1 , four claim 1 , five claim 1 , or six populations of particles.3. A powder according to claim 1 , wherein the sensations provided by the at least two populations of particles demonstrate different rates of at least one of perception or duration.4. A powder according to claim 1 , wherein the mean particle size of one of the populations of particles is less than 50% of the mean particle size of a different population of particles.5. A powder according to claim 4 , wherein one population of particles has a mean particle size of 7-350 μm claim 4 , and a different population of particles has a mean particle size of 350-750 μm.6. A powder according to claim 1 , wherein the first population of particles has a smaller mean particle size and comprises a stimulant claim 1 , and the second population of particles has a larger mean particle size and comprises a flavorant claim 1 , and wherein the stimulant is capable of being perceived quickly by the user and taking effect rapidly claim 1 , and the flavorant is capable of being perceived later and persisting for a longer duration.7. A powder according to claim 1 , wherein at least one of the particle populations comprises a tobacco extract.8. A powder according to claim 1 , wherein the stimulant comprises nicotine claim 1 , caffeine claim 1 , theophylline claim 1 , or theobromine.9. A ...

SKIN SENSITIZER DELIVERY SYSTEM

A skin-sensitizing formulation is provided in an edible, softgel pill. A person engaged in a sexual activity bites down on the pill, thereby effectuating the oral release of the skin-sensitizing formulation. This allows the skin-sensitizing formulation to be spread to a sexual partner, on any part of the skin or sexual region of the body preferably through oral contact with the partner. The skin-sensitizing substance is spread to the partner directly on the skin or through oral contact or beneath a condom worn by the partner. The skin-sensitizing formulation may include an essential mint oil, analog or derivative, and may further includes an enhancer, rubefacient, counterirritant, anesthetic, k-opioid receptor activator, or TRPM8 activator. Various inactive ingredients are also disclosed. 1. A method of delivering a skin-sensitizing substance , comprising the steps of:providing a skin-sensitizing formulation in an edible, softgel pill;biting down on the pill to effectuate the oral release of the skin-sensitizing formulation; andspreading the skin-sensitizing formulation to a sexual partner through oral contact.2. The method of claim 1 , wherein the skin-sensitizing formulation includes an essential mint oil.3. The method of claim 1 , wherein the skin-sensitizing formulation includes mentha piperita.4. The method of claim 1 , wherein the skin-sensitizing formulation includes menthol.5. The method of claim 1 , wherein the skin-sensitizing formulation includes cinnamon oil.6. The method of claim 1 , wherein the skin-sensitizing f01mulation includes cornmint oil.7. The method of claim 1 , wherein the skin-sensitizing formulation includes eucalyptus oil.8. The method of claim 1 , wherein the skin-sensitizing formulation includes citronella oil.9. The method of claim 1 , wherein the skin-sensitizing formulation includes camphor oil.10. The method of claim 1 , wherein the skin-sensitizing formulation further includes an enhancer claim 1 , rubefacient claim 1 , ...

Fragrance compositions comprising essential oils and products comprising same for reducing fatigue and improving brain function

The present technology generally relates to fragrance compositions comprising essential oils and products comprising the same. The present technology also relates to methods of using the fragrance compositions to reduce fatigue and improve executive brain function.

MELALEUCA QUINQUENERVIA EXTRACTS AND USES OF THE SAME

A extract and its uses are provided. The extract is extracted by a first polar solvent, wherein the first polar solvent is a C3-C6 ethanol. The extract is especially useful for inhibiting the Wnt/β-catenin signaling pathway. 1Melaleuca quinquenerviaMelaleuca quinquenervia. A method for inhibiting Wnt/β-catenin signal transduction pathway in a subject comprising administering to the subject in need an effective amount of a extract , wherein the extract is prepared by extracting with a first polar solvent , wherein the first polar solvent is a C3-C6 alcohol.2. The method as claimed in claim 1 , wherein the first polar solvent comprises butanol.3. The method as claimed in claim 1 , wherein the first polar solvent is n-butanol.4. The method as claimed in claim 1 , wherein the extract is prepared by a method comprising the following steps:{'i': 'Melaleuca quinquenervia', '(a) extracting with a second polar solvent to provide a first extraction fluid, wherein the second polar solvent is methanol, water, or a combination thereof;'}(b) partitioning the first extraction fluid with a first polar solvent and collecting the first polar solvent phase; and(c) optionally removing the first polar solvent from the first polar solvent phase.5. The method as claimed in claim 4 , wherein the step (a) includes:{'i': 'Melaleuca quinquenervia', '(a1) extracting the with methanol to provide a methanol extraction fluid;'}(a2) optionally concentrating the methanol extraction fluid to obtain a concentrated solution; and(a3) adding water into the concentrated solution to obtain the first extraction fluid.6. The method as claimed in claim 4 , wherein the method for preparing the extract further comprises at least one of the following steps prior to the step (b):(b1′) partitioning the first extraction fluid with a C5-C8 alkane and removing the alkane phase; and(b2′) partitioning the product of step (b1′) with ethyl acetate and removing the ethyl acetate phase.7Melaleuca quinquenervia.. The ...

NON-PRESCRIPTION MOTION SICKNESS MEDICATION CONTAINING AN ANALGESIC, AN H2 BLOCKER, AND AT LEAST ONE ANTACID

The present invention provides a compounded non-prescription medication for the treatment of motion sickness. The medication comprises: at least one analgesic selected from the group consisting of acetaminophen, ibuprofen, naproxen and salicylates; at least one histamine H-receptor antagonist selected from the group consisting of nizatidine, famotidine, cimetidine, ranitidine. famotidine; and at least one antacid selected from the group consisting of calcium carbonate, sodium bicarbonate, magnesium hydroxide, aluminum hydroxide, and bismuth subsalicylate. The medication may optionally comprise at least one additional ingredient selected from the group consisting of spearmint extract and ginger extract. The formulations are consistent in their effectiveness and devoid of the side effects of drowsiness and dry mouth. A presently preferred embodiment of the medication comprises primarily of ibuprofen, famotidine, calcium carbonate, magnesium hydroxide, spearmint extract and ginger extract. 1. A compounded non-prescription medication for the treatment of motion sickness comprising:at least one analgesic selected from the group consisting of ibuprofen, acetaminophen, naproxen and salicylates;{'sub': '2', 'at least one histamine H-receptor antagonist; and'}at least one antacid.2. (canceled)3. The compounded non-prescription medication of claim 1 , wherein said at least one antacid is selected from the group consisting of calcium carbonate claim 1 , sodium bicarbonate claim 1 , magnesium hydroxide claim 1 , aluminum hydroxide claim 1 , and bismuth subsalicylate.4. The compounded non-prescription medication of claim 1 , wherein said at least one histamine H-receptor antagonist consists primarily of famotidine claim 1 , and said at least one antacid consists primarily of calcium carbonate and magnesium hydroxide.5. (canceled)6. The compounded non-prescription medication of claim 4 , wherein the analgesic is primarily ibuprofen having a mass within a range of about 180 mg to ...

FOUNTAIN OF YOUTH - Steeped Herbal Anti-Bacterial Body Water For Consumption And Topical Use - The Thyme Lavender Oregano Mint Neem Solution For Acne, Eyelash And Pore Cleansing, Wrinkles, Body Odors, Breath Freshening, Vaginal Douching, Toenail Fungus, Blephritis, Comedones, Wound Care, And More...

This innovation is a unique, natural, CONSUMABLE and topical treatment for many of my body's ailments that has helped me in ways other products never did. The anti-bacterial herbs appear to fight the root cause of the many ailments listed, instead of just masking them. 1. (canceled)2. (canceled)3. A healthcare product comprising a solution derived from the oils or steeping of plant leaves of one or more of the plants thyme , oregano , lavender , mint , and neem for the application to the eyes , eye lashes , and eyelids for the well being of said areas , as a method for drainage of excessive and impacted eye mucus and comedones , wherein the solution is extracted in concentrations derived from steeping about one to one and one half tablespoons of each of the plant's leaves in about one cup of hot water. My Provisional Patent Number is 61/696,912 and this is the explanation of my product for my non-provisional patent application please.This innovation is a unique, natural, CONSUMABLE and topical treatment for many of my body's ailments that has helped me in ways other products never did. The anti-bacterial herbs appear to fight the root cause of the many ailments listed, instead of just masking them.It not only cleansed my pores for acne, but I used it both in and on my eyes, using a spray, although an eyedropper form would work, too. It gently allowed sebaceous debris, often called eye mucous, to painlessly ooze away from eyelash pores and other eye glands like NO other product I have heard of. It appears to unclog the micro eyelid circulation greatly reducing the puffiness we all get with age. It appears to cleanse pores, allowing the skin circulation to improve, healing itself better, reducing wrinkles and even my acne scars.By naturally killing bacteria that cause odors under your arms and orally, it has greatly improved my body odors. Because it is consumable, it works safely all the way down the back of the tongue where scrappers and chemical washes can't reach. ...

System and Method for Natural Hair Loss Prevention Oil

A first composition of essential oils, including 0.3% each of cedarwood, lavender, rosemary, thyme, and peppermint essential oils are thoroughly combined until evenly distributed. A second composition of oils are thoroughly combined, including 9.85% jojoba oil, 9.85% argan oil, and 78.79% grapeseed oil until evenly distributed. The first composition of essential oils is gradually stirred into the second composition of oils, producing a combined oil composition. The scalp is coated with the resulting combined oil composition, followed by massaging the oil composition into the scalp with kneading, squeezing and pinching motions, for 1-3 minutes and subsequently maintaining the oil mixture on the scalp for at least 30 minutes. 1) A composition for treatment and/or prevention of hair loss comprised of:cedarwood essential oil, lavender essential oil, rosemary essential oil, thyme essential oil, peppermint essential oil, jojoba oil, argan oil, and grapeseed oil.2) A composition for treatment and/or prevention of hair loss comprised of:a mixture of essential oils including 0.3-5% cedarwood essential oil, 0.3-5% lavender essential oil, 0.3-5% rosemary essential oil, 0.3-5% thyme essential oil, and 0.3-5% peppermint essential oil, anda base oil mixture of 9.85-16.85% jojoba oil, 9.85-16.85% argan oil, and 68.79-88.79% grapeseed oil.3) The composition of claim 2 , wherein said essential oil mixture is mixed independently until said oils of said mixture are evenly distributed and said base oil mixture is mixed independently until said oils of said base oil mixture are evenly distributed claim 2 , andwherein said essential oils mixture is further mixed gradually into said base oil mixture.4) The composition of claim 2 , wherein the composition is used to coat a user's scalp claim 2 , and said oil composition is kneaded into said scalp with squeezing and pinching motions claim 2 , for 1-3 minutes claim 2 , and allowed to remain on said scalp for at least 30 minutes.5) A ...

UCP-1 Expression Promoter

It is intended to provide a drug, a quasi-drug, a dermatological preparation for external use, or a material to be contained to drugs, quasi-drugs, dermatological preparations for external use, food products, or the like which has an excellent UCP-1 expression-promoting action and promotes conversion of adipose to brown adipose (browning). The present invention provides a UCP-1 expression promoter comprising a PPARγ activator and a Smad3 inhibitor in combination. The present invention also provides a UCP-1 expression promoter comprising a PPARγ activator, a Smad3 inhibitor, and a β3 adrenaline receptor activator or a TGR5 activator in combination. 17.-. (canceled)8. A UCP-1 expression promoter , a promoter of conversion to brown adipose , an energy consumption promoter , a body fat accumulation inhibitor , a preventive or ameliorative agent for obesity , a preventive or ameliorative agent for diabetes mellitus , or a preventive or ameliorative agent for hyperlipidemia , comprising rosiglitazone or pioglitazone as a PPARγ activator , and comprising SIS3 as a Smad3 inhibitor , as active ingredients.9. A method for promoting UCP-1 expression , a method for promoting conversion to brown adipose , a method for promoting energy consumption , a method for inhibiting body fat accumulation , a method for preventing or ameliorating obesity , a method for preventing or ameliorating diabetes mellitus , or a method for preventing or ameliorating hyperlipidemia , comprising ingesting or administering a PPARγ activator and a Smad3 inhibitor in combination , or combining an ingestion or administration of a PPARγ activator with a treatment for inhibiting Smad3.10. (canceled)11. The method according to claim 9 , wherein the PPARγ activator is rosiglitazone or pioglitazone claim 9 , and the Smad3 inhibitor is SIS3.12. The method according to claim 9 , wherein the PPARγ activator is any one or more selected from the group consisting of rosiglitazone claim 9 , pioglitazone claim 9 , ...

ANTIMICROBIAL & ANTIVIRAL COMPOSITION

A method of reducing the number of microorganisms entering the nose and proliferating in the nasal cavity including application of a solution of an antimicrobial, antiviral and antifungal composition to the anterior vestibular region of the nares. The antimicrobial, antiviral and antifungal solution includes ethyl alcohol as an active ingredient. Various embodiments may also include one or more of the following additional ingredients: orange oil; coconut oil; soy oil; emu oil; grapefruit seed extract; glycine soja; simmondsia chinensis (Jojoba); lauric acid; chlorhexidine gluconate; ginger oil; lavender oil; peppermint oil; spearmint oil; aloe oil; and a preservative, such as benzalkonium chloride and vitamin E. 1. A method of reducing the number of microorganisms entering the nose and proliferating in the nasal cavity of a human in need thereof consisting essentially of administering to said human's nose an applicator with a composition consisting essentially of ethanol and a component selected from the group consisting of orange oil , jojoba oil , vitamin E , coconut oil , benzalkonium chloride , lauric acid , chlorhexidine gluconate , ginger oil , lavender oil , peppermint oil , spearmint oil and aloe oil , wherein said number of microorganisms are reduced from entering the nose of the human.2. The method of claim 1 , wherein the applicator is a porous tip for delivering the composition to the human's nose.3. The method of claim 1 , wherein the applicator is a porous tip and a breakable glass ampoule.4. The method of claim 1 , wherein the applicator is a flocked swab.5. The method of claim 1 , wherein the applicator is a cotton swab.6. The method of claim 1 , wherein the applicator is a human finger.7. The method of claim 1 , wherein the applicator is a device structured to hold the composition and apply the composition to the inner surface of the nostril openings of the human's nose. This patent application is a Continuation-In-Part (CIP) of patent application ...

COMPOSITIONS, MEANS AND METHODS FOR A NOVEL INSECT REPELLENT

An insect repellent composition for repelling insects from mammals and vegetation. This composition comprises: dihydroxyacetone (DHA) and a carrier suitable for insect repellent compositions. DHA is the active ingredient and the composition is efficacious in repelling insects. 2. The composition of claim 1 , wherein said mammals are humans or animals.3. The composition of wherein said plants are selected from a group consisting of: tobacco claim 1 , cannabis claim 1 , or organically grown fruits and vegetables for human and animal consumption.4. The composition of claim 1 , wherein the concentration of DHA is in the range of 0.5% to 50% (% wt)5. The composition of claim 1 , wherein said composition is in a form selected from a group consisting of liquid claim 1 , aerosol claim 1 , lotion claim 1 , cream claim 1 , gel claim 1 , foam claim 1 , shampoo claim 1 , solid and any combination thereof.6. The composition of claim 1 , wherein said composition is suitable for topical use.7. The composition of claim 1 , wherein said composition is suitable for spatial use.8. The composition of claim 1 , wherein said insects comprise at least one selected from a group consisting of: mosquitos claim 1 , fleas claim 1 , ants claim 1 , sand flies claim 1 , spiders claim 1 , aphids claim 1 , tobacco moths and head-lice.9. The composition of claim 1 , wherein said composition additionally comprises at least one compound selected from the group consisting of water claim 1 , ethanol claim 1 , emulsifiers claim 1 , preservatives claim 1 , emollients claim 1 , humectants claim 1 , oils claim 1 , surfactants claim 1 , waxes claim 1 , solvents claim 1 , rheology modifiers claim 1 , suspending agents claim 1 , thickeners claim 1 , oils claim 1 , buffering agents claim 1 , chelating agents claim 1 , pH adjusters claim 1 , chelates claim 1 , perfumes claim 1 , brighteners claim 1 , and any combination thereof.10. The composition of claim 1 , further comprising a Maillard reaction inhibitor ...

COMPOSITIONS FOR TREATING INFECTIONS

The present invention relates to compositions and in particular to compositions for treating a skin or mucosal membrane infection. 1. A composition for treating a skin or mucosal membrane infection , the composition comprising:glycerol;at least one surfactant;an alcohol;a terpene or terpenoid compound; anda copper compound.2. The composition of wherein the terpene or terpenoid compound is present in or extracted from an essential oil.3eucalyptus. The composition of wherein said essential oil is obtained from a camphor laurel tree claim 2 , a kapur tree claim 2 , a rosemary plant claim 2 , a mint plant claim 2 , a tree or a tea tree.4. The composition of wherein the terpene or terpenoid compound is camphor.5. The composition of wherein the terpene or terpenoid compound is menthol.6. The composition of wherein the copper compound is selected from the group consisting of copper gluconate claim 1 , copper carbonate claim 1 , copper sulphate claim 1 , copper chloride and copper salicylate.7. The composition of wherein the copper compound comprises copper sulphate.8. The composition of wherein the copper sulphate comprises copper sulphate pentahydrate.9. The composition of wherein the alcohol comprises isopropyl alcohol.10Hypericum perforatum. The composition of further comprising extract.11Calendula officinalis. The composition of further comprising extract.12. The composition of further comprising aloe vera.13. The composition of further comprising vitamin E.14. The composition of wherein the at least one surfactant comprises polyethylene glycol.15. The composition of wherein the at least one surfactant comprises polysorbate 80.16. The composition of wherein the composition comprises substantially no water.17. A method of producing a composition claim 1 , the method comprising:i) combining glycerol and a copper compound to produce a glycerol solution;ii) dissolving a terpene or terpenoid compound in an alcohol to produce an alcohol solution;iii) combining the glycerol ...

NATURAL ESSENTIAL OIL COMPOSITION FOR RELAXING NERVES, SLEEPING WELL AND PREVENTING COLD AND FLU

The present invention provides a natural essential oil composition for relaxing nerves, sleeping well and preventing cold and flu. The composition comprises holy basil, lemongrass, patchouli, old coriander seeds, and tangerine peels, wherein the amount (wt %} of holy basil essential oil is about: 0.1% to about 60%; the amount (wt %) of lemongrass essential oil is about 0.1% to about 55; the amount (wt %) of patchouli essential oil is about 0.1% to about 30%; the amount: (wt %) of essential oil of old coriander seeds is about 0.1 to about 50% and the amount (wt %) of essential oil of tangerine peels is about 0.1% to about 50%. The composition of the present invention further comprises additional essential oils for further use purposes. The composition also comprises carrier oils and solvents for adjusting suit able concentrations of the composition. 1. A natural essential oil composition for relaxing nerves , sleeping well and preventing cold and flu comprising with the amounts of percentage by weight (wt %): holy basil essential oil is about 0.1% to about 60%; lemongrass essential oil is about 0.1% to about 55; patchouli essential oil is about 0.1% to about 30%; essential oil of old coriander seeds is about 0.1 to about 50% and essential oil of tangerine peels is about 0.1% to about 50%.2. The natural essential oil composition of claim 1 , wherein the amount (wt %) of holy basil essential oil is about 0.1% to about 45; the amount (wt %) of lemongrass essential oil is about 0.1% to about 30%; the amount (wt %) of patchouli essential oil is about 0.1% to about 20%; the amount (wt %) of essential oil of old coriander seeds is about 0.1 to about 40% and the amount (wt %) of essential oil of tangerine peels is about 0.1% to about 30%.3. The natural essential oil composition of claim 1 , wherein the amount (wt %) of holy basil essential oil is about 0.1% to about 30%; lemongrass essential oil is about 0.1% to about 25%; patchouli essential oil is about 0.1% to about 15; ...

Use of botanical extracts for improving brain health through enhanced neurogenesis

The present invention relates generally to a method for improving brain health by orally administering a botanical extract composition in an amount effective to promote the neurogenesis process. More particularly, the present invention relates to using spearmint ( Mentha spicata L.) extracts in order to increase the rate of neurogenesis.

PHARMACEUTICAL COMPOSITION CONTAINING CHAMPIGNON EXTRACT AND PEPPERMINT AND METHODS OF USE THEREOF

Provided herein is a pharmaceutical composition and method for reducing intestinal pain and lessening foul-smelling stool and intestinal gas associated with large intestine disorders, comprising orally administering to a subject in need thereof an effective amount of the pharmaceutical composition comprising (i) champignon mushroom extract and (ii) peppermint or spearmint. The composition is formulated to provide controlled and/or delayed release of the active substances for specific efficacy in the large intestine. 1. An oral pharmaceutical composition for reducing intestinal pain and lessening foul-smelling stool and intestinal gas , comprising (i) champignon extract , and (ii) peppermint or spearmint ,wherein the champignon extract is present in the pharmaceutical composition in an amount between about 10% to about 90% by weight of the total composition,wherein the peppermint or spearmint is present in the pharmaceutical composition in an amount between about 10% to about 90% by weight of the total composition.2. The pharmaceutical composition of claim 1 , wherein the champignon extract is present in the pharmaceutical composition in an amount between about 20% to 80% claim 1 , or between about 40% to 60% claim 1 , by weight of the total composition.3. The pharmaceutical composition of claim 1 , wherein the peppermint or spearmint is present in the pharmaceutical composition in an amount between about 20% to 80% claim 1 , or between about 40% to 60% claim 1 , by weight of the total composition.4. The pharmaceutical composition of claim 1 , wherein the champignon extract is provided in liquid or solid forms.5. The pharmaceutical composition of claim 1 , wherein the peppermint or spearmint is provided in forms including powders claim 1 , crystals claim 1 , extracts and oils.6. The pharmaceutical composition of claim 1 , wherein the oral composition is formulated for oral administration to provide controlled release of the active substances for specific local effect ...

INTAKING AN ANTIVIRAL BY INHALATION OR SPRAYING FOR RESPIRATORY TRACT INFECTION

Methods of treatment to inhibit or kill microorganisms (Bacteria or Virus) from infecting a respiratory tract of a human patient and to treat the respiratory tract when already infected by the microorganism are described. The method of treatment may include the step of administering a therapeutically effective dose of a treatment medication comprising eugenol to the patient via a nasal passageway into a respiratory system of the patient. Eugenol is found in clove oil, cinnamon oil, and other essential oils. Any one or more of these eugenol-containing oils may be used. 1. A method , comprising: administering a therapeutically effective dose of a treatment medication in a nasal passageway of the human patient to or kill the viruses, the treatment medication comprising eugenol as an active ingredient such that as the human patient breathes, the eugenol is drawn via a nasal passageway into the respiratory tract of the human patient, wherein the eugenol is an active ingredient', 'wherein a source of the eugenol as the active ingredient is either cinnamon oil or clove oil or a mixture of the cinnamon oil and the clove oil,', 'and wherein the treatment medication comprises at least 20% v/v concentration., 'administering an antiviral treatment by inhalation to kill viruses infecting a respiratory tract of a human patient, comprising24.-. (canceled)5. The method of claim 1 , wherein the step of administering the treatment medication comprising the eugenol comprises administering a combination of any two or more of the clove oil claim 1 , the cinnamon oil claim 1 , and other essential oils.6. (canceled)7. The method of claim 1 , wherein the step of administering the treatment medication comprises administering menthol.8. The method of claim 1 , wherein the step of administering the therapeutically effective dose includes providing the therapeutically effective dose via inhalation after spraying the treatment medication into the nasal passageway of the human patient.9. The ...

SKIN SENSITIZER DELIVERY SYSTEM

A skin-sensitizing formulation is provided in an edible, softgel pill. A person engaged in a sexual activity bites down on the pill, thereby effectuating the oral release of the skin-sensitizing formulation. This allows the skin-sensitizing formulation to be spread to a sexual partner, on any part of the skin or sexual region of the body preferably through oral contact with the partner. The skin-sensitizing substance is spread to the partner directly on the skin or through oral contact or beneath a condom worn by the partner. The skin-sensitizing formulation may include an essential mint oil, analog or derivative, and may further includes an enhancer, rubefacient, counterirritant, anesthetic, k-opioid receptor activator, or TRPM8 activator. Various inactive ingredients are also disclosed. 1. A method of delivering a skin-sensitizing substance , comprising the steps of:providing a skin-sensitizing formulation in an edible, softgel pill;biting down on the pill to effectuate the oral release of the skin-sensitizing formulation; andspreading the skin-sensitizing formulation to a sexual partner through oral contact.2. The method of claim 1 , wherein the skin-sensitizing formulation includes an essential mint oil.3. The method of claim 1 , wherein the skin-sensitizing formulation includes mentha piperita.4. The method of claim 1 , wherein the skin-sensitizing formulation includes menthol.5. The method of claim 1 , wherein the skin-sensitizing formulation includes cinnamon oil.6. The method of claim 1 , wherein the skin-sensitizing f01mulation includes cornmint oil.7. The method of claim 1 , wherein the skin-sensitizing formulation includes eucalyptus oil.8. The method of claim 1 , wherein the skin-sensitizing formulation includes citronella oil.9. The method of claim 1 , wherein the skin-sensitizing formulation includes camphor oil.10. The method of claim 1 , wherein the skin-sensitizing formulation further includes an enhancer claim 1 , rubefacient claim 1 , ...

HAND WRAP INCLUDING EUCALYPTUS OIL

Hand wrap includes oil absorbed in a roll of fabric material. 1. Hand wrap comprising:a roll of fabric material; and{'i': 'eucalyptus', 'oil absorbed in the roll of fabric material.'}2. Hand wrap set forth in claim 1 , wherein the roll of fabric material includes adhesive on one side of the fabric material.3. Hand wrap set forth in claim 2 , wherein the fabric material comprises cotton.4. A method of making hand wrap claim 2 , the method comprising:providing a roll of fabric material;{'i': eucalyptus', 'eucalyptus, 'adding oil to the roll of fabric material so that the oil is absorbed in the fabric material.'}5. The method of making hand wrap set forth in claim 4 , wherein the roll of fabric material includes adhesive on one side of the fabric material.6. The method of making hand wrap set forth in claim 5 , wherein the fabric material comprises cotton. The present disclosure generally relates to wrap including oil for protecting a hand of a user during an activity.Drummers, particularly hand drummers, use tape on their fingers to prevent injuries to their hands during playing. People may wrap their hands or fingers while during other activities to also prevent injuries.In one aspect, hand wrap generally comprises a roll of fabric material; and oil absorbed in the roll of fabric material.Corresponding reference characters indicate corresponding parts throughout the drawings.Referring to of the drawings, one embodiment of a roll of wrap including oil is indicated at reference numeral . The wrap is suitable for being applied to a hand of a user, which may include one or more finger. Preferably, the wrap is applied directly to skin of the user's hand. The wrap may comprise 100% cotton fabric or other suitable fabric or material for absorbing oil. In one example, the wrap comprises adhesive tape having an inner side including an adhesive material suitable for adhering temporarily to skin of the user, and an outer side preferably free from adhesive. The adhesive wrap or ...

Method for Producing Articles of Plant Origin Impregnated With a Liquid Plant Substance

The present invention relates to a method for producing articles impregnated with at least one plant substance from at least one plant, characterized in that it comprises the following steps: 1. A method for producing articles impregnated with at least one plant substance from at least one plant comprising:{'b': 1', '1, 'a) Extraction and/or pressing of at least one plant (V), or at least one part of said plant, thereby producing a liquid plant extract (E) and a solid fibrous residue (RI), then'}{'b': 1', '1, 'b) Separation of said plant extract (E) from said fibrous residue (R), and'}{'b': '1', 'c) Destructuring of said fibrous residue (R),'}{'b': '1', 'd) Production of a fibrous web or of an article made from the fibrous residue (R) obtained in step c), and'}{'b': 1', '1', '1', '1', '2', '2', '2, 'e) Impregnation of said fibrous residue (R) with (i) at least said plant extract (E), which is optionally concentrated, purified, flavored and/or fragranced, with (ii) at least one water-soluble or liposoluble plant substance isolated from said plant extract (E), with (iii) at least one composition comprising at least one optionally concentrated, purified, flavored and/or fragranced water-soluble or liposoluble substance of said plant extract (E), or with (iv) at least one plant extract (E) or at least one composition comprising at least one optionally concentrated, purified, flavored and/or fragranced water-soluble or liposoluble substance of said plant extract (E), resulting from an extraction or pressing of a plant (V) different from said plant (VI).'}2. The method according to claim 1 , wherein steps c) claim 1 , d) and e) may occur in the following order:step c) precedes step d), which in turn precedes step e), orstep c) precedes step e), which precedes step d).3. The method according to claim 1 , wherein:the plant is chosen from among food plants, medicinal plants, aromatic plants and fragranced plants; or whereinthe plant is chosen from among plants containing at ...

FEIJOA FRUIT EXTRACT

The invention relates to a fruit extract. In particular the invention relates to therapeutic uses of a fruit extract, processes for preparing the extract, and compositions comprising the extract. The fruit extract of the invention can be used in the treatment and prevention of rheumatoid arthritis and Type-2 diabetes. 131-. (canceled)33. A method of lowering serum glucose in a patient according to the method of claim 32 , wherein the patient's HbA1c levels are reduced.34. The method of claim 32 , wherein the patient is a human patient with Type-2 diabetes.35feijoa. The method of claim 32 , wherein the fruit extract comprises at least one compound selected from the group consisting of: catechin claim 32 , epicatechin claim 32 , gallocatechin claim 32 , proanthocyanidins claim 32 , flavone claim 32 , ellagic acid claim 32 , pedunculagin claim 32 , and related ellagitannins.36feijoa. The method of claim 32 , wherein the fruit extract comprises two or more compounds selected from the group consisting of: catechin claim 32 , epicatechin claim 32 , gallocatechin claim 32 , proanthocyanidins claim 32 , flavone claim 32 , ellagic acid claim 32 , pedunculagin claim 32 , and related ellagitannins.37feijoa. The method of claim 32 , wherein the fruit extract comprises:i) about 40 to about 70 weight percent oligomeric proanthocyanidin; andii) about 10 to about 20 weight percent ellagitannins, on a dry weight basis.38feijoa. The method of claim 32 , wherein the fruit extract comprises:i) about 40 to about 70 weight percent oligomeric proanthocyanidin; andii) about 10 to about 20 weight percent ellagitannins, on a total polyphenol basis.39feijoa. The method of claim 35 , wherein the fruit extract comprises flavones and/or pedunculagin.40feijoa. The method of claim 36 , wherein the fruit extract comprises flavones and/or pedunculagin.41feijoa. A process for preparing fruit extract claim 36 , including the steps of:{'i': feijoa', 'feijoa', 'feijoa', 'feijoa', 'feijoa, 'i) contacting ...

APPETITE REGULATING DIETARY SUPPLEMENT

A dietary supplement for regulating the appetite of an individual is described. The dietary supplement comprises at least one mechanical satiety regulator, and at least one chemical satiety inducer, and may additionally comprise at least one thermogen, and/or at least one side effect remover. The dietary supplement induces satiety based on a combination of occupying part of the volume of the stomach, inducing sending signals to the brain in respect of satiety. Furthermore the dietary supplement may maintain or increase metabolism and reduce side effects such as the amount of produced flatulence. The dietary supplement may comprise fibre, whey, plant parts from plants e.g. of the genus and plant parts from a species e.g. of the genus 13-. (canceled)4. A dietary supplement comprising:alginate;at least one protein hydrolysate or proteinase inhibitor;at least one vanilloid or vanilloid agonist thermogen; andat least one carminative selected from, camphor, carvacrol, carvone, eugenol, menthol, piperine, thymol, thymyl-acetate, gingerol, and capsaicin.5. The dietary supplement of claim 4 , wherein the concentration of alginate in the gel formed by contact of the supplement with gastric juice is 0.001-5% (w/v).6. The dietary supplement of claim 4 , wherein the alginate is Na-alginate.7. The dietary supplement of claim 4 , wherein the alginate has a molecular weight of 10 claim 4 ,000-600 claim 4 ,000.8. The dietary supplement of claim 4 , wherein the amount of alginate is 125-1000 mg/dose.9. The dietary supplement of claim 4 , wherein the amount of alginate is 0.05-1% (w/v) for liquid formulations.10. The dietary supplement of claim 4 , wherein the concentration of alginate in the gel formed by contact of the supplement with the gastric juice is 0.001-1%.11. The dietary supplement of claim 4 , wherein the amount of each of the at least one protein hydrolysate claim 4 , thermogen claim 4 , and carminative in the dietary supplement which is ready to be ingested is 0.1-100 mg ...

PLANT EXTRACTS FOR IMPROVING COGNITIVE FUNCTION

Extracts of plants of the Lamiaceae family, including the genus, are shown to have a positive impact on overall cognitive health, including improvements in memory, reasoning, attention/concentration, planning, mood, sleep and associated behaviors. 111-. (canceled)12. A method to treat or prevent a decline in cognitive health and/or function in a mammal , comprising administering an efficacious amount of an extract of a plant of the Lamiaceae family , wherein the primary active ingredients are rosmarinic acid and plant polyphenols.13. The method of claim 12 , wherein the mammal is a human or companion animal.14. The method of claim 12 , wherein the plant is selected from the group consisting of basil claim 12 , mint claim 12 , sage claim 12 , savory claim 12 , marjoram claim 12 , oregano claim 12 , thyme claim 12 , lavender claim 12 , spearmint claim 12 , and rosemary.15Mentha. The method of claim 12 , wherein the plant is selected from the genus.16. The method of claim 12 , wherein the extract comprises at least 8% rosmarinic acid by weight.17. The method of claim 12 , wherein the efficacious amount of the extract is between 0.01 and 50 mg/kg/day.18. The method of claim 12 , wherein the efficacious amount is an oral dose in the range of 10 to 900 mg/day.19. The method of claim 12 , wherein the extract is administered chronically.20. The method of claim 19 , wherein the extract is administered at least once daily.21. The method of claim 19 , wherein the extract is administered daily for at least 45 days.22. The method of claim 12 , wherein administration of the extract preserves learning claim 12 , executive function claim 12 , memory claim 12 , mood claim 12 , or sleep.23. The method of claim 12 , wherein administration of the extract improves quality of life.24. The method of claim 12 , wherein administration of the plant extracts protects against stress induced impairment of cognitive function.2550-. (canceled) This application is a continuation application of U.S ...

ANIMAL FEED COMPOSITION

The present invention relates to a feed composition for an animal comprising tea tree oil, wherein the tea tree oil is present in an amount sufficient to reduce bacterial infection in the animal upon ingestion of the feed composition, and to methods for preparing such a composition. 1. A feed composition for an animal comprising tea tree oil , wherein the tea tree oil is present in an amount sufficient to reduce bacterial infection in the animal upon ingestion of the feed composition.2. A feed composition of claim 1 , wherein the composition comprises tea tree oil at an amount of between 2 milligrams and 70 milligrams per kilogram of the composition.3. A feed composition of or claim 1 , further comprising a carrier agent for the tea tree oil.4. A feed composition of claim 3 , wherein the carrier agent is a vegetable oil.5. A feed composition of claim 4 , wherein the vegetable oil is rapeseed oil or canola oil.6. A feed composition of claim 5 , wherein the carrier agent is canola oil.7. A feed composition of claim 6 , wherein the canola oil is present in an amount of 20 ml/kg feed composition.8. A feed composition of any one of the preceding claims claim 6 , further comprising an encapsulating agent for the tea tree oil.9. The feed composition of claim 8 , wherein the encapsulating agent is a cyclodextrin.10. A feed composition of any one of the preceding claims claim 8 , further comprising any one or more of wheat claim 8 , sorghum claim 8 , mung beans claim 8 , tallow claim 8 , canola meal claim 8 , cottonseed meal claim 8 , soybean meal claim 8 , meat and bone meal claim 8 , lysine claim 8 , methionine claim 8 , vitamins claim 8 , trace minerals claim 8 , and antibiotics such as zinc bacitracin.11. A feed composition of any one of the preceding claims claim 8 , wherein ingestion of the feed composition maintains levels of feed consumption claim 8 , body weight claim 8 , efficiency of feed utilisation claim 8 , and gut microbial profile of the animal.1211. A method ...

Beverages with compositions of vinegar

A composite vinegar infused juice blend includes juice blend, including natural fruit and/or vegetable juices; and vinegar composition, including coconut vinegar; and apple cider vinegar. A beetroot based juice blend includes beet juice, carrot juice, apple juice, and water, with equal parts of coconut vinegar and apple cider vinegar. Orange and carrot, mango and sweet potato based juice blends are disclosed. A sweet composite vinegar infused beverage for alleviation or treatment of flu or cold symptoms includes apple cider vinegar, coconut vinegar, water, organic honey, and peppermint extract. Also disclosed is a method for alleviation or treatment of flu or cold symptoms.

SEBUM CONTROL AND ANTI-ACNE COMPOSITION

A method for reducing skin inflammation or reducing sebum production from sebaceous glands is disclosed. The method can include topically applying to skin in need thereof a composition comprising fruit extract and leaf extract, wherein topical application of the composition reduces skin inflammation or sebum production from sebaceous glands. 1Psidium guajavaKunzea ericoides. A method for reducing skin inflammation or reducing sebum production from sebaceous glands , the method comprising topically applying to skin in need thereof a composition comprising fruit extract and leaf extract , wherein topical application of the composition reduces skin inflammation or reduces sebum production from sebaceous glands.2. The method of claim 1 , wherein the skin in need thereof is inflamed skin.3. The method of claim 1 , wherein the skin in need thereof is oily skin.4. The method of claim 3 , wherein the oily skin has a shiny appearance.5Psidium guajavaKunzea ericoides. The method of claim 1 , wherein the fruit extract is a hydroglycolic extract and the leaf extract is an aqueous extract.6. The method of claim 1 , wherein the composition is free of alcohol.7Psidium guajavaPsidium guajava.. The method of claim 1 , wherein the fruit extract does not include the leaf portion of8Psidium guajavaKunzea ericoides. The method of claim 1 , wherein the composition includes 0.01% by weight to 10% by weight of the composition of the fruit extract and 0.01% by weight to 10% by weight of the composition of the leaf extract.9. The method of claim 1 , wherein the composition does not include a UV absorption agent claim 1 , a cyanin claim 1 , aloe vera claim 1 , red clover extract claim 1 , and a silicone containing compound.10. The method of claim 1 , wherein the composition includes a moisturizing agent claim 1 , an antioxidant claim 1 , and an emulsifier.11. The method of claim 1 , wherein the composition is applied to the T-zone of a person's face. This is a continuation application of U.S. ...

METHODS OF DIAGNOSING AND TREATING DRY EYE SYNDROME AND COMPOSITIONS FOR TREATING A HUMAN EYE

In preferred embodiments the invention is directed to ocular compositions for the treatment of dry eye, methods for making such compositions, and suites comprising a plurality of different ocular compositions each having a defined composition. In preferred examples, the invention is directed to compositions comprising at least one natural oil, wherein a first member of the suite of compositions is effective in treating dry in in a first patient having a particular set of symptoms and a different second member of the suite of compositions is effective in treating dry in in a second patient having a different set of symptoms. The invention is also directed to methods of making and using the compositions, and to skin care compositions for use around the eye, such as the upper and lower eyelids having a lubricating, non-irritating base composition comprising at least one natural oil. 1. A method of diagnosing and treating dry eye syndrome comprising:testing the tears of a patient to determine whether the patient has dry eye syndrome and, if so, to determine the characteristics of the dry eye syndrome present in the eye or eyes of the patient,inquiring of the patient as to what degree of sensitivity the patient has that would affect the choice of medication to be used in treating the dry eye syndrome in the eye or eyes of the patient; and{'i': eucalyptus', 'ginseng, "providing, based on the testing and inquiring, a treatment composition for use in the patient's eye to treat the patient's dry eye syndrome, the treatment composition being selected from a series of different compositions comprising water and a natural oil component selected from the group consisting of jojoba oil, avocado oil, tea tree oil, coconut oil, argan, oleuroleupein, cottonseed oil, sunflower oil, maize oil, linseed oil, rapeseed oil, tea tree oil, argan oil, castor oil, soybean oil, caraway oil, rosemary oil, peppermint oil, sunflower oil, oil, bergamot oil, fennel oil, sesame oil, menthol oil, oil ...

Procedure and extraction of a regenerative product for vital organs and a by-product for cutaneous use

A procedure and extraction of a regenerative product and a by-product for cutaneous use consisting of an infusion based on one litre of water boiled at between 95° and 100° centigrade and where, for said quantity of water, the following products must be added, quantified by weight: 1. Procedure and extraction of a regenerative product and by-product for cutaneous use consisting of an infusion of various natural products functioning as a natural antibiotic with regenerative qualities , and especially indicated for the regeneration of vital organs which have degenerated as a consequence of illness and other cellular degenerative processes , characterised essentially because the procedure in the invention consists of an infusion based on one litre of water boiled at between 95° and 100° centigrade and where , for said quantity of water , the following products must be added , quantified by weight:{'i': 'Rosmarinus officinalis', '12 g rosemary ()'}{'i': 'Eucaliptus camaldulensis', '6 g eucalypt ()'}{'i': 'Thymus vulgaris', '6 g thyme ()'}{'i': 'Laurus nobilis', '6 g bayleaf ()'}{'i': 'Tilia', '3 g linden flower (sp.)'}{'i': 'Mentha', '3 g fresh mint (ssp)'}{'i': 'Origanum vulgare', '3 g oregano ()'}the infusion is allowed to macerate for 3 hours, and yields a liquid which is filtered and considered to be natural antibiotic.2. Procedure and extraction of a regenerative product and by-product as set forth in and characterised because claim 1 , if the mixture obtained according to the previous claim is allowed to macerate a minimum of 16 hours claim 1 , a product for cutaneous use with the same antibiotic characteristics is obtained. A patent of invention for a procedure and extraction of a regenerative product and a byproduct for cutaneous use consisting of an infusion of various natural products functioning as a natural antibiotic, immediately effective and with no side-effects, where the residual byproduct of said infusion offers a series of regenerative qualities for ...

Herbal Topical Composition for Muscle and Joint Health, Recovery from Exertion, and for Pain Management

A topical liniment composition that boost muscle relaxation, increase blood flow, and increase cutaneous delivery of herbal extract that contains polyphenols derived from red chili, black pepper, cinnamon, and turmeric includes a quantity of castor-mineral oil-camphor solution, a quantity of oil, a quantity of clove oil, a quantity of peppermint oil, a quantity of frankincense oil, a quantity of herbal extract concentrate solution, and a quantity of castor oil. Aforementioned ingredients are heterogeneously mixed with each other to formulate the topical liniment composition at standard temperature and pressure (STP). Additionally, a quantity of petroleum jelly and a quantity of beeswax can be heterogeneously mixed with the topical liniment composition to formulate the topical balm composition. 1. A topical composition to boost muscle relaxation , increase blood flow , and increase cutaneous delivery of herbal extract that contains polyphenols comprises:a quantity of castor-mineral oil-camphor solution;{'i': 'eucalyptus', 'a quantity of oil;'}a quantity of clove oil;a quantity of peppermint oil;a quantity of frankincense oil;a quantity of herbal extract concentrate solution;a quantity of castor oil; and{'i': 'eucalyptus', 'the quantity of castor-mineral oil-camphor solution, the quantity of oil, the quantity of clove oil, the quantity of peppermint oil, the quantity of frankincense oil, the quantity of herbal extract concentrate solution, and the quantity of castor oil being heterogeneously mixed into a topical liniment composition.'}2. The topical composition to boost muscle relaxation claim 1 , increase blood flow claim 1 , and increase cutaneous delivery of herbal extract that contains polyphenols as claimed in comprises:the quantity of castor-mineral oil-camphor solution being about 8% to 10% (w/v) in the topical liniment composition at standard temperature and pressure (STP).3. The topical composition to boost muscle relaxation claim 2 , increase blood flow ...

Compositions for improving the appearance and/or treating fungal infections of nails, mucus membranes and the integument

Fungal infections and other disease conditions of the integument can be effectively treated with compositions containing ozonizable oils, plant extract oils and antimicrobials, when used in conjunction with solutions containing sodium chlorite. The compositions are particularly useful for treatment of resistant fungal infections.

Plant Extracts for Improving Cognitive Function

Extracts of plants of spearmint () are shown to improve memory, reasoning, attention/concentration and planning. 1. A method to enhance , improve or sustain cognitive health and/or function in mammals , comprising oral administration of an efficacious amount of an extract of a plant of the Lamiaceae family.2. A method of claim 1 , wherein said mammals are selected from the list consisting of humans and companion animals.3. A method of claim 2 , wherein said efficacious amount of said extract is between 0.1 and 100 mg/kg/day.4. A method of claim 1 , wherein said extract comprises rosmarinic acid.5. A method of claim 4 , wherein cognitive health and/or cognitive function refers to memory claim 4 , reasoning claim 4 , attention/concentration and planning.6. A method of claim 1 , wherein said plant is selected from the group consisting of basil claim 1 , mint claim 1 , sage claim 1 , savory claim 1 , marjoram claim 1 , oregano claim 1 , thyme claim 1 , lavender claim 1 , spearmint claim 1 , and rosemary.7. A method of for prevention or treatment of cognitive disorders such as dyslexia claim 4 , aspraxia claim 4 , attention-deficit-hyperactivity disorder claim 4 , attention-deficit disorder autism claim 4 , Alzheimers claim 4 , Parkinsons or stroke claim 4 , or other disorders of executive function.8. A method of for prevention or treatment of cognitive disorders or deficits associated with the normal aging process.9. A method of for maintenance of normal cognitive function under a stressful condition such as disruption of circadian rhythms as occurs in a condition selected from the list consisting of jet lag claim 4 , time zone changes claim 4 , pregnancy claim 4 , medications claim 4 , changes in routine and shift work.10. A method of for maintenance of normal cognitive function under stressful condition such as disruption of circadian rhythms as occurs in a condition selected from the list consisting of time zone changes claim 7 , pregnancy claim 7 , medications claim ...

MELALEUCA QUINQUENERVIA EXTRACTS AND USES OF THE SAME

A extract and its uses are provided. The extract is extracted by a first polar solvent, wherein the first polar solvent is a C3-C6 ethanol. The extract is especially useful for inhibiting the Wnt/β-catenin signaling pathway. 1Melaleuca quinquenerviaMelaleuca quinquenervia. A extract , which is prepared by extracting with a first polar solvent , wherein the first polar solvent is a C3-C6 alcohol.2. The extract as claimed in claim 1 , wherein the first polar solvent comprises butanol.3. The extract as claimed in claim 1 , wherein the first polar solvent is n-butanol.4. The extract as claimed in claim 1 , which is prepared by a method comprising:{'i': 'Melaleuca quinquenervia', '(a) extracting with a second polar solvent to provide a first extraction fluid, wherein the second polar solvent is methanol, water, or a combination thereof;'}(b) partitioning the first extraction fluid with a first polar solvent and collecting the first polar solvent phase; and(c) optionally removing the first polar solvent from the first polar solvent phase.5. The extract as claimed in claim 4 , wherein the step (a) includes:{'i': 'Melaleuca quinquenervia', '(a1) extracting the with methanol to provide a methanol extraction fluid;'}(a2) optionally concentrating the methanol extraction fluid to obtain a concentrated solution; and(a3) adding water into the concentrated solution to obtain the first extraction.6. The extract as claimed in claim 4 , wherein the method for preparing the extract further comprises at least one of the following steps prior to the step (b):(b1′) partitioning the first extraction fluid with a C5-C8 alkane and removing the alkane phase; and(b2′) partitioning the product of step (b1′) with ethyl acetate and removing the ethyl acetate phase.7Melaleuca quinquenervia.. The extract as claimed in claim 1 , which is prepared by extracting a leaf and/or a branch with leaves of8Melaleuca quinquenervia. A pharmaceutical composition for inhibiting Wnt/β-catenin signal transduction ...

Personal Care Composition With Increased Vapor Release

Provided herein is a personal care composition that can exhibit an increased vapor release while maintaining physical stability and texture. The personal care composition can contain from about 35% to about 90% petrolatum, from about 20% to about 50% of an olfactory composition, and a gelling agent mixture. The gelling agent mixture can contain dibutyl lauroyl glutamide, dibutyl ethylhexanoyl glutamide, and a solvent selected from the group consisting of pentylene glycol, propylene glycol, hexylene glycol, 3-methyl-1,3-butanediol, 3-methyl-1,2-butanediol, 1,5-pentanediol, and combinations thereof. The personal care composition can exhibit a vapor release of from about 35 mg to about 300 mg at 8 hours and can have an Instability Index of less than about 0.8. 2. The personal care composition of comprising from about 0.5% to about 10% of the gelling agent mixture claim 1 , by weight of the composition.3. The personal care composition of comprising from about 0.15% to about 1% of the gelling agent claim 2 , by weight of the composition.4. The personal care composition of comprising from about 0.5% to about 10% of the solvent claim 3 , by weight of the composition.5. The personal care composition of comprising from about 1% to about 5% of the solvent claim 4 , by weight of the composition.6. The personal care composition of further comprising less than about 10% of an additional microcrystalline wax claim 1 , by weight of the composition.7. A personal care composition comprising:a. greater than about 35% petrolatum, by weight of the composition;b. an olfactory composition; i. from about 0.15% to about 1% of a gelling agent comprising dibutyl lauroyl glutamide and dibutyl ethylhexanoyl glutamide, by weight of the composition; and', 'ii. a solvent selected from the group consisting of pentylene glycol, propylene glycol, and hexylene glycol, 3-methyl-1,3-butanediol, 3-methyl-1,2-butanediol, 1,5-pentanediol, and combinations thereof;', 'wherein the personal care composition ...

Compositions With Ketogenic Agents, Cannabinoids, Plant- Derived Substances And Micronutrients

A formulation comprising at least one ketogenic agent, at least one cannabinoid, at least one polyphenol, at least one phytonutrient, at least one dietary nutrient, at least one antioxidant, and at least one mineral, and mixtures and combinations thereof utilized for performance, cardiometabolic, cognitive, and women's health and wellness. 1Tribulus,. A formulation consisting of at least one ketogenic agent , at least one cannabinoid , at least one polyphenol , at least one phytonutrient , at least one dietary nutrient , at least one antioxidant , and at least one mineral , and mixtures and combinations thereof , wherein said at least one ketogenic agent is selected from a group consisting of MCT oil , ketone salts/esters , and coconut oil extracts , and mixtures and combinations thereof , said at least one cannabinoid is selected from a group consisting of cannabidiol , tetrahydrocannabinol , mixed cannibinoids , and mixtures and combinations thereof , said at least one polyphenol is selected from a group consisting of bergamot , chokeberry , curcumin , flavonoids , grape seed , olive leaf , spearmint , tea , and mixtures and combinations thereof , said at least one phytonutrient is selected from a group consisting of Damiana , Maca , and mixtures and combinations thereof , said at least one dietary nutrient is selected from a group consisting of Vitamin B3 , Nicotinamide riboside , Vitamin B6 , Vitamin B9 , Vitamin B12 , natural carotenes , lutein , Zeaxanthin , Choline , and L-carnitine , and mixtures and combinations thereof , said at least one antioxidant is selected from a group consisting of Vitamin C , Vitamin E , Alpha lipoic acid , Co-enzyme Q-10 , N-acetyl cysteine , and mixtures and combinations thereof , and said at least one mineral is selected from a group consisting of Chromium , Magnesium , Selenium , and Zinc , and mixtures and combinations thereof.2. (canceled)3. (canceled)4. (canceled)5. (canceled)6. (canceled)7. (canceled)8. (canceled)9. The ...

Aphrodisiac essential oil composition and its application method

An aphrodisiac essential oil composition for directly applying to the body, or for use in a condom or paper towel to achieve the effect of helping increasing sexual desire is prepared by mixing 10˜90 parts of peppermint oil, 10˜90 parts of ginger oil, 10˜90 parts of tea tree oil, 10˜90 parts of black paper oil, and 5˜-90 parts of base oil. An additional 10˜90 parts of cinnamon leaf oil, clary sage oil, clove bud oil, patchouli oil, petitgrain oil, bergamot oil or rose-otto oil, or their combination can be selectively added to the liquid composition.

ENTERIC COATED MULTIPARTICULATE COMPOSITION WITH PROTEINACEOUS SUBCOAT

A multiparticulate composition includes a plurality of individual enteric coated cores containing one or more terpene-based active ingredients and having a continuous proteinaceous subcoating layer covering the individual cores and separating the individual cores from their respective enteric coatings. The continuous proteinaceous subcoating layer prevents volatile terpene-based active ingredients from leaving the core, even when the core is heated during processing or stored for long periods above room temperature. The multiparticulate composition may be used to treat gastrointestinal disorders. 1. A multiparticulate composition comprising a plurality of individual spheroidal enteric coated cores having a diameter of about 0.1 mm to about 3 mm , said individual spheroidal enteric coated cores containing one or more terpene-based active ingredients and having a continuous gelatin film subcoating layer covering the individual cores and separating the individual cores from their respective enteric coatings.2. The multiparticulate composition of claim 1 , wherein the enteric coated cores further comprise a proton pump inhibitor.3. The multiparticulate composition of claim 1 , wherein the enteric coated cores further comprise an anti-inflammatory.4. The multiparticulate composition of claim 1 , wherein the enteric coated cores further comprise an immune suppressor.5. The multiparticulate composition of claim 1 , wherein the one or more terpene-based active ingredients include terpene-containing essential oils and/or L-menthol.6. The multiparticulate composition of claim 1 , wherein the one or more terpene-based active ingredients include peppermint oil and/or L-menthol.7. The multiparticulate composition of claim 1 , wherein the one or more terpene-based active ingredients include L-menthol and caraway oil.8. The multiparticulate composition of claim 1 , wherein the one or more terpene-based active ingredients include L-menthol and peppermint oil.9. The multiparticulate ...

Health Supplement using Guarana Extract

The current invention is a supplement made from a combination of herbs, vitamins, amino acids which in the preferred embodiment is a 100% vegetarian liquid capsules that are ingested allow for rapid absorption. The components of the supplement can be mint or menthol such as peppermint or spearmint, Methyl B12 or B12, Niacin, Guarana, Dimethylaminoethanol, Acetyl-L-carnitine or ALCAR, , one or more teas such as green tea, white tea or black tea, , phosphatidylserine, Tyrosine, L-Alpha Glycerylphosphorylcholine, Citicoline (INN), Huperzine A, and Vinpocetine. 1Ocimum tenuiflorumGinkgo, Rhodiola rosea. A supplement comprising: having two or more of the following components , mint or menthol such as peppermint or spearmint , Methyl B12 , Niacin , Guarana , Dimethylaminoethanol , Acetyl-L-carnitine or ALCAR , , one or more teas such as green tea , white tea or black tea , , phosphatidylserine , Tyrosine , L-Alpha Glycerylphosphorylcholine , Citicoline (INN) , Huperzine A , and Vinpocetine.2. A supplement according to further comprising being in liquid capsules.3. A supplement according to further comprising being ingested.4Ocimum tenuiflorumGinkgo, Rhodiola rosea. A supplement comprising: having two or more of the following components claim 1 , mint or menthol such as peppermint or spearmint claim 1 , B12 claim 1 , Niacin claim 1 , Guarana claim 1 , Dimethylaminoethanol claim 1 , Acetyl-L-carnitine or ALCAR claim 1 , claim 1 , one or more teas such as green tea claim 1 , white tea or black tea claim 1 , claim 1 , phosphatidylserine claim 1 , Tyrosine claim 1 , L-Alpha Glycerylphosphorylcholine claim 1 , Citicoline (INN) claim 1 , Huperzine A claim 1 , and Vinpocetine.5. A supplement according to further comprising being in liquid capsules.6. A supplement according to further comprising being ingested.7Ocimum tenuiflorumGinkgo, Rhodiola rosea. A supplement comprising: having the following components claim 4 , mint or menthol such as peppermint or spearmint claim 4 , ...

Quit Your Itching Cream

The present invention relates to compositions and methods for the treatment of topical skin conditions, comprising of peppermint oil, lavender oil, tea tree oil and a suitable amount of a pharmaceutically acceptable carriers, shea butter and coconut oil. 1. A composition effective for healing dry skin conditions , the composition comprising:(a) shea butter in an amount from 49% to 66% by weight,(b) coconut oil in an amount from 49% to 66% by weight(c) peppermint oil in an amount from 0.0001% to 1% by weight(d) lavender oil in an amount from 0.0001% to 1% by weight(e) tea tree oil in an amount from 0.0001% to 1% by weight.2. A composition effective for healing dry or itchy skin conditions.3. Method of preparation of . Combine shea butter and coconut and heat till fluid. Mix and stir off heat till oils cool to 75 to 85 degrees fahrenheit. While stirring add peppermint oil claim 1 , lavender oil claim 1 , and tea tree oil and stir till combined. The resulting mixture should be pale yellow claim 1 , and creamy to the touch. I was trying to do homework when my mother would not stop complaining about a cold sore on her lip. I became frustrated with her and went into the kitchen and combined various waxes with some essential oils and had her try the mixtures to see if they helped or not. After years of such experiments I came up with this mixture.Shea butter is commonly used for its cosmetic properties as a moisturizer, absorbing without feeling greasy. The properties include being anti-inflammatory and can help treat scars, eczema, burns, rashes, acne, dry skin, blemishes, dark spots, skin discolorations, chapped lips, wrinkles, stretchmarks, and in lessening psoriasis. Shea butter has a natural SPF varying between zero and six.Coconut oil has antioxidant properties that help protect skin from free radical damage cause by sun exposure. Coconut oil is a poor oxidizer and largely shelf stable. Coconut oil is a saturated fat mostly medium chain fatty acids and is a ...

Mint mask and methods of use thereof

Provided are methods and devices useful for treating a respiratory disease or disorder involving the central or upper airways. The methods and devices deliver to central or upper airways of a subject a vapor or aerosol comprising an effective amount of an active ingredient selected from the group consisting of menthol, menthone, neomenthol, isomenthol, and menthofuran. The methods are useful for treating conditions including cough, asthma, bronchitis, and allergic rhinitis.

ANTIFUNGAL COMPOSITIONS AND METHODS OF USING SAME

Anti-fungal compositions, methods of making same, uses thereof, and kits including one or more composition(s). A composition may include optionally, copper sulfate; a copper metal component; and one or more organic antifungal component(s). A copper metal component may be a copper powder. An organic antifungal component may be tea tree oil, jojoba oil, or the like, or a combination thereof. A composition may also include one or more carbon source(s) and/or one or more essential oil(s). A composition may be used to treat fungal infections or treat medical equipment, medical devices, food-handling implements, or the like. 1. A composition comprising:optionally, copper sulfate;a copper metal component; andone or more organic antifungal component(s).2. The composition of claim 1 , wherein the copper metal component is a copper powder.3. The composition of claim 1 , wherein the one or more organic antifungal component(s) is/are chosen from:tea tree oil, jojoba oil, and combinations thereof4. The composition of claim 1 , whereinthe copper sulfate is present at 55 to 68 percent by weight (which may be based on the total weight of the composition); and/orthe copper metal component(s) is/are present at 30 to 44 percent by weight (which may be based on the total weight of the composition) and/orthe organic antifungal component(s) is/are present at 0.5 to 2 percent by weight (which may be based on the total weight of the composition).5. The composition of claim 1 , further comprising one or more of the following:one or more carbon source(s) (e.g., activated charcoal and the like); and/orone or more essential oil(s).6. The composition of claim 1 , wherein the composition comprises:10 grams copper sulfate, 5 grams copper powder, 100 mL jojoba oil, and 50 mL tea tree oil;10 mL tea tree oil, 8 grams copper sulfate, and 5 grams copper powder;10 grams copper sulfate, 6 grams copper powder, 180 mL jojoba oil;10 grams copper sulfate, 5 grams copper powder, 100 mL jojoba oil, 50 mL tea ...

SKIN SENSITIZER DELIVERY SYSTEM

A skin-sensitizing formulation is provided in an edible, softgel pill. A person engaged in a sexual activity bites down on the pill, thereby effectuating the oral release of the skin-sensitizing formulation. This allows the skin-sensitizing formulation to be spread to a sexual partner, on any part of the skin or sexual region of the body preferably through oral contact with the partner. The skin-sensitizing substance is spread to the partner directly on the skin or through oral contact or beneath a condom worn by the partner. The skin-sensitizing formulation may include an essential mint oil, analog or derivative, and may further includes an enhancer, rubefacient, counterirritant, anesthetic, K-Opoid Receptor activator, or TRPMS activator. Various inactive ingredients are also disclosed. 1. A method of delivering a skin-sensitizing substance , comprising the steps of:providing a skin-sensitizing formulation in an edible, softgel pill;biting down on the pill to effectuate the oral release of the skin-sensitizing formulation; andspreading the skin-sensitizing formulation to a sexual partner through oral contact.2. The method of claim 1 , wherein the skin-sensitizing formulation includes an essential mint oil.3. The method of claim 1 , wherein the skin-sensitizing formulation includes mentha piperita.4. The method of claim 1 , wherein the skin-sensitizing formulation includes menthol.5. The method of claim 1 , wherein the skin-sensitizing formulation includes cinnamon oil.6. The method of claim 1 , wherein the skin-sensitizing formulation includes cornmint oil.7. The method of claim 1 , wherein the skin-sensitizing formulation includes eucalyptus oil.8. The method of claim 1 , wherein the skin-sensitizing formulation includes citronella oil.9. The method of claim 1 , wherein the skin-sensitizing formulation includes camphor oil.10. The method of claim 1 , wherein the skin-sensitizing formulation further includes an enhancer claim 1 , rubefacient claim 1 , ...

NATURAL VOLATILE PLANT OILS TO REPEL ARTHROPODS

A composition and method for the controlled release of natural plant oils (essential oils) from a wax matrix to repel insects, arachnids, and other arthropods. 1. A composition that is effective at repelling insects , arachnids and other arthropods by the slow release volatilization of essential oils into a gas phase , comprising:one or more essential oils or their extracts;one or more natural waxes;a support material onto which a matrix of the essential oil and the natural wax is solidified; anda housing or container that retains the essential oil-wax matrix on the support material with sufficient air permeability or diffusivity to allow volatilization, mass transfer and diffusion of the volatile fraction of the essential oil from the essential oil-wax matrix.2Litsea cubeba,. The composition of claim 1 , wherein the one or more essential oils are selected from the group consisting of Bergamot claim 1 , Cajeput claim 1 , Catnip claim 1 , Cedar claim 1 , Cinnamon claim 1 , Citronella claim 1 , Clove claim 1 , Eugenol claim 1 , Eucalyptus claim 1 , Eucalyptus Lemon claim 1 , Eucalyptus Peppermint claim 1 , Garlic claim 1 , Geraniol claim 1 , Geranium claim 1 , Lavender claim 1 , Lemon claim 1 , Lemon Balm claim 1 , Lemongrass claim 1 , d-Limonene claim 1 , Long Leaf Pine claim 1 , Neem claim 1 , Orange claim 1 , Patchouli claim 1 , Peppermint claim 1 , Rosemary claim 1 , Sandalwood claim 1 , Scotch Pine claim 1 , Tea Tree claim 1 , Thyme claim 1 , Virginia Cedarwood claim 1 , and combinations.3Cedrus deodora, Rosmarinus officinalis, Syzgium aromaticum, Cymbopogon winterianus, Mentha piperita, Cinnamomum zeylanicum, Cymbopogon flexuosus,. The composition of claim 1 , wherein the one or more essential oils comprise and Geraniol extract.4Eucalyptus citriodora,Lavandula angustifolia, Cymbopogon winterianus, Mentha piperita, Melaleuca alternifolia, Azadirachta indica,Cymbopogon flexuosus.. The composition of claim 1 , wherein the one or more essential oils comprise d- ...

NUTRITIONAL COMPOSITIONS COMPRISING AN OXIDIZABLE COMPONENT AND WATER-SOLUBLE PLANT EXTRACT

A nutritional composition including an oxidizable component and a water-soluble plant extract is provided. The water-soluble plant extract includes rosmarinic acid and has a total phenolic content, such that a ratio of the total phenolic content to the rosmarinic acid is between about 1.1:1 to about 3.5:1. A method of reducing off-flavors and aromas in a nutritional composition having an oxidizable component is also provided. 1. A nutritional composition comprising:(a) a protein;(b) a carbohydrate;(c) a fat; and(d) a water-soluble plant extract comprising rosmarinic acid and having a total phenolic content;wherein at least one of the protein, the carbohydrate, and the fat includes an oxidizable component; andwherein a ratio of the total phenolic content to the rosmarinic acid ranges from about 1.1:1 to about 3.5:1.2. The nutritional composition of claim 1 , wherein the rosmarinic acid comprises from about 0.0004 wt % to about 0.07 wt % of the nutritional composition.3. The nutritional composition of claim 1 , wherein the total phenolic content is from about 1 mg to about 600 mg of gallic acid equivalents per serving of the nutritional composition claim 1 , wherein a serving is 237 mL.4. The nutritional composition of claim 1 , wherein the water-soluble plant extract comprises a water-soluble rosemary extract.5. The nutritional composition of claim 1 , wherein the water-soluble plant extract comprises a water-soluble spearmint extract.6. The nutritional composition of claim 1 , wherein the protein is about 1 wt % to about 30 wt % of the nutritional composition claim 1 , the carbohydrate is about 5 wt % to about 25 wt % of the nutritional composition claim 1 , and the fat is about 0.5 wt % to about 20 wt % of the nutritional composition.7. The nutritional composition of claim 1 , wherein the protein is selected from the group consisting of whey protein concentrates; whey protein isolates claim 1 , whey protein hydrolysates claim 1 , acid caseins claim 1 , sodium ...

SKIN SALVE FOR TREATING INTERTRIGO

The subject patent application relates to a skin salve which is comprised of (1) petrolatum, (2) beeswax, and (3) peppermint oil, wherein the beeswax is present in said salve at a level of at least 11 weight percent. The present invention also discloses a method for treating irritated skin which comprises topically applying a skin salve to the irritated skin, wherein the skin salve is comprised of (1) petrolatum, (2) beeswax, and (3) peppermint oil, wherein the beeswax is present in said salve at a level of at least 11 weight percent. 1. A method for treating irritated skin which comprised topically applying a skin salve to the irritated skin , wherein the skin salve is comprised of (1) petrolatum , (2) from 11 weight percent to 60 weight percent beeswax , and (3) from 0.25 weight percent to 10 weight percent peppermint oil , wherein the skin salve has a viscosity at 25° C. which is within the range of 11 Pa·s to 15 Pa·s at a shear rate of 35 l/s.2. The method as specified in wherein the skin salve is allowed to remain in contact with the irritated skin for a period of at least 4 hours.3. The method as specified in wherein the skin salve is allowed to remain in contact with the irritated skin for a period of at least 8 hours.4. The method as specified in wherein the skin salve is allowed to remain in contact with the irritated skin for a period of at least 10 hours.5. The method as specified in wherein the skin salve is applied to the irritated skin on multiple occasions.6. A method for treating intertrigo on the underside of a female breasts which comprises (1) soaking the female breasts in warm water claim 1 , (2) drying the female breasts claim 1 , (3) applying a skin salve to the underside of the dried female breasts claim 1 , wherein the skin salve is comprised of (i) petrolatum claim 1 , (ii) from 11 weight percent to 60 weight percent beeswax claim 1 , and (iii) from 0.25 weight percent to 10 weight percent peppermint oil claim 1 , wherein the skin salve has ...

Drug Combinations and Uses in Treating a Coughing Condition

The present specification discloses compositions comprising a plurality of therapeutic compound having antitussive activity and methods and uses for treating a coughing condition with such compositions. 1. A liquid composition comprising Theobromine , peppermint oil , and an ascorbic acid.2. The liquid composition according to claim 1 , wherein the composition further comprises a sweetening agent.3. The liquid composition according to claim 1 , wherein the composition further a physiological substance.4. The liquid composition according to claim 1 , wherein the composition further an antioxidant.5. The liquid composition according to claim 1 , wherein the composition comprises about 0.5 mg/mL to about 10 mg/mL of Theobromine and about 0.1 mg/mL to about 7.5 mg/mL of peppermint oil.6. The liquid composition according to claim 5 , wherein the composition comprises about 0.5 mg/mL to about 6 mg/mL of Theobromine and about 0.1 mg/mL to about 5 mg/mL of peppermint oil.7. The liquid composition according to claim 6 , wherein the composition comprises about 1 mg/mL to about 3 mg/mL of Theobromine and about 0.5 mg/mL to about 3 mg/mL of peppermint oil.8. The liquid composition according to claim 7 , wherein the composition comprises about 2 mg/mL of Theobromine and about 1.0 mg/mL of peppermint oil.9. A method of treating cough claim 1 , the method comprising the step of administering a therapeutically-effective amount of the liquid composition of .10. The method according to claim 9 , wherein the composition further comprises a sweetening agent.11. The method according to claim 9 , wherein the composition further a physiological substance.12. The method according to claim 9 , wherein the composition further an antioxidant.13. The method according to claim 9 , wherein the composition comprises about 0.5 mg/mL to about 10 mg/mL of Theobromine and about 0.1 mg/mL to about 7.5 mg/mL of peppermint oil.14. The method according to claim 13 , wherein the composition comprises ...

Enteric Coated Multiparticulate Controlled Release Peppermint Oil Composition and Related Methods

A multiparticulate composition is formed from a plurality of individual cores including a hydrophobic phase containing peppermint oil dispersed in a microcrystalline cellulose-based gel and a hydrophilic phase containing a hydrogel. An enteric coating is over the individual cores. The multiparticulate composition can be used to treat gastrointestinal disorders. 1. A composition providing controlled-release of peppermint oil , the composition comprising a plurality of enteric coated solid spheroidal cores , the cores comprising peppermint oil , microcrystalline cellulose , and a hydrophilic binder , the cores having a diameter of about 0.1 to about 3 mm.2. The composition of claim 1 , wherein the cores are spheroidal and have a diameter of about 1 mm to about 2.5 mm.3. The composition of claim 1 , wherein the cores are spheroidal and have a diameter of is less than about 1.4 mm.4. The composition of claim 1 , wherein the cores release no more than about 20% of the peppermint oil within about two hours of being placed in a 0.1 N HCl solution and claim 1 , subsequently no less than about 85% of the peppermint oil within about eight hours of being placed in a substantially neutral pH environment.5. The composition of claim 1 , wherein the cores release no more than about 20% of the peppermint oil within about two hours of being placed in a 0.1 N HCl solution and claim 1 , subsequently no less than about 60% of the peppermint oil within about two hours of being placed in a substantially neutral pH environment.6. The composition of claim 1 , wherein the peppermint oil in the cores is present in combination with at least one terpene-based substance selected from L-menthol claim 1 , caraway oil claim 1 , orange oil claim 1 , ginger oil claim 1 , turmeric oil claim 1 , curcumin oil claim 1 , and fennel oil.7. The composition of claim 1 , wherein the peppermint oil in the cores is present in combination with more L-menthol than provided by the peppermint oil itself.8. The ...

Methods of Clinical Treatment of a Mammal Experiencing a Viral Respiratory Infection and/or Inflammation Resulting from a Viral Respiratory Infection Using Botanical Infusion

As described herein, the invention includes methods for the treatment of a respiratory infection of a coronavirus and/or respiratory inflammation resulting from a coronavirus infection in a mammalian individual. The method includes administering to the individual an effective amount of a water-based infusion prepared by steeping the leaves of eucalyptus globulus Labill, the root of astragalus membranaceus, and the leaves of mentha X piperita in a liquid for a time duration and administering to the patient an effective amount of the infusion. Such administration may be via an oral or an inhalable route. Also included are methods of making a composition for use in the clinical treatment of a COVID-19 (SARS-CoV-2) infection and/or to treat inflammation resulting from an is COVID-19 (SARS-CoV-2) infection comprising steeping in a liquid leaves of eucalyptus globulus Labill, roots of astragalus membranaceus, and the leaves of mentha X piperita, for a duration of time. 1. A method for the treatment of a respiratory infection of a coronavirus and/or respiratory inflammation resulting from a coronavirus infection in a mammalian individual comprising administering to the individual an effective amount of a water-based infusion prepared by steeping the leaves of eucalyptus globulus Labill , the root of astragalus membranaceus , and the leaves of mentha X piperita in a liquid for a time duration and orally administering to the patient an effective amount of the infusion.2. The method of wherein the liquid is 100% water.3. The method of wherein the liquid is a mixture of water and an alcohol.4. The method of wherein the leaves or root of each of the eucalyptus globulus Labill claim 1 , astragalus membranaceus claim 1 , and mentha X piperita are independently in a dried form.5. The method of wherein the leaves or root of each of the eucalyptus globulus Labill claim 1 , astragalus membranaceus claim 1 , and mentha X piperita are independently in a form selected from powdered ...

COMPOSITIONS AND METHODS FOR ACUTLEY RAISING NITRIC OXIDE LEVELS

Disclosed herein are compositions and methods for acutely raising nitric oxide levels in a subject. In one example, the composition can include, an effective amount of a NOS dependent source of nitric oxide; an effective amount of a NOS independent source of nitric oxide; and an effective amount of a myeloperoxidase inhibitor; wherein the composition acutely raises nitric oxide levels in a subject above a level provided by the available sources of nitric oxide in the subject prior to administration of the composition. Further presented is a method of treating a subject for a condition or disorder that is response to nitric oxide therapy, including: acutely raising nitric oxide levels in a subject by simultaneously increasing biosynthesis of nitric oxide, increasing nitrate/nitrite levels, and inhibiting meyloperoxidase activity. 1. A composition for acutely raising nitric oxide levels in a subject , comprising:an effective amount of a NOS dependent source of nitric oxide;an effective amount of a NOS independent source of nitric oxide; andan effective amount of a myeloperoxidase inhibitor;wherein the composition acutely raises nitric oxide levels in a subject above a level provided by the available sources of nitric oxide in the subject prior to administration of the composition.2. The composition of claim 1 , wherein the level of nitric oxide in the subject following administration of the composition is greater than an amount provided by an equivalent amount of any one of the NOS dependent source of nitric oxide claim 1 , the NOS independent source of nitric oxide claim 1 , or the myeloperoxidase inhibitor.3. The composition of claim 1 , wherein the NOS dependent source of nitric oxide comprises from about 1 wt % to about 80 wt % of the composition.4. The composition of claim 1 , wherein the NOS dependent source of nitric oxide comprises a member selected from the group consisting of L-arginine claim 1 , L-citrulline claim 1 , ornithine claim 1 , or a combination ...

METHOD AND COMPOSITION FOR TOPICAL PAIN RELIEF

A method, product by process, and composition for aiding in pain relief. The user adds hot water to methylsulfonylmethane (MSM), then stirs the resulting mixture until the MSM is dissolved. The user then adds room temperature water, bromelain, aloe vera juice, and papain to the batch, and continues to stir. Coconut oil and palm kernel oil are stirred in, along with a sweet oil mixture. The sweet oil mixture is a mixture of natural, unconcentrated, oils such as lemon oil, sweet orange oil, arnica, sweet almond oil, peppermint oil, grape seed oil, comfrey oil, eucalyptus oil, grapefruit seed extract, and fragrance oils such as mango and kiwi. Finally, xanthan gum is stirred into the mixture, resulting in a batch of desired composition, which can be used topically for pain relief. 1. A method of preparing a composition comprising:adding first water to methylsulfonylmethane, resulting in a first mixture;adding second water, bromelain, aloe vera juice, and papain to the first mixture, resulting in a second mixture;adding coconut oil and palm kernel oil to the second mixture, resulting in a third mixture;combining a plurality of sweet oils, resulting in a sweet oil mixture;adding the sweet oil mixture to the third mixture, resulting in a fourth mixture;adding xanthan gum to the fourth mixture, resulting in the composition.2. The method of claim 1 , wherein the first water is at a temperature between 135-150° F. claim 1 , inclusive.3. The method of claim 2 , wherein the second water is at a room temperature.4. The method of claim 1 , further comprising:stirring the first mixture and the second mixture at a lower rate; andstirring the third mixture, the fourth mixture, and the composition at a higher rate, wherein the lower rate and higher rate are with respect to one another.5. The method of claim 4 , wherein the lower rate is 1 claim 4 ,500 rpm and the higher rate is 12 claim 4 ,000 rpm.6. The method of claim 1 , wherein the plurality of sweet oils comprises lemon oil ...

COMPOSITION FOR USE IN AN INHALATION DEVICE AND INHALATION DEVICE USEFUL THEREFOR

The present invention pertains to the field of the prophylaxis and therapy of diseases, preferably by means of the application of essential oils or oil mixtures by inhalation. The invention relates, in particular, to an especially designed inhalation stick and to a composition suitable therefor based on essential oils. 115-. (canceled)16. An inhalation stick for inhalation through the nose ,wherein the inhalation stick comprises an elongated housing sleeve and a rod shaped storage means for storing at least one essential oil, wherein the housing sleeve comprises an inner receptacle space for receiving the storage means,wherein at least one fixing projection, which protrudes in particular in the radial direction into the receptacle space, is provided in the interior in the housing sleeve for the friction-locked fixing of the storage means in the housing sleeve,wherein a plug sleeve, which is insertable into the rear sleeve region, is provided for closure of the housing sleeve and wherein fixing projections, which are provided with terminal intake stops and are formed as ribs, are provided in the plug sleeve for the terminal fixing of the storage means.17. The inhalation stick according to claim 16 ,wherein a plurality of fixing projections are provided in the housing sleeve.18. The inhalation stick according to claim 16 ,wherein the storage means exclusively presses against the fixing projections, without pressing against the remaining inner wall regions of the receptacle space.19. The inhalation stick according to claim 16 ,wherein the storage means is arranged centered in the receptacle space by fixing projections, which are distributed uniformly around the circumference and are formed as elongated ribs.20. The inhalation stick according to claim 16 ,wherein the housing sleeve has a front sleeve region formed as an inhalation region and a rear sleeve region formed as a handle region.21. The inhalation stick according to claim 16 ,wherein at least one nose opening, ...

Particle containing at least a volatile substance and process for its preparation

The invention is directed to a particle containing at least a volatile substance comprising a core comprising at least one matrix material and the at least one volatile substance and at least one coating layer, whereby a first coating layer is a non-confluent layer comprising at least a carrier material, whereby optionally the non-confluent layer contains at least one hydrophobic substance, and optionally the particle is surrounded by at least one confluent layer and/or further non-confluent layer(s) as well as to a process for producing the same.

ANALGESIC COMPOSITIONS AND METHODS OF USE

The invention relates to the fields of pharmacology and medicine, and provides anesthetic compositions and methods for the treatment of pain using compositions comprising Tea tree oil and one or more additional agent. The invention relates to analgesic compositions for the treatment of pain associated with a variety of disorders or conditions, particularly oral or dental disorders or conditions such as alveolar osteitis or dental caries. 1. An anesthetic composition comprising a combination of Tea tree oil and one or more additional agent , comprising 0.1 ml to 1.0 ml of Tea tree oil.2. The anesthetic composition of claim 1 , wherein the ratio of Tea tree oil to the one or more additional agent is a 6:1 part by weight relationship.3. The composition of claim 1 , wherein the additional agent is selected from the group consisting of Ginger root oil claim 1 , Peppermint leaf oil claim 1 , Chamomile flower oil claim 1 , Olive leaf extract oil claim 1 , Grape seed oil claim 1 , Clove oil claim 1 , a flavoring syrup claim 1 , and an additional anesthetic agent.4. The composition of claim 3 , wherein the flavoring syrup is Cherry syrup.5. The composition of claim 3 , wherein the additional anesthetic agent is a topical anesthetic agent.6. The composition of claim 5 , wherein the topical anesthetic agent is selected from the group consisting of benzocaine claim 5 , lidocaine claim 5 , and tetracaine.7. The composition of claim 5 , wherein the topical anesthetic is benzocaine.8. The composition of claim 2 , comprising the Tea tree oil claim 2 , Ginger root oil claim 2 , Peppermint leaf oil claim 2 , Chamomile flower oil claim 2 , Olive leaf extract oil claim 2 , Grape seed oil claim 2 , Clove oil claim 2 , the flavoring syrup claim 2 , and an additional anesthetic agent in a ratio of about a 6:1:1:1:1:1:1:1:1 part by weight relationship.9. The composition of claim 1 , wherein the composition further comprises zinc oxide and/or water soluble poly(ethyleneglycol) (PEG).10. The ...

COMPOSITIONS FOR DELIVERY OF ORAL COMFORT SENSATIONS

TREK-1 agonist comprising composition that reduces perceived oral discomfort sensation and a method for measuring TREK-1 potassium channel activation. 1. A personal care composition comprising a TREK-1 agonist.2. The personal care composition of wherein the personal care composition is an oral care composition.3. The personal care composition of claim 2 , wherein the oral care composition is an oral care strip comprising a strip of material and an oral care substance.4. The personal care composition of claim 3 , wherein the TREK-1 agonist is present in the oral care substance.5. The personal care composition of claim 4 , wherein the oral care substance comprises at least one of oxalic acid claim 4 , potassium salts of oxalic acid claim 4 , hydrogen peroxide claim 4 , carbamide peroxide claim 4 , sodium fluoride claim 4 , sodium monofluorophosphate claim 4 , pyrophosphate claim 4 , chlorhexidine claim 4 , polyphosphate claim 4 , triclosan claim 4 , or enzymes.6. The personal care composition of claim 1 , wherein the TREK-1 agonist is present in an amount of from about 0.01% to about 0.8% based on the total weight of the personal care composition.7. The personal care composition of claim 1 , wherein the TREK-1 agonist is at least one or more of L-carvone; gamma-dodecalactone; 4-ethyloctanoic acid; 2-Isopropyl-5-methyl-2-hexenal; 4-Methylnonanoic acid; trans-2-Decenal; Tributyl Phosphate; Dioctyl Adipate; Bis(2-ethyl hexyl)Phosphate; Spearmint oil; Synthetic Cassia; Methyl salicylate; Wintergreen oil; Thymol; or Eugenol.8. The personal care composition of claim 7 , wherein the personal care composition comprises a potassium salt.9. The personal care composition of claim 8 , wherein the potassium salt is at least one of potassium oxalate or potassium nitrate.10. The personal care composition of claim 1 , comprising a TREK-1 antagonist.11. The personal care composition of claim 10 , wherein the TREK-1 antagonist is at least one of tributyl phosphate; Bis(2-ethyl hexyl) ...

Mixture of Specific Essential Oils for the treatment of arthritis

The presept invention provides methods for the treatment of arthritis using a mixture of specific essential oils in a certain formula as a topical treatment. The essential oils used are Orange Oil () and Peppermint Oil (). These oils are categorised as “Active” and can be mixed with any “Non-Active” or “Carrier” oils, to apply topically to the effected area. 1Citrus SinensisMentha Piperita. An effective and temporary relief of the symptoms and effects of arthritis consisting of a mixture of Orange Oil () and Peppermint Oil () along with any other vegetable based Oil2. The arthritic relief mixture of wherein the concentration of Orange Oil is between 25%-45% of volume3. The arthritic relief mixture of wherein the concentration of Peppermint Oil is between 10%-20% of volume4. The arthritic relief mixture of wherein the concentration of any other vegetable oil is between 40%-70% of5. The method of where the administration is topical6. The method of where the administration is injected7. The method of where the application is on a human being8. The method of where the application is on an animal9. The method of where the use is only Orange Oil10. The method of and where Orange Oil is mixed with Peppermint Oil11cocas nucifera. The method of where an extract from the following vegetable oil is used claim 1 , such as Coconut oil or otherwise known as claim 1 , Olive Oil or otherwise known as Olea Europaea claim 1 , Canola Oil claim 1 , Corn Oil claim 1 , Cotton seed Oil claim 1 , Flaxseed Oil claim 1 , Linseed Oil claim 1 , Palm Oil claim 1 , Peanut Oil claim 1 , Safflower Oil claim 1 , Soybean Oil or Sunflower Oil. Arthritis is a major disease effecting the bone or joint. This consists of inflammation, loss of bone, inflamed joints, wear and tear and eventual loss of cartilege or tissue. As a result the human body suffers pain and stiffness and loss of motion.Arthritis usually affects the elderly as a result of continuous wear and tear.The most common affected areas in ...

Enteric Coated Multiparticulate Controlled Release Peppermint Oil Composition and Related Methods

A multiparticulate composition is formed from a plurality of individual cores including a hydrophobic phase containing peppermint oil dispersed in a microcrystalline cellulose-based gel and a hydrophilic phase containing a hydrogel. An enteric coating is over the individual cores. The multiparticulate composition can be used to treat gastrointestinal disorders. 1. A composition that provides a controlled-release of peppermint oil in a subject's intestines , the composition comprising: (a) a solid spheroidal core including microcrystalline cellulose, methyl cellulose, and 10 mg to 140 mg peppermint oil, the peppermint oil being dispersed within a gel formed between the microcrystalline cellulose and peppermint oil;', '(b) a gelatin coating adhered to the solid spheroidal core, the gelatin coating predominantly including a dried gelatin film; and', "(c) a polymeric enteric coating that substantially prevents the peppermint oil from releasing into the subject's intestines, the polymeric enteric coating being over the gelatin coating."], 'an orally ingestible multiparticulate pharmaceutical dosage form including a plurality of individual spheroidal particulates having a diameter of 1 mm to 2.5 mm, the individual spheroidal particulates comprising, individually2. The composition of claim 1 , wherein the individual spheroidal particulates have a diameter of less than about 1.4 mm.3. The composition of claim 1 , wherein the individual spheroidal particulates release no more than about 20% of the peppermint oil within about two hours of being placed in a 0.1 N HCl solution and claim 1 , subsequently no less than about 85% of the peppermint oil within about eight hours of being placed in a substantially neutral pH environment.4. The composition of claim 1 , wherein the individual spheroidal particulates release no more than about 20% of the peppermint oil within about two hours of being placed in a 0.1 N HCl solution and claim 1 , subsequently no less than about 60% of the ...

Method of Marking Film-Like Dosage Forms

Disclosed is a method for marking film-type dosage forms, comprising at least the positioning of a film-type dosage form between two layers of a scalable packaging material, the sectional heat-scaling of the two layers of the scalable packaging material so as to obtain an edge-sealed bag containing the film-type dosage form, and the blind-embossing of the film-type dosage form contained in the edge-sealed bag through at least one of the two layers of packaging material of the edge-sealed bag. 1. A method of marking film-type dosage forms including at least the following steps:placing a film-type dosage form between two layers of sealable packaging material;sectionally heat sealing the two layers of the sealable packaging material to form an edge-sealed bag containing the film-type dosage form; andblind embossing the film-type dosage form contained in the edge-sealed bag through at least one of the two packaging material layers of the edge-sealed bag.2. The method as claimed in ;wherein the two layers of sealable packaging material are provided in the form of a strip-shaped rolled product.3. The method as claimed in ;wherein the blind embossing is effected with a pressure of at least 2 bar and not more than 10 bar.4. The method as claimed in ;wherein the embossing tools used for the blind embossing are cooled.5. The method as claimed in claim 1 ,wherein the blind embossing is flat embossing or relief embossing.6. The method as claimed in ;wherein the blind embossing is effected with at least one embossing tool selected from the group consisting of embossing stamps, embossing wheels, and embossing rollers.7. The method as claimed in ;wherein the blind embossing forms at least one mark on the film-type dosage form selected from the group consisting of numbers, letters, symbols, shapes, and combinations thereof.8. The method as claimed in claim 1 , further comprising:sectionally heat sealing the two layers of the sealable packaging material to form a second edge-sealed ...